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Abstract
A mass of cells that grow without normal bounds is termed a benign tumour if
it does not invade locally into the tissue and malignant when it invades into its
surrounding tissue. Benign tumours are often harmless unless the pressure they
exhibit onto the tissue surrounding it causes trouble to the functioning of the
human body as is often the case in brain tumours (gliomas) or other vital organs
of the body. It is malignant tumours that are deemed to be made up of cancer
cells and it is this process of invasion that defines them and will be studied in
this thesis.
We do this by considering two scales of interest in cancer cell invasion. In Chap-
ters 4 and 5, we focus on tissue scale dynamics of a cancerous mass and the
processes by which the cancerous mass is able to invade the surrounding tissue.
Correspondingly, we focus on a continuum, deterministic approach to protease-
dependent invasion where matrix degrading enzymes cleave collagen fibrils and
other ECM components. Specifically, in Chapter 4 we formulate a PDE model
of cancer cell invasion primarily through haptotaxis as the result of degradation
of tissue from the proteolytic activity of the membrane bound MT1-MMP pro-
tein and the soluble MMP-2 protein in addition to the complexes formed, and
consequences thereof, from interactions they have with one another and their en-
dogenous inhibitor TIMP-2. In Chapter 5 we develop the PDE model of cancer
ix
cell invasion to incorporate additional dynamics of the tissue and how these may
hamper cancer cell invasion and tissue degradation. Further, we investigate how
the tissue may be reconditioned by MT1-MMP proteins to allow for additional
cancer cell movement and tissue degradation.In Chapter 6, we consider how small
protrusions from the cell termed invadopodia can affect the production of MMP-2
proteins and the focussing of ECM degradation, which has the consequence of
allowing cancer cells to overcome barriers in the extracellular matrix.
1Chapter 1
Introduction
Cancer cell invasion is of particular significance when considering the development
of the disease as it is intrinsically linked with metastasis, which is responsible for
approximately 90% of cancer deaths. Matrix degrading proteins are of critical
importance when it comes to the degradation of healthy tissue that allows for
the growth and spread of cancer cells and these proteins and their inhibitors can
have non-linear dynamics (cf. the activation system for matrix metalloproteinase
2; MMP-2). This motivates the use of mathematical models to fully understand
the complex process of invasion.
In Chapter 2, we outline some of the biological dynamics that are important in
cancer cell invasion in order to provide evidence for the incorporation of these
biological motivations in the proposed mathematical models. In Chapter 3, we
provide a summary of the historical and current mathematical models of cancer
invasion which form the foundations on which the current work stands.
We have developed a continuum (PDE) model of cancer cell invasion incorpo-
rating the activation system for matrix metalloproteinase 2 in Chapter 4 and
2provided details on how it is formulated and parameterised. We explore the
significance of the level of tissue inhibitor of metalloproteinases 2 (TIMP2) on
cancer cell invasion and identify the individual roles that MMP-2 and the mem-
brane bound-1 matrix metalloproteinases (MT1-MMP) play.
The surrounding environment of the cancer cells plays a significant role in cancer
cell invasion and so while we have considered a relatively simple formulation of
the environment in Chapter 4, in Chapter 5 we proceed to expand upon the
proposed model with the incorporation of additional roles of the environment,
including pore size, etc., on cancer cell invasion. Additionally we explore how the
significance of MT1-MMP changes when the additional dynamics that are solely
the domain of MT1-MMP are considered.
In Chapter 6, we investigate how small protrusions of a single cell (invadopodia)
into the surrounding tissue may cause additional and significant changes as to
how cancer cell invasion proceeds. The inclusion of shuttling of MT1-MMP to
invadopodia is investigated with relation to the activations system of MMP-2 as
well as how this may affect the lifespan of invadopodia. This is modelled through
a stochastic approach where only a small spatial scale, and therefore small number
of proteins are considered.
A discussion of the proposed works focusing on results obtained from the mod-
elling efforts is included in Chapter 7 before a discussion of the proposed works
including both their usefulness as prognostic tools and the exploration of as-of-yet
not fully defined biological systems The presented work is then brought to an end
with the offering of potential avenues of continued research.
3Chapter 2
The Biology of Cancer Invasion
Cancer is a classification of over 200 diseases which all arise progressively from
an alteration in a single cell’s genetic structure. A cancer cell is defined as one
which proliferates beyond the bounds a normal cell experiences and one which
invades and replaces cells of neighbouring areas. Alberts et al. (2008) describes
the body as a “society or ecosystem where dynamics such as self-preservation are
put below that of self-sacrifice”, a statement which we will support by describing
the functions of healthy cells, before continuing on to show how cancerous cells
demonstrate behaviour that violates this description.
Cancers gain their classification from either the location from which they arise
(brain cancer, breast cancer, cervical cancer, etc.) or from their tissue type
(blastomas-embryonic tissues, carcinomas-epithelial tissue, leukemias-blood pro-
duction site, lymphomas-lymphatic tissue, myeloma-bone marrow, sarcomas-connective
tissue etc.). Carcinomas are the most common classification accounting for ap-
proximately 90% of all cancers.
Cancer grading measures the abnormality of the cancer cells from biopsies and
4generally follows the three grades (some cancers and countries have varying grad-
ing systems) of: (i) the cancer cells appear normal (differentiated) and grow
slowly, (ii) the cancer cells are abnormal (poorly differentiated) and grow quickly
and (iii) the cancer cells are very abnormal (undifferentiated) and grow very
quickly.
Cancer staging measures the extent of the disease’s spread. There are a number
of systems to measure this. However we present only one numerical system here:
stage 0 (cancer limited to surface cells), stage 1 (cancer exhibiting growth but
remains at original site), stage 2 (local invasion of cancer cells), stage 3 (further
reaching invasion of cancer cells) and stage 4 (metastasis).
2.1 Biology of Healthy Cells and Tissue
In order to understand the processes that cancerous cells perform, a basic un-
derstanding of the processes a healthy cell may undergo is required. This also
applies when we look at how a mass of cancer cells interact with their surrounding
healthy stroma and so here we provide a minimal overview of both.
A cell (discovered by Hooke in 1665 (Hooke, 1665)) is the biological entity which
all living organisms are made up of, whether single cell organisms or multicellular
(humans contain approximately 3.72× 1013 cells (Bianconi et al., 2013)). A cell
is the fundamental building block of life as nothing smaller than it can perform
all of the following: contain hereditary data (DNA), obtain resources/nutrients
from its environment, convert these resources/nutrients to energy, use this energy
to multiply by creating a duplicate of itself.
5Figure 2.1: The four stages of G1, S, G2 and M that a cell cycles through are illus-
trated where G0 represents a removal, however temporary, from this cycle. ©Alberts
et al. (2008), reproduced by permission of Garland Science/Taylor & Francis LLC.
The communication between cells is extensive and is done by a myriad of extra-
cellular signals. A cell needs to receive multiple signals in order to survive. De-
priving a cell of one or more of these signals can initiate cell death. If a cell
receives the required signals to survive, it can then either divide or differentiate
if appropriate additional signals are received. Despite receiving the same signals,
different cells may react in different ways to the same signals depending on their
ability to interpret these signals through receptor proteins.
The cell-cycle, as outlined in Figure 2.1, describes the functional stages a cell
goes through in order to continually divide and is defined by four stages. The
interphase is the period that contains the first three of these stages: G1 phase
(cell grows), S phase (DNA synthesis resulting in a doubling of each chromosome),
G2 phase (the cell continues to grow). The interphase is followed by the M phase
(mitosis-nuclear division and cytokinesis-cell division). G0 phase is the state a
cell goes into when it is no longer taking part in this cell-cycle where the cell is
considered to be resting.
6Healthy tissue constructs made up of the extracellular matrix (ECM) are rigid
structures of cellular components that are constantly undergoing remodelling.
The rate at which this remodelling takes place is boosted during development and
wound repair. What determines the remodelling of ECM can be one of the follow-
ing factors: cell-surface receptors, matrix degrading proteins and stress/tension.
Comprehensive overviews for the structure of the ECM are provided in Vakonakis
and Campbell (2007), Daley et al. (2008) and Hynes (2009).
In order for cellular structures to be formed, there must a way of linking cells
together. This is done either directly with cell-cell bonds of either homophilic or
heterophilic type, or by the use of a medium such as the rigid ECM structure,
which multiple cells can connect to. Integrins are transmembrane/cell-surface
receptors that allow for cell-cell or cell-ECM bonds to form. This gives rise to
the two forms of animal tissue. Epithelial tissues are formed of closely packed
epithelial cells while connective tissues, which the ECM is, has a much sparser
distribution of cells. Epithelial cells are themselves architectures of cells that
form sheets that line cavities and structures throughout the body. Typically, a
layer of epithelial cells will create the surface of a structure encasing the basement
membrane, beyond which lies the connective tissue made up of collagen and a
variety of other ECM material. This is outlined in the diagrams of Figure 2.2.
Collagens are a family of triple helical proteins that are responsible for tissue
assembly and maintenance. This definition leaves some blurring in the distinc-
tion between collagens and collagen-like proteins (Kadler et al., 2007). Of the
collagens, collagen type-I is the most abundant and can be found in connective
tissue throughout the body. The three chains that form the collagen protein are
α chains while the majority of collagen proteins are homotrimers. Collagen type-I
in its standard form is heterotrimeric and consists of two identical α − 1 chains
while the third is an α− 2 chain.
7Figure 2.2: Schematic of epithelium leading into connective tissue. ©Alberts et al.
(2008), reproduced with permission from Garland Science/Taylor & Francis LLC.
The family of collagens in the ECM are triple-helical proteins (cf. Figure 2.3)
proteins that are extremely strong and flexible and provide the ECM with its
tensile strength. The triple helix form of collagen is resistant to many forms of
degradation. The end segments of collagen fibres are not in the triple-helical form
and feature N- and C-termini. The crosslinking of collagen fibres to form fibrils
occurs at these termini where the C-terminus of one collagen molecule is linked
to the N-terminus of another collagen molecule. A collection of three stranded
collagen type-I molecules can form collagen fibrils of diameter 50-200nm which
have the structure outlined in Figure 2.3. Collagen fibrils are then organised into
fibrous structures by fibroblasts (Ehrlich and Krummel, 1996; Alberts, Johnson,
Lewis, Raff, Roberts and Walter, 2008).
The three-dimensional aspect of the ECM plays a pivotal role in regulating cel-
lular adhesion, migration, morphogenesis, growth and apoptosis (see Klein et al.,
2003, and references therein) by affecting cells at the level of signal transduction
(Daley et al., 2008).
Matrix Turnover, or matrix degradation, occurs in normal tissue and is in fact
an essential process in healthy tissue. There are biological processes in a healthy
8Figure 2.3: The triple-helical nature of the rope-like collagen strands and their for-
mation within the larger constructs of fibrils and fibres. ©Nature Publishing Group,
reproduced with permission from Mouw et al. (2014).
body that require the degradation of extracellular matrix to either provide the
space required by a cell to replicate or to allow the cell to travel through the
matrix. These processes occur in bones adapting to stresses (Chiquet et al.,
1996), the branching growth of mammary glands during embryonic development
(Vu and Werb, 2000) and other epithelial structures and in immune response
where white blood cells migrate across the basal lamina of blood vessels. An
essential part of investigating ECM turnover, whether in a positive case such as
wound healing or a negative case such as cancer, is the the consideration of MMPs
and TIMPs (Kerrigan et al., 2000).
As natural turnover of ECM is required within a healthy body, MT1-MMP and
MMP-2 are produced at certain times outside of cancer invasion. MT1-MMPs
can be seen as a method for fibroblast (these lay down the foundation of the
ECM) invasion of tissue (happens on a single based scale that causes only small
degradation of tissue far below what we would see in cancer) to allow the fibrob-
lasts to reach areas of tissue that have been damaged and need to be repaired.
This process involves MT1-MMP (and therefore MMP-2) being expressed con-
tinuously until the wound has been healed. When we consider this process in the
9context of cancer invasion we can see that this feedback loop (technical details
involve collagen activating ERK which upregulates MT1-MMP which causes a
feedback loop by encouraging the ERK again) causes the wholesale destruction
of tissue (Lu et al., 2011).
2.2 Biology of Cancerous Cells and Their Envi-
ronment
The most common form of cancer is the grouping of solid carcinoma accounting
for ∼ 80− 90% of all cancers. Carcinomas are formed from epithelial cells.
If we recall the body as a “society of cells” then it is clear that cancer cells subvert
this society towards their own ends.
Meyskens et al. (1984) estimated the number of cells per cancerous cell mass
(from order 100 − 102 number of cancer cells of cell diameter 12.0 − 44.5µm
in oblate spheroid masses of diameter up to 150µm in a semisolid medium) as
2.40× (diameter of mass of cells)
2.378
(diameter of cell)2.804
.
Here, we will use the framework provided by Hanahan and Weinberg (2000)
in Figure 2.4 where they characterise cancer as having 6 “hallmarks”, with an
additional 3 hallmarks proposed in their follow-up paper (Hanahan and Wein-
berg, 2011): enabling replicative immortality, inducing angiogenesis, resisting cell
death, sustaining proliferative signalling, evading growth suppressors, activating
invasion and metastasis, deregulating cellular energetics. These are the basic
characteristics that they believe have emerged that can define most, if not all,
human cancers. We note that there exists some criticism in the literature of these
“hallmarks”, for example, in the paper of Sonnenschein and Soto (2013) where
10
Figure 2.4: The six originally identified “hallmarks of cancer”. ©Elsevier, reproduced
with permission from Hanahan and Weinberg (2000).
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they instead extol the tissue organisation field theory where cancer is viewed as
a tissue-based disease.
Replicative immortality of cancer cells allows them to be able to undergo mitosis
limitlessly. This is in contrast with normal healthy cells which can only do so a
limited number of times. Human cells can perform mitosis approximately 40-60
times under the Hayflick limit (Hayflick and Moorhead, 1961).
Resisting cell death permits the growth rate of a mass of cancer cells, defined
by the balance between the production and death rates of the cell, to increase
beyond levels that would be considered normal in healthy tissues. Apoptosis
(cell-death) can be triggered by environmental stimuli and was proposed by Kerr
et al. (1972).
Inducing angiogenesis provides cancer cells with the required nutrients necessary
for them to grow. This can be supplied in the form of oxygen diffusing from
blood vessels. As such, it is profitable for masses of cancer cells to stimulate the
growth of blood vessels in the same vicinity as the cancer cells and is indeed a
requirement for solid tumours to grow past ∼2-3mm in diameter. This is done by
the release of tumour angiogenic factors (TAF) that provide signals to the blood
vessels to grow toward the cancerous mass.
Sustaining proliferative signalling of cancer cells, where these cells gain the ca-
pability of continued generation of their own growth signals through oncogenes
(characterised as growth factors, growth factor receptors, signal transduction pro-
teins, nuclear regulatory proteins and cell cycle regulators), independent of the
surrounding tissue, allowing for the overcoming of homeostasis.
Evading growth suppressors that would promote homeostasis. Homeostasis oc-
curs where there is a balance of both promoting growth and suppressing growth,
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where appropriate. Malignant tumours are clear violators of homeostasis and as
such it is not surprising that they feature both sustained growth, as discussed in
the previous sub-topic, as well as insensitivity to anti-growth signals. The part
of homeostasis that is violated in this context is the ability of signals to force
cells into the quiescient state (G0 of the cell cycle) or postmitotic state. These
antigrowth signals are picked up by integrins on the cell-surface, which in turn in-
ternalise the signal. As such, one manner of cancerous cells evading these growth
signals in the manipulation of the expression of cell surface receptors away from
those that pick up antigrowth signals.
Tissue invasion and metastasis where tissue invasion depends on cell motility
through neighbouring regions of healthy tissue. This may be achieved by either
enzyme dependent means through the degradation of the surrounding extracellu-
lar matrix or enzyme independent means through collective cell migration (Khalil
and Friedl, 2010; Vargas and Zaman, 2011; Schlu¨ter, 2013). Metastasis is the
seeding of new environs, which occurs when certain barriers within the body are
overcome, such as allowing cancer cells to enter into the blood vessels or lymph
system, allowing for the creation of secondary tumours to form.
Deregulating cellular energetics causes glycolysis to be upregulated, resulting in
additional cellular respiration.
Tumour-promoting inflammation occurs where the co-opting of the immune sys-
tem causes it to promote cancer cell invasion.
Genome instability and mutation, where most types of cancer cells have chromo-
somes that deviate form the norm (aneuploidy state instead of euploid karyotypic
state) to the extent that they may have an extra copy of chromosome(s), missing
chromosome(s) or the fusion of two or more chromosomes.
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2.3 Cancer Cell Invasion
Different types of collagen act as a physical barrier to cancer cell invasion or as a
surface to move along depending on the structure. For invasion and metastasis to
occur, cancer cells are required to overcome several collagen-endowed tissue barri-
ers. One such obstacle is the basement membrane that lines vascular endothelial
cells and is made up of largely collagen type IV. Another obstacle is the structural
ECM in the tissue (stroma), which can be largely made up of collagen type I.
The ECM is a fairly rigid and stable structure which has displayed decades long
half-life in vivo. Protease-dependent invasion (as opposed to force based models
of movement along fibres) rely on enzymes (such as MMPs) to cleave the collagen
fibrils that would otherwise impede movement through the region.
One form of cancers, gliomas (brain cancers), can have an identifiable tumour
centre, boundary and invasive region ahead of the boundary with MT1-MMP be-
ing overexpressed in cells at the border of the tumour and in invasive cells ahead
of the tumour (Guo et al., 2005). Guo et al. (2005) perform a statistical analysis
of their results and find that for all grades of tumour (I-IV), there exists a signif-
icant association between the upregulation of MT1-MMP and MMP-2 with the
invasiveness of the glioma. However, glioblastomas, the most highly malignant of
gliomas, are characterised by rapid invasion into the surrounding parenchyma and
blur tumour margins with single cell invasion occurring at the invasive front and
the formation of small colonies of cancer cells in advance of the tumour. This ren-
ders the potentially curative treatments of surgery, immunotherapy, radiotherapy
and chemotherapy to be palliative care only (Nakada et al., 2007).
Metastates (secondary tumours/cancers) account for more than 90% of cancer
deaths (Steeg, 2006). For metastasis to occur, cancer cells must exhibit invasion
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through a variety of structured media such as the highly dense collagen consti-
tution of some peritumoral stroma (Hanahan and Weinberg, 2000, 2011). This
can occur by the secretion of enzymes that are capable of degrading components
of the ECM or by the adoption of an amoeboid phenotype that allows cancer
cells to travel through the medium in a protease-independent manner (Friedl
and Wolf, 2003a; Sahai, 2005). Cancer cells from a primary tumour break away
from the central mass and are disseminated throughout the body where they re-
grow to form secondary tumours. The main steps of metastasis are intravasation,
survival/travelling of the blood stream, extravasation. A tumour may release
millions of cells in a day to only have a few survive these final two processes.
2.3.1 Matrix Degrading Enzymes
Matrix degradation is accomplished by proteins such as the urokinase plasmino-
gen activator (uPA) and the family of matrix metalloproteinases (MMPs). There
are 24 MMPs in humans (named MMP-,1-3,7-17,19-21,23A,23B,24-28, Quesada
et al., 2009), 18 of which are freely-diffusive with the remaining 6 being bound
to the membrane of the cell. Collectively they can degrade all components of
healthy tissue (Kleiner and Stetler-Stevenson, 1999; Egeblad and Werb, 2002).
This in turn facilitates cancer growth and spread by virtue of the available space
left in the absence of the degraded ECM as well as by VGEF proteins that are
released by the degraded tissue encouraging the cancer growth (Lo´pez-Ot´ın and
Overall, 2002), (Werb, 1997). MMPs are zinc-dependent endopeptidases whose
main function is the homeostatic regulation of the ECM, that is to say the regular
turnover of the ECM (Nagase and Woessner, 1999). This process is exploited in
cancer growth and invasion where various MMPs are over expressed. The ex-
pression of MMPs faces control at the level of transcription but can also face
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inhibition when moving from the proMMP precursor state to an active MMP as
well as inhibition when it exists in its active state (Overall and Lo´pez-Ot´ın, 2002;
Clark et al., 2008).
The first member of the matrix metalloproteinase family discovered was MMP-1
(originally named tadpole interstitial collagenase) from evidence of collagenolytic
activity in tadpole tail metamorphosis (Gross and Lapiere, 1962). While MMPs
have gone through several name changes, the generally accepted naming conven-
tion for them is now MMPs. Even once we have settled upon the notation of
MMP, we still find that numerous expansions of this abbreviation exist: namely,
metalloendopeptidase, metallopeptidase, metalloproteinase, or metalloprotease.
MMPs feature a lack of upregulation by gene amplification/activation in cancer
cells but instead transcriptional changes result in the over-expression of MMPs in
cancer invasion Shapiro and Senior (1999). This distinguishes them from typical
oncogenes. It is important to note that MMPs play a part in many diseases as
well as in healthy tissue, for example, cancer, arthritis, skeletal development and
growth plate disorders, heart disease, central nervous system (CNS), meningitis,
multiplesclerosis, Alzheimers disease, inflammatory myopathies (Malemud, 2005).
The family of MMPs can exhibit both pro- and anti-invasive characteristics (No¨el
et al., 2012) but in this work we focus on the pro-invasive MMPs of MMP-2
and MT1-MMP. MMP-2 is secreted in the inactive zymogen form of proMMP-2
whereas the fully active MT1-MMP is expressed on the cell surface after being
activated internally. This interplay between the enzymes is emphasised by the
coexpression of proMMP-2, MT1-MMP, MMP-2 and TIMP2 in a variety of tissues
(Kinoh et al., 1996). While MT1-MMP was initially thought to have activity
limited to activating MMP-2, it has since been found to also have a direct role in
tissue degradation (d’Ortho et al., 1997).
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MMPs that play a crucial role in cancer invasion are MMP-2, MMP-9 and the
various MT-MMPs (mainly MT1-MMP). Some MMPs even have the opposite ef-
fect with MMP-8 in particular exhibiting anti-invasive properties. Even amongst
the pro-cancer MMPs there seems to be some location specific properties with
MMP-2 and-9 being more important in liver cancer with a minimal (at best) role
of MT1-MMP whereas other locations (breast in particular) has a high depen-
dence on the specific properties offered by the MT1-MMPs due to the make-up
of the 3D collagen type-I structure.
MMP-2 was one of the earliest discovered MMPs, it has known many names:
matrix metallopeptidase 2, gelatinase A, 72kDa gelatinase, 72kDa type IV colla-
genase, Mr72, 000 MMP.
ECM substrates of MMP-2 are: elastin, fibronectin, various collagens, laminin,
aggrecon, vitronectin. MMP-2 has a non-ECM substrate of TGF-beta (conse-
quence uncertain but it is a growth factor), IGFBP3 (causes increased cell prolif-
eration and survival) and CCL7 (a chemokine that allows the transformation of
a chemotactic agonist into a chemotactic antagonist).
MMP-2 and MMP-9 are seen to strongly correlate with glioma progression and
malignancy. MMP-2 and MT1-MMP are overexpressed in invading cells of gliomas
in humans (Guo et al., 2005).
Integrin αvβ3 is found to be implicated in the activation process of MMP-2 by
MT1-MMP and TIMP2 in glioma cells (Deryugina et al., 2001). However Sakai
et al. (2011) confirm the findings of Gilles et al. (1997) and Nguyen et al. (2000)
that the MMP-2 activation from 3D collagen induced MT1-MMP is independent
of integrins and matrix stiffness.
MT1-MMP is activated from proMT1-MMP by furin-like proprotein convertases
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into active MT1-MMP (a process that can be inhibited by the convertase in-
hibitors of α 1-PDX and HIV aspartyl protease inhibitor). This means that by
the time it reaches the surface of the cell, it is in its active form.
MT1-MMP localises to the front of migrating cells. This allows degradation
of ECM components that are in front of the invading cancer cells that would
otherwise be a physical barrier to invasion. ECM substrates of MT1-MMP are:
fibronectin, vitronectin, laminin-1,-5, fibrin, collagen type I, II, III, gelatin, casein
and elastin. MT1-MMP has a non-ECM substrate of pro-αv integrin (offers an
increase motility). As well as degrading and remodelling components of the ECM,
MT1-MMP can cause the detachment of cell-cell and cell-substrate adhesion links
by cleaving cell adhesion molecules such as CD44 and integrin αv chain.
MT1-MMP confers cancer cells with the ability to proteolytically degrade the
basement membrane scaffolding, initiate invasive pseudopodia (where a single
cell changes its geometry to reach out in a specific direction) and facilitate trans-
migration through the endothelial monolayer and the basement membrane (∼100
nm thick and consisting of largely collagen type-IV).
MT1-MMPs are responsible for the invasive potential of fibroblasts and other
single cell invasion capabilities. Hotary et al. (2000) find that MT1-MMP invasion
is independent of the activation of MMP-2. While MT1-MMP is essential for
cancer cell invasion in 3D (Sabeh, Shimizu-Hirota and Weiss, 2009; Li et al.,
2008), Lund et al. (2014) find that it is not sufficient in itself for invasion of 3D
collagen by human muscle satellite cells.
Of MMP-mutant gene knockout mice, only the mmp14 gene-knockout is lethal
in mice. They are born without abnormalities but develop these and die aged
3-12 weeks (Holmbeck et al., 1999; Zhou et al., 2000). Key findings of their work
includes that MT1-MMP and MMP-2 knock-out mice die fastest followed by
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MT1-MMP knockout mice followed by MMP-2 knockout mice (who may not even
die from the internal failures that they suffer). MT1-MMP deficient mice produce
only a faint level of MMP-2. Angiogenesis and tumour growth are severely limited
in MMP-2-null and MT1-MMP-null mice.
TIMP2 is one of four members of the gene family of “tissue inhibitor of metallo-
proteinases” consisting of: TIMP1, 2, 3, 4. These genes encode the proteins that
act as protease inhibitors and can collectively inhibit all members of the MMP
family. proMMP-2 and proMMP-9 (the latent forms of MMP-2 and MMP-9) are
the only pro-enzymes of the MMP family that are capable of forming complexes
with TIMPs. proMMP-2 can bind to TIMP2 and this complex plays a role in
its activation mediated by MT1-MMP to MMP-2. TIMP2 has an N-terminal
domain and a C-terminal domain. When TIMP2 inhibits MT1-MMP, the N-
terminal domain of the TIMP2 binds to the catalytic domain of the MT1-MMP.
When TIMP2 is involved in the activation of MMP-2, the proMMP-2 uses its
hemopexin-like domain to bind to the remaining free C-terminal domain. As
TIMP2 has a multifaceted function, any potential inhibitor that selectively tar-
gets only MT1-MMP has been described as the “Holy Grail in MMP inhibitor
drug development” (Zucker and Cao, 2009).
2.3.2 The Extracellular Matrix in Relation to Matrix Met-
alloproteinases
The microenvironment of the tumour plays a significant role in cancer progression
(Hu and Polyak, 2008; Bissell et al., 2002) with matrix metalloproteinases, among
other matrix degrading enzymes, acting as regulators, allowing obstacles to be
overcome (Rowe and Weiss, 2009; Kessenbrock et al., 2010).
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While collagen type-I will normally exist as a heterotrimer, it can also exist in a
homotrimeric form in the cases of fetal tissues, fibrosis and human cancers (see
Chang et al., 2012, and references therein). This difference in possible struc-
ture may play a significant but not yet fully understood role in cancer invasion.
McBride et al. (1997) propose that the structure formed by collagen type-I is
proposed to be due to the α − 2 chain and Kuznetsova et al. (2003) find that
homotrimeric collagen denaturates 100 times slower than heterotrimeric colla-
gen when performed at the same temperature. Denatured collagen is gelatin, a
substrate of MMP-2.
The main constituent of the stroma (dense connective tissue) is the insoluble,
structural, cross-linked type I collagen. MT1-MMP exhibits strong type I col-
lagenolytic capabilities and weak gelatinolytic capabilities. Conversely, MMP-2
exhibits weak type I collagenolytic capabilities and strong gelatinolytic capabil-
ities (Tam et al., 2004) where it is unable to degrade cross-linked collagen type
I and type IV but is able to degrade the uncross-linked variants (Zhang et al.,
2013). MMP-2 can, however, critically degrade type IV collagen, the main com-
ponent of the basement membrane and an extracellular barrier. As MT1-MMP
is bound to cancer cells, its region of proteolytic activity is more restricted than
that of the freely-diffusive proteolytic enzyme MMP-2.
While MT1-MMP activity is restricted in range, it has an advantage in its capa-
bility of overcoming environments of higher collagen density such as exists in some
peritumoral stroma. Sabeh, Shimizu-Hirota and Weiss (2009) have shown that
when cancer cells are faced with structural barriers created in reconstituted gels
by covalently cross-linked fibrils of type I collagen, or that exist in the stromal en-
vironment of the mammary gland, invasion is dependent on MT1-MMP-mediated
proteolysis.
20
2.3.3 Invadopodia
Cells move across a substrate by forming protrusions which attach to the ECM
before retracting, dragging the cell along. While all the protrusions are capable
of forming adhesion sites with the ECM and receiving signals, only podosomes
and invadopodia are capable of non-negligible ECM degradation when compared
to the scale of cellular invasion. These membrane protrusions are dependent
on intracellular actin structures and are classified as: filopodia, lamellopodia,
invadopodia, podosomes.
While there are many shared roles between these cell protrusions, we highlight
the main form and function of each protrusion:
Lamellipodia: sheet-like, 10–15 µm wide but only 0.1–0.3µm thick. Lifespan:
minutes. The broadest structure on the cell membrane.
Filopodia: finger-like, Lifespan: minutes. sensors that are responsible for explo-
ration of the cell surroundings and provide feedback to the cell. Located near
lamellipodia and probe the region ahead of lamellipodia. More significant in 3D
than 2D substrates. - Three-dimensional reconstruction and motion analysis of
living, crawling cells.
Podosomes: conical, Lifespan: minutes. Responsible for cellular motility through
both the degradation of matrix and the formation of adhesion sites.
Invadopodia: conical, Lifespan: hours. The overcoming of cellular barriers for
cancer cells by the degradation of ECM as well as an increased cancer cell motility.
Focal adhesions: 2–6µm. Lifespan: hours. A bridge between the cell and ECM
through which signals are received.
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Localisation of proteins to cellular protrusions has a large impact on the func-
tion of the protrusion. One example is proMMP-2 and MT1-MMP localising at
invadopodia while proMMP-2, MT1-MMP and TIMP2 localise at lamellipodia.
This higher level of TIMP2 at lamellipodia in comparison to invadopodia leads to
invadopodia being more responsible for cellular invasion and locomotion instead
of lamellipodia in cancer (Chen and Wand, 1999).
The maturation of invadopodia formation can be divided into distinct stages as
outlined in the work of Artym et al. (2006). These are: (i) aggregation of cor-
tactin, which is responsible for the shape of the actin cytoskeleton, (ii) shuttling
of MT1-MMP to invadopodia, (iii) matrix degradation and (iv) MT1-MMP me-
diated dissociation of cortactin.
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Chapter 3
Mathematical Modelling of
Cancer Cell Invasion
3.1 Continuum Modelling
Mathematical modelling of cancer growth and invasion has expanded from the
seminal, though not necessarily the first, work of Greenspan (1976) as it has
attempted to fill the ever-expanding areas that cancer biology research has ex-
amined/unearthed/discovered. The burgeoning levels of mathematical models in
the field owes, in part, its existence to the surge in computational power that has
facilitated ever-complex numerical simulations that could not have been under-
taken in decades past. However, simulations of any organ in full is still not possi-
ble despite the particular advances towards such models of the liver (Holzhu¨tter
et al., 2012; Drasdo et al., 2014).
While we highlight the most relevant of mathematical works on cancer cell inva-
sion, for a more expansive overview of the following topics, we refer the reader
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to the review papers and the references therein: Araujo and McElwain (2004),
Roose et al. (2007), Quaranta et al. (2008) Bellomo et al. (2008), Bellomo and
Delitala (2008), Tracqui (2009), Preziosi and Tosin (2009), Lowengrub et al.
(2010), Byrne (2010), Rejniak and McCawley (2010), Deisboeck et al. (2011),
Rejniak and Anderson (2011) and Scianna and Preziosi (2012).
The general mathematical form for how a species (variable c) moves in response
to a gradient in either its own concentration/density or that of another species is
modelled by the equation:
∂c
∂t
+∇ · J =
m∑
i=1
fi, (3.1)
where J is the sum of the flux terms and m is the number of source terms, fi.
One such movement that can be modelled by this type of formulation is that of
chemotaxis where chemotaxis describes the process by which an object, e.g. a cell,
moves in response to a chemical concentration gradient. For example, Escherichia
coli moves in response to gradients in its nutrient’s concentration (Adler, 1973)
as can be mathematically modelled in continuum form by the Patlak-Keller-Segel
(P-K-S) equations (Patlak, 1953; Keller and Segel, 1970, 1971a,b).
The P-K-S equations were introduced to study the movement of the diffusible Es-
cherichia coli (variable c) in response to gradients in a diffusible nutrient (variable
v) that the Escherichia coli, themselves, produce. They considered this to take
place in a multi-dimensional space with zero-flux boundary conditions. Therefore
c ≡ c(x, t) = c(x, y, z, t), v ≡ v(x, y, z, t) and n ·∇c = n ·∇v = 0 on the boundary
∂Ω, where n is the outward unit normal. The P-K-S equations can therefore be
of the form:
∂c
∂t
= ∇ · (Dc∇c− χc∇v), (3.2)
∂v
∂t
= Dv∆v − βvv + µvc, (3.3)
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where Dc is the diffusion rate of the Escherichia coli, χ is the chemotaxis sensi-
tivity function (in this case a parameter), Dv is the diffusion rate of the nutrient,
βv is the death rate of the nutrient and µv is the production rate of the nutrient.
The generalised form of considering the chemotactic flux is:
J = χ(·)∇v, (3.4)
where various functional forms of chemotactic sensitivity function, χ(·), are pre-
sented in Hillen and Painter (2001), Painter and Hillen (2002) and Hillen and
Painter (2009) where they discuss appropriate forms to avoid overcrowding (fi-
nite time blow-up solutions).
From the initial mathematical models of chemotaxis (Keller and Segel, 1971a,b),
there has developed a wide variety of problems that can be modelled by variations
on these equations as seen in the reference paper of Horstmann (2003), as well
as the expansive work of Hillen and Painter (2009) and the references therein.
While chemotaxictic flux is defined as being in response to a chemical gradient,
haptotactic flux is defined as being in response to a density gradient. In the pre-
sented work, we will consider cancer cells to react haptoactically towards density
gradients in the non-diffusible tissue.
This movement in response to gradients may not only act as an attractant for a
species but instead as a chemo-repellent (Adler and Tso, 1974; Tso and Adler,
1974) as is the case in the work of Perumpanani et al. (1998), where they consider
degradation of tissue to release solubilised fibronectin that then impedes invasion
by acting as a chemo-attractant in the opposite direction of overall travel.
Invasion mediated by oxygen distribution where cancer cells use oxygen as a nutri-
ent has been one of the first methods of studying cancer growth mathematically.
We present a brief journey through the developments to mathematical models of
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cancer growth over a twenty year period from Thomlinson and Gray (1955) to
Deakin (1975) before considering the works of Orme and Chaplain (1996) and
referring the reader to the review works of Araujo and McElwain (2004) and
Roose et al. (2007). We note that the mathematical models of cancer invasion
considering oxygen distribution after this period tend to consider cancer cells as
discrete entities, e.g., Powathil et al. (2012) and so will be considered in more
depth later in this chapter.
Thomlinson and Gray (1955) and Burton (1966) established mathematical models
where oxygen was modelled as a nutrient diffusing from the outer edge (boundary)
of a tumour inwards to investigate its role in necrosis. Burton (1966) obtained
approximations for how wide this viable ring of cancer cells was in relation to
the entirety of the tumour. These works were expanded in Greenspan (1972) and
Greenspan (1974) where the addition of surface tension resulted in the removal
of cells due to necrosis in the centre of the tumour being countered by the surface
tensions of the tumour causing a compact tumour to form. Deakin (1975) used
a varying consumption rate of oxygen by cells to expand these works to include
the result of the viable rim reducing in size slowly in response to necrosis at the
centre of the tumour.
More recent works that have continued this work on multicellular spheroids and
avascular tumour development with a necrotic core include the works of Byrne
and Chaplain (1995), Byrne and Chaplain (1996), Orme and Chaplain (1996).
For mathematical models of tumour-induced angiogenesis, we refer the reader to
the review papers of Mantzaris et al. (2004), Chaplain et al. (2006) as well as
Scianna et al. (2013) and the references therein.
Invasion mediated by the acidity of the environment was championed by Gatenby
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and Gawlinski (1996) where they formulated a system of partial differential equa-
tions (P.D.Es) to model cancer cell (variable c) invasion of the extracellular ma-
trix (ECM) where the ECM (v) is degraded by H+ ions (Λ). They consider
cancer cells to experience flux in the form of non-linear diffusion, modelled by
J = Dc(1− v)∇c, which has a maximum diffusive rate at v = 0, which decreases
for increasing density of v where there is no diffusion for v = 1. The non-linear
diffusion term models the limiting/prevention of cancer cells diffusing into a re-
gion of highly dense ECM where diffusion at a higher rate occurs once the ECM
has begun to be degraded by H+ ions.
Their model can be presented in the form:
∂c
∂t
= ∇ · (Dc(1− v)∇c) + µcc(1− c), (3.5)
∂v
∂t
= −δvΛv + µvv(1− v), (3.6)
∂Λ
∂t
= ∇ · (DΛ∇Λ) + µΛ(c− Λ), (3.7)
where cancer cells self reproduce at a rate of µc, limited by the amount of cancer
cells already at that location. The ECM is degraded at rate δv by the amount of
H+ ions and self reproduces in a manner that is limited by the amount of ECM
at that location. The H+ ions can diffuse at rate DΛ and are produced by the
cancer cells until a value defined by the amount of H+ ions.
We present the two key results of their model where, firstly, they identify an
interstitial gap as a result of a pH gradient extending into the ECM surrounding
the cancer cells (caused by the diffusion of excess H+ ions produced by the cancer
cells) where there is a region between the cancer cells and ECM where neither
are present. This is backed up by in vitro experiments and clinical observations.
Secondly, they identify the value of the degradation rate of ECM by excess H+
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ions (δv = 1) at which there is a transformation of the cancer cells from non-
invasive tumours (δv < 1) into invasive tumours (δv > 1).
We make the observation that in the case where an interstitial gap is found to
exist, haptotaxis cannot, by definition, be a force that causes cancer cells to
migrate.
Gatenby and Gawlinski (2003) and Gatenby et al. (2006) then further developed
the above model in three ways. First, they changed the volume filling terms of
(1−v) and (1−c) to (1−c−v) in the diffusion of cancer cells, production of cancer
cells and productions of ECM to incorporate competition for space between the
two populations. Secondly, they modified the H+ ion concentration removal by
considering it to be proportional to the difference between H+ ion concentration
in the considered domain and that in serum. Finally, they changed the way in
which the excess H+ ions degrade the ECM to be the function:
δv(1− exp(−(H −H
opt
v
2Hwidthv
)2)), (3.8)
and introduced a term to model the death of cancer cells from acidity of:
δc(1− exp(−(H −H
opt
c
2Hwidthc
)2)), (3.9)
where δc, δv are the death and degradation rates, H
opt
c , H
opt
v are defined to be
the H+ concentration at an optimal level of pH and Hwidthc , H
width
v represent the
half-widths of the inverted Gaussian functions (the distance from the centre of
the distribution to the inflection point).
Further mathematical models of acid-mediated invasion have been investigated
by Webb et al. (1999) and Smallbone et al. (2005).
Invasion mediated by matrix degrading proteins whereby the matrix degrading
proteins degrade the ECM resulting in cancer cells moving in response to the
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resultant ECM gradients has given rise to many mathematical works, with the
framework for these models initially laid out in Perumpanani et al. (1996). Hap-
totaxis is the process by which a cell moves as a result of a physical gradient
through adhesion. It was stated in the form that is considered today by Carter
(1967) who found that cellulose acetate did not offer adhesion sites for cells to
adhere to and as such cells would not move across the surface unless the cellulose
acetate was first coated with a layer of the adhesion site-offering palladium upon
which cells would move in response to the gradient of the palladium.
Hilltopping is another form of haptotaxis and is the act of the male of a species
locating to the highest area while demonstrating territorial behaviour to attract a
mate which results in there being a high proportion of males at the hill top. This
behaviour is common in low density species of insects and lepidoptera (Scott,
1968). Individual cancerous cells migrate along stromal collagen fibres (Wang
et al., 2002) which when examined at the tissue scale would show cancer cells
moving from regions of lower collagen fibre density to that of higher collagen
density.
Haptotaxis of cancer cells in response to ECM gradients during cancer invasion
was first modelled mathematically by Perumpanani et al. (1996) and can be seen
to compare with the P-K-S equations outlined above. Their model considered...
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and can be presented in the following form:
∂c(X,t)
∂t
= ∇ · (θ(v)(Γc(c, n1, n2)∇c− cχ(v)∇v − cΨ(s)∇s))
+cf2(c, n1, n2), (3.10)
∂v(X,t)
∂t
= ∇ ·K(vθ(v)(Γn1(∇c+∇n2) + Γc∇c− cχ(v)∇v − cΨ(s)∇s))
−δ(v,m), (3.11)
∂n1(X,t)
∂t
= ∇ · (θ(v)(Γn1(c, n1, n2)∇c)) + n1f1(c, n1, n2), (3.12)
∂n2(X,t)
∂t
= ∇ · (θ(v)(Γn1(c, n1, n2)∇n2)) + n2f2(c, n1, n2), (3.13)
∂m(X,t)
∂t
= ∇ · (Dm∇m) + αm(c, v)− βmc, v,m, (3.14)
∂s(X,t)
∂t
= ∇ · (Ds∇s) + αs(v,m), (3.15)
where, to consider the effects of the ECM density either blocking or retarding
cellular motion,
θ(v) =

k26, if 0 < v < k27,
k28 − v
k28 − k27 , if k27 < v < k28,
0, if k28 < v.
(3.16)
Cells exhibit logistic growth, i.e.,
f1 = k1(k2 − n1 − n2 − c), (3.17)
f2 = k4(k5 − n1 − n2 − c). (3.18)
To represent adhesion in the cellular diffusion terms,
Γn = k3
k18
k19 + k25(k25n1 + k25n2 + k20c)
, (3.19)
Γc = k6
k18
k19 + k20(k25n1 + k25n2 + k20c)
. (3.20)
While the haptotaxis and chemotaxis terms were considered to be constants of
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χ(v) = k17 and ψ(s) = k16 and the forced movement of ECM components is
considered proportional to the flux of the cellular motions.
The production of proteolysed ECM is considered as proportional to the degra-
dation of ECM, αs(v,m) ∝ δ(v,m). Matrix degrading proteins are considered to
only be produced at the cancer-ECM interface with the function αm(c, v) = k1cv
while the inhibition and natural decay of these proteins is represented by the
function βm(c, v,m) = −k12m− k13mc− k14mv.
The number of mathematical models that have similar frameworks to Perumpanani
et al. (1996), where the underlying solutions can have travelling wave or travelling
wave-like solutions, is expansive where a partial listing of these models includes
the study of vasculature-mediated taxis movement of cancer cells in Orme and
Chaplain (1996), cancer cell flux as a form of taxis towards degraded ECM compo-
nents, which opposes cancer cell invasion in Perumpanani et al. (1998), cancer cell
flux as taxis up an ECM gradient supporting cancer cell invasion in Perumpanani
et al. (1999) and Anderson et al. (2000), where the latter is additionally dis-
cretised to form a discrete model of cancer cell invasion, the investigation of
travelling waves of shock-like appearance in a model with minimal cellular dif-
fusion and dominated by haptotaxis in Marchant et al. (2001), the introduction
of the uPa system with tactic-driven instabilities giving rise to highly dynamic,
spatially heterogeneous solutions in Chaplain and Lolas (2005) and Chaplain and
Lolas (2006), non-local adhesion in the haptotactic flux of cancer cells used to
represent cell-cell and cell-ECM adhesion in Gerisch and Chaplain (2008) and
Painter et al. (2010), further expansion of the uPA system in Andasari et al.
(2011), the role of MT1-MMP and its impact on MMP-2 activation and both
restructuring and degradation of the ECM in Deakin and Chaplain (2013), the
coupling of MMP reactions at the invasive front with tissue-scale dynamics of
cancer cell and ECM densities in a multi-scale, moving boundary model in Trucu
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Figure 3.1: The urokinase plasminogen activation system. ©Springer, reproduced
with permission from Andasari et al. (2011).
et al. (2013).
While the presented form of taxis is frequently used to model cancer cell inva-
sion, Mallet and Pettet (2006) examine an integrin-mediated haptotaxis where
they consider the matrix-mediated haptotaxis to be a subset of their model.
Additionally, non-local models of cellular adhesion exist and use a system of
integro-PDE equations, as will be discussed later.
Invasion mediated by the uPA system can be considered as one possible subset
of the above model where the matrix degrading protein is plasmin and its asso-
ciated activation system, which is presented in Figure 3.1. Chaplain and Lolas
(2005) pioneered the following mathematical model of cancer cell invasion when
mediated by the urokinase plasminogen activator system by explicitly modelling
the proteins uPA (variable u), PAI-1 (T ) and plasmin (m), which can be written
in the following form:
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∂c
∂t
= ∇ · (Dc∇c− ξc∇u− ζc∇T − χc∇v) + µcc(1− c) + φ13cu, (3.21)
∂v
∂t
= −δvm+ µv(1− v) + φ21uT − φ22Tv, (3.22)
∂u
∂t
= ∇ · (Du∇u)− φ31uT − φ33cu+ αuc, (3.23)
∂T
∂t
= ∇ · (DT∇T ) + αTm− φ41uT − φ42Tv, (3.24)
∂m
∂t
= ∇ · (Dm∇m)− φ51uT + φ52Tv + φ53cu, (3.25)
The proposed model was then modified by the inclusion of φ14Tv − ω1m in the
cancer cell source terms to consider an indirect proliferation of cancer cells in
response to an eventual activation of cancer cell-bound uPA by ECM-bound PAI-
1 as well as apoptosis in response to the overproduction of plasmin.
Models where chemotaxis influences the invasive profile of cancer by destabilising
the steady state solution are presented in Chaplain and Lolas (2005), Chaplain
and Lolas (2006) and Andasari et al. (2011), where cancer cells produce uPA
and can be bound to these molecules and causes a taxis-driven instability while
the haptotaxis reacting towards ECM gradients as a pro-invasive factor and it
is the balance of pro- and anti- invasive haptotaxis and chemotaxis that causes
the distinctive dynamics in these works of highly heterogeneous spatial-temporal
dynamics as evidenced by the dispersion relation plots presented therein.
Invasion mediated by non-local effects is studied in multiple models that result
from the novel method developed in Armstrong et al. (2006) where cellular ad-
hesion is considered in a continuum model of two interacting populations in 2
spatial dimensions where the adhesion is considered to be non-local.
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∂c
∂t
= ∇ · (Dc∇c− cKc(c, v)), (3.26)
∂v
∂t
= ∇ · (Dv∇c− vKv(c, v)), (3.27)
where the non-local advection terms, Kc, Kv, named adhesion velocity, are (in 2D
space):
Kc(c, v) =
∫ 1
0
∫ 2pi
0
rη[Scgcc(c(x+ rη), v(x))Ωcc(r)
+Cgcv(c(x+ rη), v(x+ rη))Ωcv(r)]dθdr, (3.28)
Kc(c, v) =
∫ 1
0
∫ 2pi
0
rη[Svgvv(c(x+ rη), v(x))Ωvv(r)
+Cgcv(c(x+ rη), v(x+ rη))Ωcv(r)]dθdr, (3.29)
which allows for the consideration of the dependence on the strength of the adhe-
sive binding, Ω, with consideration to the radial distance (sensing radius), S, of
both self adhesion and cross species adhesion. η represents the unit outer normal,
which depends on the angle θ, where η(θ) = (cosθ, sinθ)T while g represents the
adhesive strength functions, outlined as follows:
gcc(c, v) = gcv(c, v) =

c(1− c− v), if c+ v < 1,
0, otherwise.
(3.30)
Armstrong et al. (2006) consider Ωcc = Ωcv = Ωvv = 1 for simplicity, whereas
Gerisch and Chaplain (2008) develop upon this formulation when considering
different formulations for this strength of the adhesive binding in a continuum
based cancer cell invasion of form similar to Anderson et al. (2000). Additionally,
they modify the adhesive velocity equation so that the integration is to R instead
of 1 with the result being divided by R, i.e., previously, Armstrong et al. (2006)
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had Kc(c, v) =
∫ 1
0
f(c, v)dr whereas Gerisch and Chaplain (2008) have Kc(c, v) =
1
R
∫ R
0
f(c, v)dr.
∂c
∂t
= ∇ · (Dc∇c− cKc) + µcc(1− c− v), (3.31)
∂v
∂t
= δvm+ µv(1− c− v), (3.32)
∂m
∂t
= ∇ · (Dm∇m) + αc− βm, (3.33)
where the function f in the non-local adhesion term Kc remains as defined above.
Gerisch and Chaplain (2008) note that the integral over the sensing radius should
have a value of 1 in order to not alter the magnitude of the velocity due to
adhesion. They propose two forms of the radial dependency function in 2D:
Ω1(r) =
1
piR2
, (3.34)
Ω2(r) =
3
piR2
(1− r
R
), (3.35)
where the first proposed form results in an integrand independent of r while
the second form results in linear decay to the point R where Ω2(R) = 0. By
incorporating a linear decay into the strength of adhesive binding, it allows for
the consideration of adhesion sites further away from the initial location to have
less of an effect than adhesion sites closer to the initial location. Armstrong et al.
(2006) show that for R = 0 there remains the possibility of finite time blow-up
solutions whereas for small R, R > 0, there is an avoidance of finite time blow-up
solutions while there is still the allowance of aggregation dynamics.
Further results of biological interest are obtained in Gerisch and Chaplain (2008)
where they find that local overcrowding (c + v ≥ 1) is permitted in cases where
the total amount of c and v within a region of radius R from the location X is
bound such that
∫ X+R
X−R
c+ v ≤ R. They identify the value of cell-cell adhesion of
Scc = 0.5 when considered with their parameter set blocks all cancer cell invasion
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to the point of creating a spatially heterogeneous steady state solution as the cells
are bound strongly together in a small region near the origin. However, when
they increase the cell-ECM adhesion, Scv, they find that invasion is permissible
and that more cancer cells break off from the original mass of cells with increasing
cell-ECM adhesion. Andasari (2011) incorporates the non-local advection terms
presented in Gerisch and Chaplain (2008) into the model developed in Chaplain
and Lolas (2005).
Mathematical models of MMP-2 activation exist in the literature where we here
remind the reader that we will develop upon these directly in the presented work
within the context of cancer cell invasion. Karagiannis and Popel (2004) were
the first to propose a mathematical model of the activation system of MMP-2
in a model of collagen type-I degradation with a system of ODEs to represent
bulk collagenolysis in a well-mixed state. We note that while they provide a
“sample equation” in the supplementary material of their work, they do not
provide the equations for all proteins or protein complexes. However, the ODEs
can be reconstructed from the reactions listed where we present these in Figure
3.2.
Their model combines the ectodomain shedding of MT1-MMP, collagen degra-
dation by both MMP-2 and MT1-MMP, MMP-2 inhibition by TIMP2 as well
as the activation of MMP-2. Here, we present a reconstruction of the equa-
tions likely underpinning their results, broken down into the different processes
of ectodomain shedding, degradation of collagen, MMP-2 inhibition by TIMP2
and the activation of MMP-2.
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Figure 3.2: The MMP-2 activation system in combination with collagen type-I degra-
dation and ectodomain shedding of MT1-MMP (Karagiannis and Popel, 2004). MT1
represents MT1-MMP, MT1cat represents the catalytic domain of MT1-MMP when it
has been isolated from the rest of the molecule, MT!t represents the truncated part of the
MT1-MMP that is left when the catalytic domain has been severed from the molecule,
T2 represents TIMP2, pM2 represents proMMP-2, C1 represents collagen type-I and
C1D represents denatured collagen type-I.
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Ectodomain shedding is modelled by:
d[MT1]
dt
= 2koffMT1,MT1[MT1 ·MT1]− 2konMT1,MT1[MT1]2
+kshedMT1[MT1 ·MT1] = ESMT1, (3.36)
d[MT1 ·MT1]
dt
= −koffMT1,MT1[MT1 ·MT1] + konMT1,MT1[MT1]2
−kshedMT1[MT1 ·MT1] = ESMT1·MT1, (3.37)
d[MT1cat]
dt
= +kshedMT1[MT1 ·MT1] = ESMT1cat , (3.38)
d[MT1t]
dt
= +kshedMT1[MT1 ·MT1] = ESMT1t . (3.39)
Degradation of collagen type-I by both MMP-2 and MT1-MMP is modelled by:
d[MT1]
dt
= koffMT1,CI [MT1 · CI]− konMT1,CI [MT1][CI]
+kcatMT1,CI [MT1 · CI] = DCMT1, (3.40)
d[CI]
dt
= koffMT1,CI [MT1 · CI]− konMT1,CI [MT1][CI] = DCCI , (3.41)
d[MT1 · CI]
dt
= −koffMT1,CI [MT1 · CI] + konMT1,CI [MT1][CI]
−kcatMT1,CI [MT1 · CI] = DCMT1·CI , (3.42)
d[CID]
dt
= +kcatMT1,CI [MT1 · CI] + kcatM2,CI [M2 · CI] = DCCID , (3.43)
d[M2]
dt
= koffM2,CI [M2 · CI]− konM2,CI [M2][CI] + kcatM2,CI [M2 · CI]
= DCM2, (3.44)
d[M2 · CI]
dt
= −koffM2,CI [M2 · CI] + konM2,CI [M2][CI]− kcatM2,CI [M2 · CI]
= DCM2·CI . (3.45)
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MMP-2 inhibition by TIMP2 is modelled by:
d[M2]
dt
= +koffM2,T2[M2 · T2]− konM2,T2[M2 · T2] = MIM2 (3.46)
d[T2]
dt
= +koffM2,T2[M2 · T2]− konM2,T2[M2 · T2] = MIT2 (3.47)
d[M2 · T2]
dt
= konM2,T2[M2 · T2]− koffM2,T2[M2 · T2] + k−inhM2,T2[M2 · T2∗]
−kinhM2,T2[M2 · T2∗] = MIM2·T2 (3.48)
d[M2 · T2∗]
∂t
= +kinhM2,T2[M2 · T2∗]− k−inhM2,T2[M2 · T2∗] = MIM2·T2∗ (3.49)
Activation of MMP-2 is modelled by:
d[MT1]
dt
= koffMT1,T2[MT1 · T2]− konMT1,T2[MT1][T2]
−konMT1,T2,M2p,MT1[MT1 · T2 ·M2p][MT1]
kactM2[MT1 · T2 ·M2p ·MT1] = AMMT1, (3.50)
d[T2]
dt
= koffMT1,T2[MT1 · T2]− konMT1,T2[MT1][T2] = AMT2, (3.51)
d[MT1 · T2]
dt
= konMT1,T2[MT1][T2]− koffMT1,T2[MT1 · T2]
+koffMT1,T2,M2p[MT1 · T2 ·M2p]
−konMT1,T2,M2p[MT1 · T2][M2p]AMMT1·T2, (3.52)
d[M2p]
dt
= koffMT1,T2,M2p[MT1 · T2 ·M2p]
−konMT1,T2,M2p[MT1 · T2][M2p]AMM2p, (3.53)
d[MT1 · T2 ·M2p]
dt
= konMT1,T2,M2p[MT1 · T2][M2p]− koffMT1,T2,M2p[MT1 · T2 ·M2p]
+koffMT1,T2,M2p,MT1[MT1 · T2 ·M2p ·MT1]
−konMT1,T2,M2p,MT1[MT1 · T2 ·M2p][MT1]
= AMMT1·T2·M2p, (3.54)
d[MT1 · T2 ·M2p ·MT1]
dt
= konMT1,T2,M2p,MT1[MT1 · T2 ·M2p][MT1]
−koffMT1,T2,M2p,MT1[MT1 · T2 ·M2p ·MT1]
−kactM2[MT1 · T2 ·M2p ·MT1] = AMMT1·T2·M2p·MT1, (3.55)
d[MT1 · T2∗]
dt
= kactM2[MT1 · T2 ·M2p ·MT1] = AMMT1·T2∗ , (3.56)
d[M2]
dt
= kactM2[MT1 · T2 ·M2p ·MT1] = AMM2. (3.57)
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Which, when combined into one system of ODEs can be written as:
dYi
dt
= ESYi +DCYi +MIYi + AMYi (3.58)
for i =1 to 17 with Y = (MT1,MT1 ·MT1,MT1cat,MT1t, CI,MT1 ·CI,CID,
M2,M2 ·CI, T2,M2 · T2,M2 · T2∗,MT1 · T2,M2p,MT1 · T2 ·M2p,MT1 · T2 ·
M2p ·MT1,MT1 ·T2∗)T , where undefined values of ESj, DCj,MIj and AMj are
set to be equal to zero for j=1 to 17.
Key results of the model are providing characterisation of the MMP-2 activation
system while finding that TIMP2 levels which are either too high or too low
inhibit the activation process. By studying the ectodomain shedding of MT1-
MMP in conjunction with the activation process of MMP-2, they determine that
the more MT1-MMP molecules that have undergone ectodomain shedding, the
fewer free MT1-MMP molecules that are available to take part in the activation of
MMP-2. Additionally, they found that the level of TIMP2 modified the amount
of ectodomain shedding where the complex of TIMP2·MT1-MMP was protected
from the shedding process. As they are the first to mathematically model this
system, with the addition of collagen degradation by both MT1-MMP and MMP-
2, they provide a base for future development on quantitative approaches in
identifying the ranges at which collagen is degraded most extensively by the
combination of activated MMP-2 and MT1-MMP.
They later expanded upon the outlook of their ODE formulation of the processes
outlined above to consider the impacts on angiogenisis in Karagiannis and Popel
(2006) by examining collagen degradation at the tip endothelial cell of a sprouting
vessel. Specifically, they considered cell migration to be a function of proteolysis
in the vicinity of the cell and included production of MT1-MMP, proMMP-2 and
TIMP2 by the tip cell of the sprouting vessel and changed the system of ODEs
into one of PDEs where MMP-2, TIMP2·MMP-2 and proMMP-2 are all freely
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diffusible. By doing so they found estimates for cell velocities through a variety of
collagen compositions. Additionally, they found that at higher levels of collagen
density, proteolysis was largely performed by MT1-MMP and limited to the in-
vading edge of the cell whereas at lower collagen densities there was a concurrent
degradation of collagen by MT1-MMP and MMP-2 and this degradation was less
localised. Donze´ et al. (2011) performed global robustness and sensitivity of the
model and explored the possibility of oscillatory dynamics in the system.
A second notable attempt to characterise the activation of MMP-2 along with
secondary issues is presented in Hoshino et al. (2012) where they considered an
extensive set of potential complexes that may eventually lead to forms that are
relevant to the activation of MMP-2 from proMMP-2 by the process involving
TIMP2 and MT1-MMP, outlined in Figure 3.3. They consider two “pools” to rep-
resent two regions that consider differing internalisation processes for MT1-MMP
of pool X and Y where internalisation is dependent on bafilomycin concentra-
tion and surface density, respectively. A-Cell (Ichikawa, 2001) is then used to
generate the equations which form the basis of their model, which are provided
in the supporting information of their paper, and consists of 39 ODEs. Experi-
mental validation alongside their computational model is used to investigate the
significance of turnover of MT1-MMP for proteolysis at an invadopodium.
They find that the rapid turnover of MT1-MMP is responsible for the increased
degradation of ECM at invadopodia and found that the blocking of vesicle trans-
port in their model, and in their experiment, blocked ECM degradation.
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Figure 3.3: The MMP-2 activation system and related complex formation. The bold
arrow indicates insertion of MT1-MMP while the dotted arrow indicates internalisation
of MT1-MMP. Reproduced from Hoshino et al. (2012).
3.2 Discrete Modelling
Discrete models of individual cancer cell invasion focus on the individual cancer
cells through the lattice-based cellular automata (CA) models (extensions include
the cellular Potts models (CPMs) and lattice-gas cellular automata (LGCA) mod-
els) or through lattice-free, force-based models.
In the context of cancer cell invasion, CAMs are discrete lattices in 2 or 3 spatial
dimensions where each lattice point can be considered to be in two states (“on”
or “off”) to represent there either being a subcellular element of a cancer cell/an
entire cancer cell in that location or an absence of cancer in that location. A 2D
spatial lattice where each point represents an area where an individual cancer cell
can exist allows for cancer cells to move with either 4 or 8 degrees of freedom.
The initial state of the model evolves trough predefined rules where each lattice
point considers several factors (the neighbouring lattice points on/off status, local
oxygen distribution, intracellular signalling, etc.) to determine if the cancer cell
at that location will move to a neighbouring lattice point, remain unchanged
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or die. By the inclusion of intracellular processes and/or the impact of oxygen
concentration, determined from a PDE covering the entire lattice, these models
are frequently multiscale in nature.
Examples of models where each grid point describes an individual cancer cell
can be found in the works of Anderson and collaborators (Anderson et al., 2000;
Anderson, 2005; Anderson et al., 2006) where they discretise a PDE governing
cancer cells to determine the rules that govern the movement, proliferation and
apoptosis of cancer cells in invasion. The individual cancer cells respond to a
system of PDEs governing the density of the extracellular matrix and some matrix
degrading proteins. Their framework is capable of considering cancer cells having
different phenotypes where each lattice point was considered to have more data
than the “on” and “off” states of a typical CAM. As such, it has been expanded to
look at evolutionary dynamics of the cancer cells and how the microenvironment
affects the evolutionary process in the works of Anderson and Gerlee (Gerlee and
Anderson, 2007, 2008, 2009a,b, 2010).
A CA model with a hexagonal lattice was proposed in Aubert et al. (2006) to
study the migration of glioma cells where the cells were defined to have an at-
traction to each other that preferentially biases movement.
In order to maintain the distinctness of each cancer cell, an approach is to use
a Potts model where each cell is assigned a unique index, Q, termed the spin
number. Potts models have cancer cell populations evolving in ways that min-
imise the effective energy. Cells move by an iterative process of the movement
of the boundary elements of the cell. Models that consider a large amount of
cancer cells are termed large-Q Potts models. The Potts model considers a single
surface energy across multiple cells whereas an extended large-Q Potts model,
known as a cellular Potts model (CPM), considers each cell to have an individual
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surface energy that allows for the growth and shrinking of cells in response to
its neighbouring cells and lattice points. This also allows for the consideration
of each cell going through different physical sizes and can be used to prescribe
maximum and minimum cell sizes. This allows for more complex morphologies of
the cancer cells to be considered along with their respective adhesion properties
and other cell-cell dynamics.
Models that focus specifically on cancer cell growth and invasion using a CPM
include the works of Stott et al. (1999); Turner and Sherratt (2002); Jiang et al.
(2005); Rubenstein and Kaufman (2008); Andasari et al. (2012). We refer the
reader to the review papers of Moreira and Deutsch (2002); Hatzikirou et al.
(2008); Szabo´ and Merks (2013) for a review of CPM in cancer cell growth,
invasion and evolution.
CPMs have seen a number of developments in the last decade (see the recent
review paper of Scianna and Preziosi, 2012), one of which is the introduction of a
lattice-gas cellular automaton (LGCA) model. How a LGCA model varies from
a CAM/CPM is through the inclusion of cellular velocity where cells are also
capable of colliding with one another. Of the LGCA models, Wurzel et al. (2005)
consider apoptosis, proliferation and movement of cancer cells in gliomas while
Hatzikirou and Deutsch (2008) model the effect of a more general hetereogeneous
ECM layout on cancer cell movement in the absence of apoptosis and prolifera-
tion. Further LGCA models of cancer invasion include the works of Hatzikirou
et al. (2010); Tektonidis et al. (2011); Bo¨ttger et al. (2012). Additionally, a hy-
brid LGCA-CPM has been proposed in Ghaemi and Shahrokhi (2006) to model
avascular cancer growth. Another notable modified CPM is that proposed in Li
and Lowengrub (2014) where they no longer consider cell size to depend on cell
velocity.
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Not all individual models of cancer cell invasion consider cancer cells to be fixed
to lattice points. These models are termed off-lattice and can be force-based, such
as cell-centred models (Drasdo and Ho¨hme, 2003; Drasdo and Hoehme, 2005), in
which there is a proliferating rim and cancer cells either move there centre point or
reorientate to minimise the energies resulting from adhesion to local neighbouring
cells and the pressure caused by the mitosis of neighbouring cells. They used
their model to investigate the transition of exponential growth of cancer cells in a
multicellular spheroid to a sub-exponential growth as the result of the depletion
of a nutrient. Ramis-Conde et al. (2008) developed a lattice-free model of discrete
cancer cells to study cellular adhesion through the interaction of the intracellular
proteins of E-cadherin and β-catenin. It is the distance between the centre of
each cell that determines the size of the contact area between two cells. This
work was then developed in Ramis-Conde et al. (2009) to study the role of these
proteins in the intravasation of cancer cells in one of the few mathematical works
focussing on metastasis. Further, Kim et al. (2007) developed a hybrid model of a
tumour spheroid where the core of necrotic cells and quiescent cells are governed
by PDE dynamics whereas the rim of the tumour is modelled discretely to allow
for cellular adhesion to be incorporated at the cellular level.
An alternative approach to modelling off-lattice dynamics is to use the immersed
boundary method. Here, the ECM is considered as a viscous incompressible fluid
in which cancer cells are immersed, has been implemented by Rejniak, Dillon and
coauthors to study tumour growth and invasion (Rejniak, 2005, 2007; Rejniak and
Dillon, 2007; Dillon et al., 2008). Cancer cells are considered to be viscous fluids
with elastic links on the cell membrane. Fluid can be gained by the cell, initiating
cell growth, which causes the shape of the cell to change. The process of the
splitting of the cell into two daughter cells is determined by elastic forces where
each cell is defined as having elastic links, termed the contractile force link, linking
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each point of the cell membrane with a corresponding point on the opposite side of
the cell. The cell cycle is modelled independently in each cell. Cells are therefore
capable of having individually defined sizes as well as the biomechanical properties
relating to cell growth, division, senescence, adhesion and the receiving of signals
from the ECM. The ECM is modelled by the inclusion of elastic links between
cells, which model cellular adhesion. Further, Rejniak et al. (2010); Rejniak
(2012) have used the same technique to study the development of preinvasive,
intraductal tumours and their development into invasive tumours.
The level-set method has been used to incorporate complex morphologies in mov-
ing boundary models of cancer cell invasion (Macklin and Lowengrub, 2006, 2008).
These nonlinear works can be coupled with angiogenesis (Zheng et al., 2005), in-
cluding the blood flow in these networks (Macklin et al., 2009) and emphasise the
significance of the heterogeneity of the tissue in tumour morphologies (Macklin
and Lowengrub, 2007).
3.3 Multiphase Modelling
Multiphase models attempt to deal with the mechanical forces and stresses that
tissues and cancer cells are exposed to through the use of the theory of mixtures.
It is in invoking the theory of mixtures that these models differ most significantly
from the previous methods of modelling cancer cell growth and invasion as where
previously, a spatial domain is said to be made up of only one element, the theory
of mixtures defines each location to be made up of fractions of the considered
components. Multiphase models of cancer invasion therefore consider tumours to
be made up of a multiphase mixture of cancer cells, ECM and extracellular fluid.
Tumours are defined to be moving within a porous domain made up of the ECM,
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which is wetted by extracellular fluid. For a greater understanding of multiphase
models, see Preziosi and Tosin (2009) and the references therein.
3.4 Modelling Techniques of the Presented Work
Having acknowledged that there are a large number of papers of varying ap-
proaches/types on the topic of cancer invasion, we will present 3 research chap-
ters in this thesis where the first two will feature P.D.E. models that have been
formulated and analysed as far as possible (linear stability analysis Keener and
Sneyd, 1998; Murray, 2002; Britton, 2012) with appropriate computational simu-
lations. The third of the research chapters will focus on a non-spatial, stochastic
approach to modelling MMP-2 activation mediated by MT1-MMP and TIMP2
at invadopodia.
47
Chapter 4
A PDE Model of Cancer Invasion
Focussing on the Role of MMPs
4.1 Introduction
One of the hallmarks of cancer growth and metastatic spread is the process of local
invasion of the surrounding tissue. Cancer cells achieve protease-dependent inva-
sion by the secretion of enzymes involved in proteolysis. These overly-expressed
proteolytic enzymes then proceed to degrade the host tissue allowing the cancer
cells to disseminate throughout the microenvironment by active migration and
interaction with components of the extracellular matrix (ECM) such as collagen.
In this chapter we develop a mathematical model of cancer invasion using a system
of partial differential equations to consider the role matrix metalloproteinases
(MMPs) play in local invasion as the result of an existing, minimally invasive
tumour. Specifically our model will focus on two distinct types of MMP i.e.
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soluble, diffusible MMPs (e.g. MMP-2) and membrane-bound MMPs (e.g. MT1-
MMP), and the roles each of these has when the cancer cells move into areas of
differing extracellular environments.
Mathematical modelling has been used to investigate a number of topics in cancer
progression and invasion, including models taking into account: oxygen/nutrient
driven dynamics, the immune response, the acidity of the environment, force-
based pressure, the microenvironment in general and protease-dependent inva-
sion. These effects can be modelled using a variety of techniques, including partial
differential equations for densities of cells, individual-based models including cel-
lular automaton models and multi-scale models as outlined in the review papers
of Araujo and McElwain (2004), Rejniak and McCawley (2010) and Lowengrub
et al. (2010) and the references therein. Alternatively, the variables involved in
these modelling works can be modelled through the theory of mixtures, as done in
the multiphase works outlined in the review paper of (Preziosi and Tosin, 2009)
and the references therein.
4.2 Model Development
MMPs fall into two broad categories: soluble and bound. Soluble MMPs, such
as, MMP-2, MMP-9, etc. have some comparable dynamics to the generic se-
cretory matrix degrading enzymes investigated in previous mathematical models
(Perumpanani et al., 1996; Anderson et al., 2000; Anderson, 2005; Gerisch and
Chaplain, 2008) such as the ability to freely diffuse and degrade the ECM it
comes in contact with. As such, these previous models may be suitable for the
consideration of these MMPs. We note, however, that there are both additional
processes in the activation of these enzymes that are critical to invasion that have
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Figure 4.1: The full schematic diagram of MMP-2 activation. Plot A indicates
whether a protein or complex is bound to the membrane of the cell or capable freely dif-
fusing throughout the domain. Plot B illustrates the first pathway by which proMMP-2
can become activated while plot C illustrates the alternative route by which proMMP-
2 can become activated. In all plots, ‘MT1’ represents MT1-MMP, ‘T2’ represents
TIMP2, pM2 represents proMMP-2 and M2 represents MMP-2, while in plots B and
C, a protein/complex is in a blue box if it is directly produced by a cancer cell and black
if it is formed from later reactions.
not been considered, along with the exemption of membrane-bound MMPs, and
thus there is still much to be investigated. In this chapter, we develop this style of
modelling with partial differential equations when considering how such a model
will be formulated for the soluble MMP, MMP-2, the membrane-bound MMP,
MT1-MMP, and the activation process of MMP-2 that requires MT1-MMP, as
outlined in Figure 4.1.
In our model we denote by c(x, t) the cancer cell density, v(x, t) the ECM den-
sity, ms(x, t) the MMP-2 concentration and by mt(x, t) the MT1-MMP concen-
tration. In addition, we let T (x, t) denote the TIMP2 concentration, f(x, t) the
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concentration of the complex of MT1-MMP:TIMP2 (with an assumed proMMP-2
attached). As we simulate our model in 2 spatial dimensions, we define a vector
u such that:
u ≡ (c(x, y, t), v(x, y, t),ms(x, y, t),mt(x, y, t), T (x, y, t), f(x, y, t))T . (4.1)
We develop our model according to the conservation of mass equations, i.e.:
∂u
∂t
+∇ · J = H, (4.2)
with flux and source terms as modelled by J = (J1, ..., J6)
T and H = (H1, ..., H6)
T ,
respectively.
Cancer cell density, c:
The cancer cell density flux, J1, considers the movement of cancer cells according
to cellular diffusion, modelled by Dc∇c, for some constant Dc, in addition to a
haptotactic flux of cχ(c, v)∇v, for some haptoptactic sensitivity function χ(c, v).
The cancer cell density source, H1, is formed from the production of cancer cells
in accordance to the availability of “free space” as determined by the densities of
the cancer cells and ECM, represented by F (c, v).
As the cancer cells and ECM are in a form of “competition for space”, we consider
their growth functions, as well as the haptotactic sensitivity function, to be linked.
Therefore, we will define the ECM reaction equations before providing the precise
forms of the growth functions F (c, v), for the production of cancer cells and
G(c, v), for the production of components of the ECM as well as the haptotactic
sensitivity function χ(c, v).
∂c
∂t
= ∇ · (Dc∇c− cχ(c, v)∇v) + F (c, v). (4.3)
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ECM density, v:
The ECM flux, J2 is zero as the ECM is considered to be normally static in
healthy tissues over the scale of cellular invasion where a healthy tissue will have
a half-life of decades.
The ECM source, H2, incorporates matrix degradation (proteolysis) by either
MMP-2, ms, or MT1-MMP, mt. This results in a loss of ECM density, as mod-
elled by −δmsmsv and −δmtmtv, respectively. Further, the ECM is remodelled
according to the available space, as determined by the densities of the cancer cell
population and the ECM. We identify this remodelling rate as the function G.
We can define a constant δ such that δδ1 = δms and δδ2 = δmt, for some constants
δ1 and δ2.
∂v
∂t
= −δv(δ1ms + δ2mt) +G(c, v). (4.4)
An overview of the forms that the growth functions for cancer cell and ECM
densities have taken in the modelling literature is presented in Table 4.1. To
justify our choice of functions F and G, we provide a summary of the biologi-
cal means by which cancer cells and ECM components are produced. A more
expansive description of these processes can be found in the biological review
presented in Chapter 2 of this work. In essence, cancer cells produce copies of
themselves through mitosis and therefore must have zero production rate where
c = 0 whereas ECM components are produced by fibroblasts and are therefore
capable of having a non-zero production rate where v = 0.
We incorporate these dynamics into a coupled volume filling, or “competition for
space”, approach, where we define constants Z, k, l to represent the maximum
amount, Z, of k cancer cells and l ECM constituent parts that are able to either
fill a region of space or be supported by the region. Further, we note that as we
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F(c,v) G(c,v) Source
0 0 Anderson et al. (2000),
Anderson (2005).
−c 0 Sherratt (1993).
fc(Z − kc) 0 Painter et al. (2010), Marchant et al. (2001),
Perumpanani et al. (1999).
Lc(Z − kc) 0 where L represents the intracellular acidity,
Webb et al. (1999).
c(Z − kc) v(Z − lv) Gatenby and Gawlinski (1996),
Chaplain and Lolas (2005),
Andasari et al. (2011).
c(Z − kc− lv) v(Z − kc− lv) Chaplain and Lolas (2006),
Gatenby et al. (2006).
c(Z − kc− lv) (Z − kc− lv) Gerisch and Chaplain (2008),
Andasari et al. (2011),
Deakin and Chaplain (2013).
Table 4.1: Existing forms of the functions representing cancer cell growth, F (c, v), and
ECM remodelling, G(c, v), are presented in a dimensionalised form where Z represents
the maximum amount of either k cancer cells or l ECM components, along with their
respective sources.
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consider the proteins and protein complexes to take up a negligible amount of
space, the populations of these do not influence the volume filling between the
cancer cell and ECM densities. We are therefore able to identify (Z − kc− lv) as
an appropriate multiplier to represent such a competition for space with forms of
the functions F (c, v) and G(c, v) of:
F = µcc(Z − kc− lv),
G = µv(Z − kc− lv),
for some constants µc and µv. Central in the use of volume filling terms is that
there is reduced production as the free space is filled by cancer cells and ECM
constituent parts to the point where there is no production where there is no free
space. Further, the volume filling terms can act as a correcting term when there
is a location with more cancer cells and/or ECM constituent parts than are able
to be stably supported.
As such, we can consider there to be volume filling criteria of:
kc+ lv < Z, for production,
kc+ lv = Z, for stasis,
kc+ lv > Z, for death/degradation,
with the strict conditions for production or stasis to exist of:
kc >= 0,
lv >= 0,
kc <= Z,
lv <= Z.
We note that by the definition of the volume filling maximum, a small breach of
the maximum amount of cancer cells and/or ECM constituent parts that are at
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a spatial location is still biologically relevant as the volume filling terms will act
to correct the over subscription of that spatial location beyond that which can be
supported. What is at odds with a biological interpretation of the model is when
such a correction is outstripped by further cancer cells or ECM constituent parts
being moved or produced at the spatial region, as is the case in finite-time blow up
solutions where an infinite number of cells would be said to exist within a defined
spatial region. Such finite-time blow up solutions can be avoided by considering
the above approach to volume filling in the haptotactic sensitivity function, χ(c, v)
(Stevens and Othmer, 1997; Painter and Hillen, 2002; Hillen and Painter, 2009).
As such, we choose a haptotactic sensitivity function of χ(c, v) = v(Z − kc− lv).
As the haptotactic flux happens at a rate of cχ(c, v)∇v, there is no haptotaxis
possible when either there are no cancer cells to move (c = 0), no ECM constructs
for cancer cells to move through (v = 0) or no free space for cancer cells to move
into (Z = kc+ lv).
As the volume filling terms in the production of cancer cells, ECM constituent
parts and cancer cell haptotaxis can be trivially seen to not cause an increase in
the populations above the critical values of kc=Z, lv=Z, kc+lv=Z in isolation,
we consider the cases of production or stasis to be normal, whereas the case of
death/degradation as a result of volume filling terms to be abnormal. Once we
have established the full model, an examination of what may cause such a breach
of the critical values along with the implications on the model will be discussed.
The remaining equations of the model describe the interplay between MMPs in
cancer invasion, specifically MT1-MMP activation of MMP-2, the balance be-
tween TIMP2 inhibition of both MT1-MMP and MMP-2, and the dual role of
TIMP2 as inhibitor of active MMP-2 and being necessary for the activation pro-
cess of MMP-2. The full process of MMP-2 activation is shown in Figure 4.1. The
proteins in a blue box are produced directly by a cancer cell while those in the
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black box are only formed through later interactions. Whether a species/complex
is free to move, without considering lateral diffusion on a cell and the relative
movement of a cell, is also indicated. Proteins of proMMP-2 have their “pro”
domain cleaved to form fully active MMP-2 through a process involving both
MT1-MMP and (paradoxically) TIMP2. This process is accomplished through
two methods, which while differing in their first two stages, share the same third
and fourth stage.
For the first method, the first two stages involve the binding of a protein of TIMP2
to the catalytic domain of an MT1-MMP protein. This inhibits the MT1-MMP
protein from degrading the surrounding ECM but leaves it otherwise intact on the
cell surface. A proMMP-2 protein then binds to this complex to form the trimer
MT1-MMP:TIMP2:proMMP-2. Alternatively, the first two stages of the second
method features a proMMP-2 protein binding to a TIMP2 protein, a reaction that
does not necessarily happen near the membrane of a cancer cell. This complex
then binds to a MT1-MMP protein on the surface of the cell to form the trimer
MT1-MMP:TIMP2:proMMP2.
The remaining two stages, which are shared between the two methods of MMP-
2 activation, are the binding of a free MT1-MMP to this trimer and then the
cleavage of the pro domain of the proMMP-2, which results in a complex of
MT1-MMP:TIMP2, MT1-MMP and a fully active MMP-2 protein.
As we feel that these dynamics can be sufficiently captured by only two stages,
we simplify the full schematic of reactions into the two stages, as laid out in Fig-
ure 4.2. This involves making the assumption that every protein of TIMP2 has
an attached proMMP-2 protein, reducing stage 1 and stage 2 of Figure 4.1 into one
stage. Further, as the dissociation rate of the complex MT1-MMP:TIMP2:proMMP-
2:MT1-MMP is much smaller than the rate of the pro domain of the proMMP-2
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Figure 4.2: Simplified schematic diagram of MMP-2 activation which will be imple-
mented in the PDE model presented herein. ‘MT1’ represents MT1-MMP, ‘T2’ rep-
resents a TIMP2 molecule with an assumed proMMP-2 molecule attached, ‘complex’
represents the intermediate complex f defined as the complex of MT1-MMP, TIMP2
and proMMP-2 and ‘M2’ represents MMP-2.
being shed, we assume that these processes can be adequately condensed into one
stage, reduced from stage 3 and stage 4 of Figure 4.1.
The use of the reduced schematic for MMP-2 activation outline in Figure 4.2
therefore relies on three conditions: (i) there is a sufficiently high concentration
of proMMP-2 (ii) the majority of proMMP-2 proteins in the body are already
bound to a protein of TIMP2 (Eroschenko and Di Fiore, 2013) and (iii) unbound
proMMP-2 proteins can quickly bind to any free TIMP2 protein (reaction rate of
3.26× 104M−1s−1 Olson et al., 1997).
MMP-2 concentration, ms:
The MMP-2 flux, J3, is determined from MMP-2 being a freely diffusible protein
and so we model the flux as Dms∇ms, for some constant Dms.
The MMP-2 source, H3, has several components where MMP-2 is inhibited by
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TIMP2 at a rate of φ31, produced from the cleavage of complex f by a free
MT1-MMP at a rate of φ32 and has a natural decay rate of βms.
∂ms
∂t
= ∇ · (Dms∇ms)− φ31Tms + φ32mtf − βmsms. (4.5)
MT1-MMP concentration, mt:
The MT1-MMP flux, J4, is determined by the movement of cancer cells as MT1-
MMP proteins are tethered to the membrane of cancer cells. While MT1-MMP
proteins can diffuse along the surface of the cell and internalise before appearing
on the membrane of the cell at a different location, we consider these processes to
be unimportant in regards to the overall movement of MT1-MMP in cancer cell
invasion. Movement of cancer cells will directly result in the movement of the all
tethered proteins and complexes and so the flux of the MT1-MMP proteins is in
proportion with both amount of MT1-MMP proteins and the flux of the cancer
cells, J1, i.e. ∇ · J4 = γmt∇ · J1.
As this is a non standard method for obtaining the flux of a variable, we provide
further description in order to justify our choice. If we consider the cancer cell
density equation, c, as the sum of discrete cancer cells within a unit region, i.e.
c =
p∑
1
1. Further, we can group these individual cancer cells into subpopulations
delineated by the amount of MT1-MMP proteins attached to the individual cells,
i.e. c =
q∑
i=1
αi, where alphai is the total amount of cancer cells with i MT1-MMP
proteins attached.
We note that as the amount of free MT1-MMP proteins on any individual cancer
cell can be changed through the reaction terms of mt, the individual cancer cells
can freely move from one defined subpopulation of cancer cells to another.
The movement of αi cancer cell will therefore result in the movement of αii
proteins of MT1-MMP in the same direction.
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As the total flux of cancer cells is expressed as ∇ · J1, which can also be written
as ∇γJγ = γ∇ · Jγ, the flux term for the MT1-MMP proteins is γmt∇ · Jγ.
The MT1-MMP source, H4, is found from the following reactions. MT1-MMP
proteins are inhibited reversibly by TIMP2 at a rate of φ41 with a dissociation rate
of φ42. MT1-MMP proteins are produced by the cancer cells at a rate of αmtZ.
Additionally, we include collagen-induced expression (Haas et al., 1998; Zigrino
et al., 2001; Guo et al., 2005) in our model at a rate of αmtn. This may take into
account observations showing that collagen-dense mouse mammary tissues result
in cancer cells with a more invasive phenotype (Provenzano et al., 2008). Auto-
degradation of MT1-MMP on the cancer cell surface means that there is never
too much MT1-MMP on the surface at one time. The MT1-MMP is internalised
(inside the cell) and is recycled before being put back on the cell surface. This is
how the lifespan of active MT1-MMP is increased. We incorporate this by having
a natural decay term of βmtmt.
∂mt
∂t
= γmt∇ · (Dc∇c− χcv(Z − kc− lv)∇v)
−φ41Tmt + φ42f − βmtmt + αmtc(Z + nv). (4.6)
TIMP2, T :
The flux of TIMP2, J5, is determined from TIMP2 proteins being freely diffusible
and so we model this flux as DT∇T , for some constant DT .
The source of TIMP2, H5, models the characteristics of TIMP2 proteins binding
to the catalytic domains of MMP-2 and MT1-MMP proteins at rates φ51 and
φ52, respectively. While the binding of TIMP2 to MMP-2 is considered to be
irreversible, we consider the dissociation of the complex MT1-MMP:TIMP2 to
occur at the rate φ53. In addition, we consider TIMP2 proteins to be produced
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at a rate of αT by cancer cells.
∂T
∂t
= ∇ · (DT∇T )− φ51Tms − φ52Tmt + φ53f + αT c. (4.7)
The intermediate complex, f :
The flux of the intermediate complex of MT1-MMP:TIMP2:proMMP2, J6, is
determined in a similar way to that of free MT1-MMP as they are both tethered
to cells’ membranes. As such, we have ∇ · J6 = γf∇ · J1.
The source of the intermediate complex, H6 is determined from the reversible
binding of a TIMP2 protein to an MT1-MMP protein at a formation rate of φ61
and a dissociation rate of φ63. The cleavage of the prodomain of a proMMP-2
protein by a free MT1-MMP protein, that is illustrated in stage 4 of Figure 4.2,
occurs at a rate of φ62. We note that auto-degradation of MT1-MMP on the
cancer cell surface is blocked when a MT1-MMP protein is bound to TIMP2 and
so it plays no role in the intermediate complex source term.
∂f
∂t
= γf∇ · (Dc∇c− χcv(Z − kc− lv)∇v)
+φ61Tmt − φ62fmt − φ63f. (4.8)
The system of equations are closed by applying zero-flux boundary conditions of:
Ji · n = 0,
for i = 1, ..., 6 at all spatial locations on the boundary where n is the outward
unit normal.
Non-dimensionalisation of equations (4.3)–(4.8) is achieved by using the refer-
ence variables τ = 104s and L = 0.1cm where numerical simulations will be
run over a non-dimensionalised spatial domain of length 0-4 (0-4mm) and non-
dimensionalised temporal range of either 0-40 (0-4.6 days) or 0-100 (0-11.5 days).
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This provides sufficient space and time allowances for the consideration of local
cancer invasion. As we have developed a model in a field that has a rich history of
PDE models (Anderson et al., 2000; Gerisch and Chaplain, 2008; Andasari et al.,
2011) we follow these models by obtaining the non-dimensionalisation reference
parameters of c0 and v0 by the same method, namely, c0 = 6.7 × 107cells cm−3
and v0 = 10
−1nM (Terranova et al., 1985).
While the exact enzyme concentration ranges in ECM can be difficult to ob-
tain, we take the reference enzyme concentration to be 1nM with concentrations
throughout the considered timeframe to be within the range 0-25nM. This is
broadly in line with experimental data for concentrations obtained from serum
although precisely how the concentrations in serum relate to the concentrations
in ECM is not known. Tutton et al. (2003) find pre-operative MMP-2 levels
in plasma of colorectal cancer patients of 568.9ng/ml = 7.89nM, Song et al.
(2012) find preoperative serum levels of MMP-2 in breast cancer of ∼200ng/ml
= 2.81nM, Gohji et al. (1998) find serum levels of MMP-2 in men with prostrate
cancer of mean values 570.6ng/ml = 7.91nM to 723.0ng/ml = 10.03nM when us-
ing the Japanese system of T1-T4 for clinical stage. MT1-MMP concentrations
of 0.38nM were found in Baker et al. (1994), 3 ng/mL = 0.04nM in Petrella and
Brinckerhoff (2006) and TIMP2 concentrations of 2-9.19nM were found in Baker
et al. (1994) while Butler et al. (1998) and English et al. (2001) performed in
vitro experiments with enzyme concentrations of order 101 − 102nM.
We non-dimensionalise by using the substitutions of c = cˆc0, v = vˆv0, ms =
mˆsms0 , mt = mˆtmt0 , T = Tˆ T0, f = fˆf0 and t = tˆτ and by setting the parameters:
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Dˆc =
Dcτ
L2
, χˆ =
χv0
2τZ
L2
, µˆc = µcτZ,
kc0
Z
= 1,
lv0
Z
= 1, δˆ1 = δδ1τms0 , δˆ2 =
δ2mt0
δ1ms0
, µˆv =
Zµvτ
v0
,
Dˆms =
Dmsτ
L2
, φˆ31 = φ31T0τ , ˆβms = βmsτ , γ =
1
c0
,
φˆ41 = φ41T0τ , φˆ42 =
φ42f0τ
mt0
, ˆβmt = βmtτ , ˆαmt =
αmtc0τZ
mt0
,
nv0
Z
= 1, φˆ61 =
φ61T0mt0τ
f0
, φˆ62 = φ62mt0τ φˆ63 = φ63τ .
Upon dropping the hats for notational simplicity, we obtain the non-dimensionalised
system of equations of:
∂c
∂t
= ∇ · (Dc∇c− χcv(1− c− v)∇v) + µcc(1− c− v), (4.9)
∂v
∂t
= −δ1v(ms + δ2mt) + µv(1− c− v), (4.10)
∂ms
∂t
= ∇ · (Dms∇ms)− φ31Tms + φ32mtf − βmsms, (4.11)
∂mt
∂t
= mt∇ · (Dc∇c− χcv(1− c− v)∇v)
−φ41Tmt + φ42f − βmtmt + αmtc(1 + v), (4.12)
∂T
∂t
= ∇ · (DT∇T )− φ51Tms − φ52Tmt + φ53f + αT c, (4.13)
∂f
∂t
= f∇ · (Dc∇c− χcv(1− c− v)∇v)
+φ61Tmt − φ62fmt − φ63f, (4.14)
where we present both the dimensionalised and dimensionless parameters in Table
4.4.
In order to close the system, we perform computational simulations with zero-
flux boundary conditions to equations (4.9), (4.11)–(4.14). The initial conditions
imposed depend on the precise invasion scenario we are considering. In our the
first set of simulation results (Invasion Scenario 0A, cf. Figures 4.8–4.10) we have
a cluster of cancer cells in the centre of a homogeneous ECM with a minimal
removed section in which the cancer cells exist with a small amount of activated
enzymes already released i.e. c(0) = e(
−(x2+y2)
0.02
), v(0) = 1− c(0), ms(0) = mt(0) =
62
T (0) = f(0) = 5c(0).
4.2.1 Parameter Estimation
Parameters are largely obtained from either the biological literature or compa-
rable mathematical models and are presented here and in Table 4.4. As we will
have to perform some further simulations to obtain the parameters used in the
reduced schematic of Figure 4.2 that is used in the cancer invasion model, we will
also present how the parameters used in these further simulations represented by
equations (4.15)–(4.21) and equations (4.22)–(4.25) are obtained.
As previously discussed, there are a large number of PDE models in this field and
while we require new sources for parameters relating to the MMPs, we do not
need to begin de novo for the remaining parameters. These can be obtained from
the comparable models of Anderson et al. (2000), Anderson (2005), Chaplain
and Lolas (2006), Gerisch and Chaplain (2008), Andasari et al. (2011) and the
references therein. As such, we follow these models to obtain estimates for the
parameters of Dc, χ, µc, µv, δ1, δ2
Anderson et al. (2000) use the experimental data of Bray (1992) to find a range
of cancer cell diffusion of 10−10 − 10−9cm2s−1 and so we choose to use the di-
mensionalised parameter of Dc = 3.5× 10−10cm2s−1. A haptotaxis rate of cancer
cells towards ECM gradients of 2.6 × 10−6cm2s−1nM−1 is assumed in Ander-
son et al. (2000) and many of the models following on from their work while we
note that movement along collagen is found to be slower than movement along
fibronectin (Wojciak-Stothard et al., 1997) and as such we use the value of χ =
5×10−7cm2s−1M−1. Chaplain and Lolas (2006) provide extensive biological refer-
ences for the parameter defining cell division of 0.02h−1−0.72h−1 and as such we
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Figure 4.3: A comparison of the functions determining the production of the cancer
and ECM densities in order to determine which is larger for a range of cancer and
ECM densities. The functions of 0.3c(1 − c − v) and 0.2(1 − c − v) are compared for
the full range of values of 0 ≤ c ≤ 1 and 0 ≤ v ≤ 1. When the first function is larger,
we indicate this with the colour red and when the second function is larger, we indicate
this with the colour green. The two functions are equal to one another along the white
line.
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choose a dimensionalised parameter value of µc = 0.108h
−1. Gerisch and Chap-
lain (2008) use a value of ECM remodelling to be 3.6 × 10−3h−3nM−1 while we
choose an ECM remodelling term of double that where µv = 7.2×10−3h−3nM−1.
We have chosen a value for µc and µv in accordance with Figure 4.3 which iden-
tifies which is greater between µcc(1− c− v) and µv(1− c− v) when µc = 0.3 and
µv = 0.2. This shows which is reaching closer to the fully filled stage, however it
does not necessarily show which is producing cells more quickly.
As the rates taken for the degradation of ECM constituents vary with regard to
acidity, temperature and the exact make-up of the constituent parts, we choose
to consider matrix degradation by MMP-2 and MT1-MMP to be equal (δ2 = 1),
however this would not be true for each of the constituent parts of the ECM at
all acidity levels. What we are measuring is not then the exact amount of ECM
degraded but instead the amount of potential tissue that may be degraded. For
exact measurement of ECM degradation to be accurately predicted by our model,
precise imaging of both the position and identification of the constituents would
need to be analysed along with a consideration of the acidity of the environment.
By varying the parameters δ1, and δ2, it would be possible to gain an overview of
how the overall proportion of degradation performed by either MMP aids cancer
cell invasion. This is not necessary in the current work and would provide most
benefit when a patient specific assessment is carried out.
Collier et al. (2011) find the diffusion of MMP-2 on collagen type-1 to be 1.29×
108cm2s−1 and we consider the diffusion of proMMP-2, TIMP2 to be of the same
order. Therefore we have Dms = Dpms = DT = 1.29× 108cm2s−1.
The parameters βms , βmt , αmt and αT were chosen so that the concentrations of
active MT1-MMP and MMP-2 are in the range 0-25nM for the entire domain
and 0-10nM for the cancer-ECM interface. As the values of serum level of free
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MMP-2 and TIMP2 do not correlate with tumour staging Kolomecki et al. (2001);
Oberg et al. (1999) as well as the MMP-2/TIMP2 complex (Oberg et al., 1999)
and as we have previously discussed that serum levels of MMP-2 have been seen
in the range 2.81-10.03nM, we consider this to be an appropriate range for our
continuum based mathematical model.
However some parameters cannot be obtained from the literature directly (φ32, φ62)
as we are using the reduced schematic of Figure 4.2, thus here we show how they
are estimated.
We consider a model (submodel A) of the full MMP-2 activation system repre-
sented in Figure 4.1 to take place in the spatial domain represented in Figure 4.4
to estimate the rate at which MT1-MMP binds to TIMP2 which has an attached
proMMP-2. We then compare this rate to a model (submodel B) of the simplified
representation of the MMP-2 activation system represented in Figure 4.2 that is
consider in the full model of equations (4.9)–(4.14). We note that for both sub-
models that as the diffusive enzymes have such a high diffusion rate, there is little
difference between that of the spatial and ordinary differential equation model
despite having interactions that can only happen near the cell boundary.
Toth et al. (2000) find the binding rate of MT1-MMP to TIMP2 to be 2.74 ×
106M−1s−1 as well as the dissociation of this complex of 2× 10−4s−1. Therefore
we have the non-dimensionalised parameters of a1 = b1 = 2.74 × 10−3 and a2 =
b2 = 2× 10−4 with φ41 = φ52 = φ61 = 27.4 with φ51 = φ63 = 2.
Olson et al. (1997) find the binding rate of the complex of MT1-MMP and TIMP2
to that of proMMP-2 to be 1.4 × 105M−1s−1 as well as the dissociation of this
three enzyme complex of 4.7× 10−3s−1. Therefore we have a3 = 1.4× 10−4 with
a4 = 4.7× 10−3s−1.
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Figure 4.4: The domain and boundary conditions used in submodel A and B. The
domain is square and contains an entire cancer cell in addition to parts of four cells.
The cancer cells are of equal shape with a diameter of 40 µm. The red region is the
area that membrane-bound interactions can take place and the blue region is where
the freely-diffusive enzymes can move into. The boundary between the white and red
region is considered to be zero-flux and the boundary between red region and blue region,
presented in green, has conservation of flux across it.
67
SubModel A :
We formulate submodel A, where all parameters have estimates or estimated
ranges in the literature, with the sole purpose of simulating a specific circumstance
to provide a resultant profile of MMP-2 that submodel B can be compared with.
This allows for the estimation of the unknown parameter of b3 in submodel B,
which is equivalent to φ32 = φ62 in the proposed model of cancer invasion of
equations (4.9)–(4.14).
We use the non-dimensionalisation parameters of τ = 1s, L = 0.001cm and a ref-
erence enzyme concentration of 1nM to determine the following non-dimensionalised
system of equations where we have chosen αpM2 = αMT1 = αT2 = 0 to close the
system to be able to compare the results obtained from the schematic used in
this submodel and the later submodel B.
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∂[pM2]
∂t
= ∇ · (DpM2∇[pM2]) + αpM2 − a3[MT1 : T2][pM2]
+a4[MT1 : T2 : pM2] (4.15)
∂[M2]
∂t
= ∇ · (DM2∇[M2]) + a7[MT1 : T2 : pM2 : MT1] (4.16)
∂[MT1]
∂t
= +αMT1 + a2[MT1 : T2]− a1[MT1][T2]
−a5[MT1 : T2 : pM2][MT1]
+a6[MT1 : T2 : pM2 : MT1]
+a7[MT1 : T2 : pM2 : MT1] (4.17)
∂[T2]
∂t
= ∇ · (DT2∇[T2]) + αT2 + a2[MT1 : T2]
−a1[MT1][T2] (4.18)
∂[MT1 : T2]
∂t
= +a4[MT1 : T2 : pM2]− a3[MT1 : T2][pM2]
+a7[MT1 : T2 : pM2 : MT1] + a1[MT1][T2]
−a2[MT1 : T2] (4.19)
∂[MT1 : T2 : pM2]
∂t
= a3[MT1 : T2][pM2]− a4[MT1 : T2 : pM2]
−a5[MT1 : T2 : pM2][MT1]
+a6[MT1 : T2 : pM2 : MT1] (4.20)
∂[MT1 : T2 : pM2 : MT1]
∂t
= a5[MT1 : T2 : pM2][MT1]
−a6[MT1 : T2 : pM2 : MT1]
−a7[MT1 : T2 : pM2 : MT1] (4.21)
We use initial conditions in the region near the cell of proMMP-2=100nM, MT1-
MMP=200nM and TIMP2=160nM with Figure 4.5 showing the subdomain in-
tegration of concentration levels for chosen species changing over the combined
region.
The one parameter which we have chosen to estimate is the rate at which free
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Dimensionless Original
value value Source
DpM2 1.29× 102 1.29× 108 cm2s−1 Collier et al. (2011)
DM2 1.29× 102 1.29× 108 cm2s−1 Collier et al. (2011)
DT2 1.29× 102 1.29× 108 cm2s−1 Collier et al. (2011)
a1 2.74× 10−3 2.74× 106 M−1s−1 Toth et al. (2000)
a2 2× 10−4 2× 10−4 s−1 Toth et al. (2000)
a3 1.4× 10−4 1.4× 105 M−1s−1 Olson et al. (1997)
a4 4.7× 10−3 4.7× 10−3 s−1 Olson et al. (1997)
a5 4.3× 10−5 4.3× 104 M−1s−1 estimated
a6 9× 10−7 9× 10−7 s−1 Karagiannis and Popel (2004)
a7 2× 10−2 2× 10−2 s−1 Karagiannis and Popel (2004)
αpM2 0
αMT1 0
αT2 0
Table 4.2: Parameter set A as used in submodel A, relating to the full activation
system of MMP-2 at the cellular scale.
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MT1-MMP proteins bind to the complex of MT1-MMP:TIMP2:proMMP-2, pa-
rameter a5. The reason for doing so is that the literature offers a wide range of
values for this rate. The mathematical model of Karagiannis and Popel (2004)
estimates the value to be 3×103M−1s−1 through comparisons with the biological
data of English et al. (2001). Indeed, when we use the biological data of English
et al. (2001) and Butler et al. (1998) (as shown in the later stochastic model in-
troduced in Chapter 6, Figure 6.5), we find a comparable value of 3×103M−1s−1.
However, the mathematical work of Hoshino et al. (2012), where they have also
performed original biological experiments, estimate the parameter to be a much
larger value of 2× 106M−1s−1.
This discrepancy in parameter value estimates may in part be explained where
experiments performed in Butler et al. (1998) and English et al. (2001) used the
severed catalytic region of MT1-MMP proteins and performed experiments in a
well-mixed bulk. This may result in a parameter estimate that is smaller than
the case in vivo. We have chosen to estimate the parameter a5 as a value between
these estimates and as such have used a5 = 4.3×104M−1s−1 for all computational
simulations of our presented model.
SubModel B :
We formulate submodel B using known parameters in conjunction with one un-
known parameter, b3. In comparing the results with that obtained from submodel
A, we are able to obtain an estimate for the unknown parameter b3, which can
then be used in the proposed model of cancer invasion of equations (4.9)–(4.14)
where b3 is equivalent to φ32 = φ62.
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Figure 4.5: Submodel A. Total protein levels as determined by domain integrations
of the variables of the models are presented where MMP-2 is black, MT1-MMP is yel-
low, TIMP2 is blue, proMMP-2 is red and the complex of MT1-MMP:TIMP2:MT1-
MMP:proMMP-2 is shown in green.
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Parameter Dimensionless Original
value value Source
DpM2 1.29× 102 1.29× 108 cm2s−1 Collier et al. (2011)
DM2 1.29× 102 1.29× 108 cm2s−1 Collier et al. (2011)
b1 2.74× 10−3 2.74× 106 M−1s−1 Toth et al. (2000)
b2 2× 10−4 2× 10−4 s−1 Toth et al. (2000)
b3 1.95× 10−5 1.95× 104 M−1s−1 fitted
αMT1 0
αT2 0
Table 4.3: Parameter set B as used in submodel B relating to the reduced activation
system of MMP-2 at the cellular scale.
∂[MT1]
∂t
= +αMT1 + b2[f ]− b1[MT1][T2] (4.22)
∂[T2]
∂t
= ∇ · (DT2∇[T2]) + αT2 + b2[f ]− b1[MT1][T2] (4.23)
∂[f ]
∂t
= +b1[MT1][T2]− b2[f ]− b3[f ][MT1] (4.24)
∂[M2]
∂t
= ∇ · (DM2∇[M2]) + b3[f ][MT1] (4.25)
We use initial conditions in the region near the cell of MT1-MMP=200nM and
TIMP2=160nM with Figure 4.6 showing the subdomain integration of concen-
tration levels for chosen species changing over the combined region. Comparisons
of Figure 4.5 with Figure 4.6 yield the non-dimensionalised b3 = 1.95× 10−5.
Steady states of the underlying, spatially homogeneous system of equations (4.26)–
(4.32) are obtained by solving simultaneous equations in Maple 13TM, using the
baseline parameters found in Table 4.4.
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Figure 4.6: Submodel B. Total protein levels as determined by domain integrations of
the variables of the models are presented where MMP-2 is black, MT1-MMP is yellow,
TIMP2 is blue, the intermediate complex, f , is shown in green.
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Dimensionless Original
value value Source
Dc 3.5× 10−4 3.5× 10−10cm2s−1 Anderson et al. (2000)
χ 5× 10−3 5× 10−7cm2s−1M−1 Anderson et al. (2000)
µc 0.3 0.108h
−1 Chaplain and Lolas (2006)
δ1 1 1× 10−4nM−1s−1 Anderson et al. (2000)
δ2 1 scaling factor estimated
µv 0.2 7.2× 10−3h−1nM−1 Gerisch and Chaplain (2008)
Dms 1.29× 10−2 1.29× 108 cm2s−1 Collier et al. (2011)
φ31 5 5× 105 M−1s−1 estimated
φ32 0.195 1.95× 104 M−1s−1 estimated
βms 0.1 1× 10−5 s−1 estimated
αmt 5 5× 10−4 s−1 estimated
φ41 27.4 2.74× 106 M−1s−1 Toth et al. (2000)
φ42 2 2× 10−4 s−1 Toth et al. (2000)
βmt 0.1 1× 10−5 s−1 estimated
DT 1.29× 10−2 1.29× 108 cm2s−1 Collier et al. (2011)
αT 4 4× 10−4 s−1 estimated
φ51 5 5× 105 M−1s−1 estimated
φ52 27.4 2.74× 106 M−1s−1 Toth et al. (2000)
φ53 2 2× 10−4 s−1 Toth et al. (2000)
φ61 27.4 2.74× 106 M−1s−1 Toth et al. (2000)
φ62 0.195 1.95× 104 M−1s−1 estimated
φ63 2 2× 10−4 s−1 Toth et al. (2000)
Table 4.4: Baseline parameter set for the model
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0 = µcc(1− c− v), (4.26)
0 = −δ(s− 1 + v)(ms +mt) + µv(1− c− v), (4.27)
0 = −φ31Tms + φ32mtf − βmsms, (4.28)
0 = −φ41Tmt + φ42f − βmtmt + αmtc(1 + v), (4.29)
0 = −φ51Tms − φ52Tmt + φ53f + αT c, (4.30)
0 = φ61Tmt − φ62fmt − φ63f, (4.31)
0 = δsmt(1− s). (4.32)
The seven mathematical solutions of this system are:

c∗
v∗
m∗s
m∗t
T ∗
f ∗

=

1
0
21.25
19.37
0.01
0.81

,

0
1
0
0
T ∗
0

,

0
−0.04
−11.79
5.89
−0.01
−0.51

,

2
−1
−80
0
−0.02
0

,

1
0
94.48
−17.24
−0.01
−2

,

1
0
112.94
−26.47
−0.01
−1.48

,

0.01
0.99
−1.26
1.26
−0.01
−0.19

,

1.61
−0.61
1.65
−1.65
0.38
−10.25

,

2.16
−1.16
121.07
−121.07
0.00
−0.44

,
where only the first two solutions satisfy the non-negative requirement for being
biologically relevant. As such, further examination of only these first two solutions
is presented.
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Before finding the stability of these steady states, we note that the first steady
state represents a region where cancer has fully invaded the tissue and the ECM
is completely degraded while the second steady state represents the case where
all cancer cells have died out and only healthy tissue makes up the entirety of the
domain but doesn’t put any conditions on the values that T can take.
For the steady state of (c∗, v∗,m∗s,m
∗
t , T
∗, f ∗)T = (1, 0, 21.25, 19.37, 0.01, 0.81)T ,
the associated eigenvalues are: λ1 = −0.10, λ2 = −0.22, λ3 = −0.30, λ4 =
−0.48, λ5 = −4.06, λ6 = −40.83, λ7 = −639.10. As all the eigenvalues λi
for i = 1, ..., 7 are negative, we have that the steady state is stable.
For the steady state of (c∗, v∗,m∗s,m
∗
t , T
∗, f ∗)T = (0, 1, 0, 0, T ∗, 0)T , the associ-
ated eigenvalues are: λ1 = −0.2, λ2 = −0.1 − 5T ∗, λ3 = −13.7T ∗ − 1.05 +
0.05(75076T ∗2 + 11508T ∗ + 361)0.5, λ4 = −13.7T ∗ − 1.05 − 0.05(75076T ∗2 +
11508T ∗ + 361)0.5, λ5 = 0, λ6 = 0, λ7 = 0.
In order to determine the stability of the steady state associated with λ3, we plot
(not shown) 13.7T ∗− 1.05 and 0.05(75076T ∗2 + 11508T ∗ + 361)0.5. From this, we
determine that Re(0.05(75076T ∗2 + 11508T ∗ + 361)0.5) > Re(13.7T ∗ − 1.05) for
all T ∈ R(0,∞), therefore Re(λ3) > 0 and this steady state is unstable.
As discussed previously, using volume filling terms can result in “normal” or
“abnormal” states of the production functions for cancer cell density and ECM
density where normal conditions are defined as those allowing for growth or stasis
from the production function while abnormal conditions are defined as those
resulting in a loss. As these functions are primarily intended to provide growth
or stasis to the ECM and cancer cell densities, we term the switch in states to be
a “breach” in the volume filling function.
We note that while the conditions of c ≥ 0 and v ≥ 0 are inviolable in a biological
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understanding of the model. The remaining three conditions required for stasis
or production of c ≤ 1, v ≤ 1, c + v ≤ 1 can be violated to cause a breach
resulting in a switch in role of the production terms to that of encouraging loss in
the cancer cell and ECM densities. Biologically, this means that while we cannot
have a negative amount of either cancer cells or ECM components, only a certain
amount of cancer cells or ECM components can be supported. As such, a minimal
or temporary breach can be considered to be biologically relevant. However, an
unchecked breach can result in finite-time blow up solutions, which is at odds
with a biological interpretation of the model.
We separate the proposed model into two systems of equations considering either
only the reaction terms in equations (4.33)–(4.38) or only the flux of cancer cells,
ECM components and associated proteins in equations (4.39)–(4.44). This is done
to provide a clear indication of the role of each term in causing or recovering from
a breach.
∂c
∂t
= µccv(1− c− v), (4.33)
∂v
∂t
= −δv(ms +mt) + µv(1− c− v), (4.34)
∂ms
∂t
= −φ31Tms + φ32mtf − βmsms, (4.35)
∂mt
∂t
= −φ41Tmt + φ42f − βmtmt + αmtc(1 + v), (4.36)
∂T
∂t
= −φ51Tms − φ52Tmt + φ53f + αT c, (4.37)
∂f
∂t
= φ61Tmt − φ62fmt − φ63f, (4.38)
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∂c
∂t
= ∇ · (Dc∇c− χcv(1− c− v)∇v), (4.39)
∂v
∂t
= 0 (4.40)
∂ms
∂t
= ∇ · (Dms∇ms) (4.41)
∂mt
∂t
= mt∇ · (Dc∇c− χc(1− c− v)∇v) (4.42)
∂T
∂t
= ∇ · (DT∇T ) (4.43)
∂f
∂t
= f∇ · (Dc∇c− χc(1− c− v)∇v) (4.44)
It can trivially be seen that the reaction terms found in equations (4.33) and
(4.34), satisfy the three criteria for production or stasis for all t, provided it is
true for t = 0. As there are no flux terms for the ECM, v, we can declare that
v ≤ 1∀t where v(t = 0) ≤ 1 and c, v(t = 0) ≥ 0 thus any breach must be the
result of the flux terms of the cancer cell density found in equation (4.39).
When we examine the spatial terms in isolation from the kinetics, equations
(4.39)–(4.44), it becomes clear that there exists two ways in which the volume
filling criterion of 1 − c − v ≥ 0 can be breached. This can be caused by either
the diffusion or the haptotaxis term. We illustrate three cases where this breach
can either occur due to diffusion only in the plots of Figure 4.7 A&B, either
haptotaxis or diffusion in the plots of Figure 4.7 C&D or by haptotaxis only in
the plots of Figure 4.7 E&F. We will then proceed to consider the consequences
of this breached criterion, including any affect on the remaining volume filling
criteria. In all three cases outlined by Figure 4.7, we define the ECM, v to be
green and the cancer cells, c to be red and we consider only the two spatial
locations of X and Y at the two times of ti and ti +  where we define  to be
a sufficiently small value. We do not specify the proportion of ECM to cancer
and represent this graphically with the break conditions on the density axes.
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In all cases, we have conservation of mass for both the cancer cell population
and the ECM density such that c(X, ti) + c(Y, ti) = c(X, ti + ) + c(Y, ti + )
and v(X, ti) + v(Y, ti) = v(X, ti + ) + v(Y, ti + ). Furthermore, as there is no
flux terms for the ECM components, we have that v(X, ti) = v(X, ti + ) and
v(Y, ti) = v(Y, ti + ). We remark that diffusion of cancer cells causes movement
from regions of higher c to regions of lower c and that haptotaxis of cancer cells
causes movement from regions of lower v to regions of higher v at a rate that is
limited by the haptotactic sensitivity function, which in our model is χv(1−c−v).
To construct the scenario outlined in the plots of Figure 4.7 A&B ,where it
is possible for diffusion but not haptotaxis to violate this criteria, we consider
c(X, t1) > c(Y, t1), c(X, t1) + v(X, t1) = 1, v(X, t1) < v(Y, t1) and c(Y, t1) +
v(Y, t1) = 1− δ, where 0 ≤ δ << 1. We now consider how such a setup would be
modified by the flux terms. We would have diffusion from locations X to Y by
t = t1 +  which for some sufficiently small δ would cause an increase in cancer
cells at location Y such that c(Y, t1+)+v(Y, t1+) > 1. This violates the volume
filling criterion of 1 − c + v ≥ 0. Haptotaxis would move cells from location X
to Y as v(X, t1) < v(Y, t1), however no haptotaxis can take place as the volume
filling term in the haptotactic sensitivity function is zero when 1 − c − v = 0 as
is is the case at location X at t = t1.
We now discuss the third scenario outlined in Figure 4.7 E&F where it is pos-
sible for haptotaxis but not diffusion to violate the volume filling criteria be-
fore returning to the second scenario. We construct this scenario by considering
c(X, t3) = c(Y, t3), c(X, t3) + v(X, t3) = 1 − γ, c(Y, t3) + v(Y, t3) = 1 − δ and
v(X, t3) < v(Y, t3) where 0 < γ < 1 and 0 ≤ δ << 1. As we move from
t3 to t3 +  for some sufficiently small , we note that no diffusion can take
place as c(X, t3) = c(Y, t3) and that haptotaxis would move cancer cells from
location X to Y as v(X, t3) < v(Y, t3). Unlike the first case, we do not have
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Figure 4.7: We illustrate three scenarios where the flux terms can cause a breach of
the volume filling criterion of 1−c−v ≥ 0. Plots A and B illustrates the case where this
breach is caused by diffusion. Plots C and D illustrate the case where either diffusion
or haptotaxis can cause the breach and the plots of E and F illustrate the case where the
breach can be caused by haptotaxis but not diffusion. We represent the ECM by green
and the cancer cells by red and consider two spatial locations of X and Y at two time
points of ti and ti +  for i = 1, 2, 3.
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1− c(X, t1)− v(X, t1) = 0 and so the haptotactic event can take place. Provided
that δ is sufficiently small and γ sufficiently large, we will have a breach of the
volume filling criterion of 1− c− v ≥ 0 as c(Y, t3 + ) + v(Y, t3 + ) > 1.
If we construct the second scenario as outline in Figure 4.7 C&D in the same way
as the third scenario with the exception of c(X, t2) > c(Y, t2), it is now trivial to
show a breach of the volume filling criterion by either the diffusion or haptotaxis
as c(Y, t2 + ) + v(Y, t2 + ) > 1 provided δ is sufficiently small and γ sufficiently
large.
As we have found that the two conditions required for production or stasis of
c + v ≤ 1 and c ≤ 1 can be violated, we must consider the consequences of
such a breach. We do this by by considering both the effects on the flux terms
and the reaction terms. For the flux term of equation (4.39), we note that the
diffusion term is unaffected by any such breach and will continue to act in the
same manner, however the haptotaxis term will change sign resulting becoming
what is known as a chemorepellent in chemotaxis models, and as such we coin it
to be haptorepellent. This change causes cancer cells to instead move away from
regions of higher v towards regions of lower v.
We now consider what effect the breaking of the volume filling criterion of 1 −
c − v ≥ 0 has on the reaction terms (the examining of the after effects of this
change is the equivalent to examining the effect of having an initial condition
for the spatially homogeneous equations of (4.33)–(4.38) that doesn’t satisfy the
condition of 1 − c − v ≥ 0) but still satisfies 0 ≤ v ≤ 1 (i.e. 0 < c). As
such we consider the reactions that will affect location Y at t = ti +  where
c(Y, ti + ) + v(Y, ti + ) > 1.
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From equations (4.33) and (4.34), we have that
∂c(Y, ti + )
∂t
= µcc(Y, ti + )(1− c(Y, ti + )− v(Y, ti + )) < 0, (4.45)
∂v(Y, ti + )
∂t
= −δv(ms(Y, ti + ) +mt(Y, ti + ))
+µv(1− c(Y, ti + )− v(Y, ti + )) < 0, (4.46)
which can be interpreted as there being a decrease in c and v at this location as
a direct consequence of the breach in the volume filling criterion of 1− c− v ≥ 0.
This cycle would remain active until 1− c−v ≥ 0. We have therefore shown that
neither the reaction or flux terms can cause an increase in v above the value of 1
despite the increase in c such that c+ v > 1 caused by the flux terms.
Provided there were no further increase from location X to Y from the flux terms,
we have shown that there will be a decrease in c at location Y from the haptotaxis
term acting as a haptorepellent and a decrease in both c and v from the reaction
terms. We have however, shown that a further increase in c at location Y is
possible from both the haptotaxis term and the diffusion. As such, it is possible
that a breach in the volume filling criterion of 1− c− v ≥ 0 will not immediately
fix itself.
As for the other criterion of volume filling, namely c ≥ 0 and v ≥ 0, we note that
these are inviolable in a biological sense as it is impossible for negative amount
of cancer cells or ECM components to be present at any location. We note that
neither the diffusion or haptotaxis terms can possibly cause a decrease to either
c or v when either are at zero and so have only the reaction terms to consider.
The reaction terms can trivially be shown to not decrease c or v past zero when
we have 1− c− v ≥ 0.
We therefore consider the cases where 1−c−v < 0 as caused by either haptotaxis
or diffusion and the effect this has on the reaction terms. In order for the violation
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to be the result of haptotaxis, we must have v(Y, ti + ) > γ for some small γ
where the haptotactic sensitivity function produces a displacement proportional
to v(c − c2 − cv) and so is unlikely to provide a movement greater than γ for
reasonable choices of χ. In order for the violation to be the result of diffusion, we
have that 0 ≤ c ≤ 1 with 1− c− v < 0 therefore v > γ. As 1− c− v ≥ 0 when
v = 0, we have that there will no longer be a decrease in c and v as a result of a
breach in the volume filling. We have therefore shown that the remaining volume
filling criteria of c ≥ 0 and v ≥ 0 are satisfied for all t.
We then have that finite time blow-up solutions are only avoided provided that
haptorepellence, degradation of ECM, production of cancer cells and remodelling
of ECM are able to move cancer cells away from location Y at a rate quicker
than any additional cancer cells that are moved to location Y from the reaction-
boosted flux terms. We remark that finite time blow-up solutions do not appear
for all ranges of parameter values considered for this model and that any results
breaking the volume filling criterion of 1− c−v ≥ 0 appear to be quickly righted.
In addition, we note that the choice of volume filling in the chemotaxis sensitivity
function, cancer cell production and ECM remodelling all decrease the likelihood
of finite time blow-up solutions. Finally, we remark that as there appears to only
be a minor violation of 1− c− v ≥ 0, we can consider this to still make biological
sense as the definition for maximum amount of cancer cells at one location may
be slightly increased at times when there are additional pressures abusing the
plasticity of the cell.
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4.3 Results
We will present two invasion scenarios in this chapter: Invasion Scenario 0A and
0B. The former represents the growth and spread of cancer cells from an initial
central mass as may be representative of an in vivo evolution of a cancerous mass
while the latter represents cancer cell invasion from an initial strip along the LHS
of the domain as may be more representative of a style of in vitro experiments.
Here we present numerical simulations of the proposed model represented by
equations (4.9)–(4.14) under zero flux boundary conditions prescribed by the
homogenous Neumann boundary conditions in two spatial dimensions, although
we note that as the initial conditions and results are radially symmetric in Invasion
Scenario 0A and the multiplicity of results and the initial conditions along the
y-axis of Invasion Scenario 0B that interpretation of results obtained under a one
dimensional spatial region would be as full and as valid as those obtained from
the presented model.
In some of the plots of the figures presented in this chapter we have added an
overlay of the contour of c = 0.01 in either white or black where we have defined
this to be the extent of cancer invasion. This is done to add clarity when inter-
preting the data represented in the plots and is stated in the caption of each plot
where relevant.
In addition to the model variables of c, v,ms,mt, T and f , we employ two “dummy
variables” of ∆vms , where
∂∆vms
∂t
= δ1vms, and ∆vmt, where
∂∆vmt
∂t
= δ1δ2vmt,
to record how much ECM has been degraded by either MMP-2 or MT1-MMP
at each point within the considered domain. We will also present functions of
these variables where it is beneficial to the interpretation of the results, namely,
∅ = 1 − c − v to represent the unfilled space left by the cancer cells and ECM
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components and ∆vtotal = ∆vms + ∆vmt to represent the total degradation as
caused by both MMP-2 and MT1-MMP. We note that for 0 < ∅ ≤ 1 we have some
empty space where ∅ = 1 means there are no cancer cells or ECM components
present, ∅ = 0 no empty space and ∅ < 0 we have an overcrowding problem.
For ∆vtotal we note that there would be a initial value of zero at all coordinates
and there would be an upper bound of 1 in the case where there is no ECM
remodelling (µv = 0) but as we have presented a model with ECM remodelling
(µv > 0), we have no upper bound on this function.
We begin with the following remarks that all results obtained from the model
defined by the equations (4.9)–(4.14) will have: (i) the spatially homogeneous
condition of 1 − c − v ≥ 0, (ii) the solutions are tending to the only stable
spatially homogeneous steady state of (1, 0, 21.25, 19.37, 0.01, 0.81)T when using
the parameters found in Table 4.4 and that this is most clear in the plots of Figure
4.13 E&H, Figure 4.14 B&E and Figure 4.15 C&F, (iii) ∅ > 0 for all cases where
ECM is degraded beyond the cancer cell invasion boundary.
If we assume at some time t = tˇ1 there is an area of cancer cells of “P” and want
to compare this area to that found at a later time of t = tˇ2 where there has been
an increase in depth of invasion by “r” in a square domain of length “d”, we
find this difference in areas to be pir2 − P for Invasion Scenario 0A and dr − P
for Invasion Scenario 0B. In other words, we have a quadratic increase of region
where there exists at least some cancer cells in Invasion Scenario 0A compared to
the linear increase in Invasion Scenario 0B when we increase the invasion depth
of the cancer cell boundary into the ECM.
Invasion Scenario 0A is the first Invasion Scenario that we consider, where a
cancer mass in the centre of a domain invades outwards in a radial fashion with the
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initial conditions representing the initial cancer mass distributed in a Gaussian
distribution of e−((x
2+y2)/0.02) (Figure 4.8, plot A) in the centre of a square region
of tissue that satisfies the initial condition v(t = 0) = 1 − c(t = 0) (Figure 4.8,
plot D). This cancer mass is determined to have an initial concentration of the
enzymes and enzyme complexes of the same distribution of the cancer cell mass
but with the increased magnitude of 5×c(t = 0) and is therefore implicitly shown
as a scaled-by-5 version of Figure 4.8, plot A. We use the baseline parameters
of Table 4.4 to solve over a 2D spatial square domain of length 0.4cm and time
range 0-4.6 days with results plotted at 0, 2.3 and 4.6 days (t = 0, 20, 40).
As can be seen from the plots in Figure 4.8 A–C, we observe a radially sym-
metric growth of the cancer cell mass with an equivalent reduced state of ECM
shown in the plots of Figure 4.8 D-F and the degraded ECM of Figure 4.8 G&H.
We note that the spatially homogeneous, stable steady state calculated above of
(c∗, v∗,m∗s,m
∗
t , T
∗, f ∗)T = (1, 0, 21.25, 19.37, 0.01, 0.81)T is beginning to emerge in
the centre of the region where c(x = (0, 0)) = 1, v(x = (0, 0)) = 0.
If we consider the region where c ≥ 0.01 and v ≥ 0.01 as the cancer-ECM interface
and provide approximations for the concentrations of MMP-2 (1-4nM) and MT1-
MMP (0.1-5nM) within this region, then we can provide further approximations
for these concentrations to the spatially homogeneous steady state and compare
favourably with biological data found in for MMP concentration in serum for
various forms of cancer, as previously outlined, of MMP-2 = 2.81-10.03nM and
MT1-MMP= 0.04-0.38nM.
From the plots of Figure 4.8 G&H we see the location and amount of ECM that
has been degraded in total. We note that this goes above the non-dimensionalised
value of 1 which was defined to be the maximum amount of ECM in any location.
The degradation of an amount above the value of 1 is due to the remodelling term
87
in the ECM equation (µv(1− c− v)) creating new macromolecules of ECM when
there is sufficient space for fibroblasts to do so. In the centre of the domain,
where there is considered to be an initial mass of cancer cells reaching the maxi-
mum density (c(x = (0, 0), t = 0) = 1) and a complete lack of ECM components
(v(x = (0, 0), t = 0) = 0, there is a lack of ECM degradation throughout the con-
sidered timeframe. This fulfils the volume filling criterion at that location for the
remodelling term and so no ECM macromolecules are produced throughout the
considered timeframe and therefore no ECM is degraded at this location. Finally,
we observe that there has been degradation of the ECM beyond the cancer cell
invasion boundary.
We can see an increase in the distribution of enzymes to a more radially expansive
region as motivated by the spread of the cancer cells as well as an increase in
maximum concentration towards the stable, spatially homogeneous steady state
for ms and mt and a decrease in maximum concentration towards the stable,
spatially homogeneous steady state for T and f as seen in the distributions shown
in the plots of Figure 4.9 at t = 20 and Figure 4.10 at t = 40.
When we examine the variables ms and mt in particular we see the increase in
region and magnitude from 5×Figure 4.8 A to Figure 4.9 A&B to Figure 4.10
A&B but to focus on the characteristics of the MMPs at the interface between the
cancer cells and the ECM, we look at the plots of Figure 4.9 D&E and Figure 4.10
D&E. The plots of specific MMP-2 concentration ranges of 0.25 ≤ ms ≤ 1 (red
region) and ms > 1 (blue region) in Figure 4.9 D and Figure 4.10 D demonstrate
that MMP-2 is free to diffuse beyond what is defined to be the boundary of the
cancer cell mass to the point where almost all of the red region at t = 20 is
outside the cancer cell invasion boundary while at t = 40 all of the red region and
a minimal amount of the blue region is outside the cancer cell invasion boundary.
This is in stark contrast to the MT1-MMP profile shown in Figure4.9 E and
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Figure 4.10 E (where we define 0.25 ≤ mt ≤ 1 to be the red region and mt > 1
to be the blue region) where neither the red nor the blue regions have been able
to move past the boundary of the cancer cells as the only movement that MT1-
MMP proteins can make is while attached to a cancer cell. This shows that all
degradation of the ECM (δv(ms + mt)) beyond the cancer cell boundary must
be due to MMP-2 rather than MT1-MMP while the increased concentration of
MT1-MMP over MMP-2 in the region closest to the centre of the cancer mass
(defined as the region where mt > ms). We also note that the distance between
the red and blue regions is increased for MMP-2 from that of MT1-MMP.
We examine the variables of T and f and find that there is not an increase in the
magnitude of the variables as they tend towards the stable, spatially homogeneous
steady state values of 0.01 and 0.81 respectively however we do see the region
in which they exist expanding due to the spread of c (cf. Figure 4.9 C&F and
Figure 4.10 C&F). We note that there is a similarity between their relation and
the relation between ms and mt where T is freely diffusible and can therefore
travel beyond the extent of the cancer cell invasive boundary while f is limited
in movement to the transport by cancer cells. We consider that there is such low
concentration of T to mean that any free TIMP2 that is produced or released
from a complex is quickly bound to either free MT1-MMP or MMP-2. We note
that there is an increase in both the T and f variable at the leading edge of the
cancer cell invasion.
Expanding on the observations made from the plots of Figure 4.8 G&H, in Fig-
ure 4.11 we have that ECM degradation beyond the cancer invasive front is the
sole domain of the freely diffusible MMP-2, ms while the degradation of ECM
components within this cancer invasion front is shared by both the MMPs. The
precise amount of ECM that has been degraded by each MMP is elucidated in
the plot of Figure 4.12 B.
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In the final figure presented for this Invasion Scenario, Figure 4.12, we compare
the subdomain integrations of the variables and functions of v, c,∅,∆vtotal,∆vms
and ∆vmt to examine the contributions of the variables to the dynamics of the
model across the considered timeframe of t = 0 − 40, corresponding to a 4.6
days consideration. We note that the non-dimensionalisation where we defined
the maximum amount cancer cells or ECM components to exist as being equal
to 1 has the consequence of the maximum of the total amount of cancer cells
or ECM components (subdomain integration of c and v) over a square domain
of length 4 to be 16. This does not, however, provide a maximum value for the
summation of the total ECM degraded as the ECM is continually remodelled
(density increased) where there is the space for it to do so, i.e., where ∅ > 0.
In the plot of Figure 4.12 A, we focus on the summation of total density of the
ECM, cancer cells and the free space, ∅, that is left for either of these to be
produced or be moved into. We note that there appears to be a near linear
growth in free space, ∅, over the considered timeframe while the total ECM
density is reduced quadratically and the total amount of cancer cells increases
quadratically. We observe that while the total of cancer cells is strictly increasing,
after some small initial time it is always below the total free space. This means
that for this Invasion Scenario 0A we have an ECM that is reduced to a level
more than twice than would be needed to simply provide space for the cancer
cells to be produced/move into for the entirety of the considered timeframe (after
some small time has elapsed). In fact, for this specific scenario we have that the
ECM is reduced to a level over three times the required amount for the entirety
of the considered timeframe, again after some small elapsed time.
In the plot of Figure 4.12 B, it is abundantly clear that the bulk of degradation
of the ECM over the considered timeframe is due to the soluble MMP-2 where
degradation by either of the MMPs increases quadratically. This is due to the
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t c v ∅ ms mt T f ∆vtotal ∆vms ∆vmt
0 0.06 15.94 0 0.31 0.31 0.31 0.31 0 0 0
20 0.57 13.14 2.29 5.29 6.02 0.04 1.19 7.29 6.21 1.08
40 2.01 9.11 4.88 24.75 25.69 0.07 3.14 25.72 23.04 2.68
Table 4.5: Invasion Scenario 0A. Table showing the subdomain integration at t = 0, 20
and t = 40 (corresponding to 0 days, ∼2.3 days and ∼4.6 days) of the model variables
in addition to the inclusion of how much degradation has occurred due to each and both
of the MMPs considered.
ability of MMP-2 to diffuse beyond the cancer cell boundary into regions where
there is a higher amount of intact ECM components.
Data which is not be immediately clear from the figures in this subsection of
Section 4.3 is shown in Table 4.6 where ∅ represents the empty space of 1− c− v
and ∆vtotal,∆vms and ∆vmt represent the amounts of of ECM degraded in total,
by MMP-2 and by MT1-MMP, respectively. Additional interpretation of the data
presented in this table is offered up in Section 5.3.
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Figure 4.8: Invasion Scenario 0A. Plots A-C show the time evolution of the cancer
cell densities from t = 0 through t = 20 (corresponding to ∼2.3 days) to t = 40
(corresponding to ∼4.6 days) with plots D-F showing the corresponding ECM densities
and plots G&H showing how much ECM has been degraded across the domain where the
black contour line shows the cancer cell density at level 0.01, chosen to represent the
maximum extent of invasion. Simulations are performed using the baseline parameter
set of Table 4.4.
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Figure 4.9: Invasion Scenario 0A. The concentrations of MMP-2, MT1-MMP, the
intermediary complex f and TIMP2 at t = 20 (corresponding to ∼2.3 days) are shown
in plots A,B,C and F respectively. Plots D&E show the MMP-2 and MT1-MMP con-
centrations again at t = 20 but with appropriate thresholds to indicate the enzyme
distributions near the invasive front of the cancer cell invasion. The white contour line
in plot D and black contour line in Plot E show the cancer cell density at level 0.01
chosen to represent the maximum extent of invasion. Simulations are performed using
the baseline parameter set of Table 4.4.
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Figure 4.10: Invasion Scenario 0A. The concentrations of MMP-2, MT1-MMP, the
intermediary complex f and TIMP2 at t = 40 (corresponding to ∼4.6 days) are shown
in Plots A,B,C and F respectively. Plots D&E show the MMP-2 and MT1-MMP con-
centrations again at t = 40 but with appropriate thresholds to indicate the enzyme
distributions near the invasive front of the cancer cell invasion. The white contour line
in plot D and black contour line in plot E show the cancer cell density at level 0.01
chosen to represent the maximum extent of invasion. Simulations are performed using
the baseline parameter set of Table 4.4.
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Figure 4.11: Invasion Scenario 0A. Plots A & B show the profiles of the density
of ECM degraded solely by ms, while plots C & D show the profiles of the density of
ECM degraded solely by mt at t = 20 and 40 (corresponding to ∼2.3 and 4.6 days,
respectively). The white contour line in plots B-D and black contour line in plot A
shows the cancer cell density at level 0.01 chosen to represent the maximum extent of
invasion. Simulations are performed using the baseline parameter set of Table4.4.
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Figure 4.12: Invasion Scenario 0A. Plot A shows the subdomain integration of the
density of ECM (green), cancer (red) and empty space (blue) over the full time range
considered (t=0-40). Plot B shows the subdomain integration of the amount of ECM
degraded in total (black), solely by ms (blue) and solely by mt (red). Simulations are
performed using the baseline parameter set of Table4.4.
Invasion Scenario 0B is the second Invasion Scenario that we consider, where
a set of initial conditions to create a situation where the cancer cell mass forms
a strip along the LHS of the domain and invades an ECM construct defined
initially as v(t = 0) = 1− c(t = 0) from left to right as is illustrated in the plots
of Figure 4.13 A&B. While in the previous Invasion Scenario we considered the
enzymes to have an initial condition of a scaled 5× the distribution of c, in this
scenario we consider the enzyme concentrations to be of the same magnitude
as the initial cancer cell distribution, i.e. ms(t = 0) = mt(t = 0) = f(t = 0) =
T (t = 0) = c(t = 0). We solve the system of equations over a 2D spatial square
domain of length 0.4cm and time range 0-11.5 days and plot the data at 0, 1.15,
5.75 and 11.5 days (t = 0, 10, 50, 100). We use the same baseline parameter set
as in the previous Invasion Scenario of Table 4.4 and as such we have the same
stable, spatially homogeneous steady state that the solutions tend to over time
of (c∗, v∗,m∗s,m
∗
t , T
∗, f ∗)T = (1, 0, 21.25, 19.37, 0.01, 0.81)T , however this dynamic
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is much clearer here as can be seen by the plots of Figures 4.13 E&H, 4.14 C&F
and 4.15 C&F.
As can be seen from the plots in Figure 4.13 A,C-E, we observe an invasion
through the domain from left to right where unlike the previous scenario, we
have linear rather than quadratic growth of the cancer invasion boundary with
corresponding ECM density profiles shown in the plots of Figure 4.13 F–H. The
plot of Figure 4.17 A offers further clarification where it can be seen that after
∼ t = 40 there appears to be a linear increase in cancer cell density of approx. 1
per 12.5t matched by an equal decrease in total ECM component density.
To focus on the characteristics of the MMPs at the interface between the cancer
cells and the ECM, as well as at other locations, we examine Figure 4.14 for
the time evolution of these enzymes and Figure 4.16 for the amount of ECM
that each MMP is able to degrade. The plots of specific MMP-2 concentration
ranges of 0.25 ≤ ms ≤ 1 (red region) and ms > 1 (blue region) in Figure 4.14 C
demonstrates the ability of MMP-2 to freely diffuse beyond what is defined to be
the boundary of the cancer cell mass to the point where it can become the sole
cause of ECM degradation (cf. Figure 4.16) while the limits of MT1-MMP being
present only on the cancer cells surface limits its range to the cancer invasion
boundary Figure 4.15 F and impacts upon its influence on ECM degradation (cf.
plots of Figure 4.16 D–F).
If we consider the region between c=0.01 and v=0.01 as the cancer-ECM inter-
face and provide approximations for the concentrations of MMP-2 (1-5.5nM) and
MT1-MMP (0.1-5nM) within this region, then we can provide further approxi-
mations for these concentrations to the spatially homogeneous steady state and
can compare favourably with biological data found in various forms of cancer
(outlined previously on Page 60) of MMP-2 = 2.81-10.03nM and MT1-MMP=
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0.04-0.38nM. We can see an increase in the growth and spread of enzymes to more
of the domain as motivated by the spread of the cancer cells and the diffusion of
ms with the stable, spatially homogeneous steady state solutions for ms and mt
of 21.25 and 19.37 respectively in Figure 4.14 C&F.
We examine the variables of T and f in Figure 4.15 can see that the intermediate
complex, f , while beginning near its own stable, spatially homogeneous steady
state of 0.81, increases to a value of almost double that in the plot of Figure 4.15
A while experiencing a steep descent to 0nM beyond the cancer cell boundary.
There is a rapid drop in concentration of TIMP2 from the initial condition where
there was a maximum value of 1 by time t = 10 towards the stable, spatially
homogeneous steady state, however it is free to diffuse beyond the cancer cell
boundary. We consider that there is such low concentration of T to mean that
any free TIMP2 that is produced or released from a complex is quickly bound to
either free MT1-MMP or MMP-2. We note that there is an increase in both the
concentrations of TIMP2 and the intermediate complex, f at the leading edge of
the cancer cell invasion while the concentrations of these variables have reached
their steady state values for a large region of the established cancer mass.
In Figure 4.16 we note that at the furthest LHS of the domain (x = (−2, y)),
where there is considered to be an initial mass of cancer cells reaching the max-
imum density (c = 1) and a complete lack of ECM components ( v = 0), there
is a lack of ECM degradation throughout the considered timeframe (Figure 4.16
A–F) as a result of the volume filling component of the “growth” term of the
ECM forbidding the production of ECM components and therefore their degra-
dation. Secondly, we have that ECM degradation beyond the cancer invasive
front is the sole domain of the freely soluble MMPs, ms while the degradation of
ECM components within this cancer invasion front is shared by both the soluble
and bound MMPs.
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Third and finally, in Figure 4.17, we compare the subdomain integrations of the
variables and functions of v, c,∅,∆vtotal,∆vms and ∆vmt to examine the con-
tributions of the variables to the dynamics of the model across the considered
timeframe of t = 0 − 100, corresponding to a 11.5 days consideration. We note
that the non-dimensionalisation where we defined the maximum amount cancer
cells or ECM components to exist as being equal to 1 has the consequence of the
maximum of the total amount of cancer cells or ECM components (subdomain
integration of c and v) over a square domain of length 4 to be 16. This doesn’t,
however, provide a maximum for the summation of the total ECM degraded as
the ECM is continually remodelled (density increased) where ∅ > 0.
In the plot of Figure 4.17 A, we focus on the summation of total density of the
ECM, cancer cells and the free space, ∅, that is left for either of these to be
produced/moved into. We note that the free space, ∅ appears to reach a steady
state of 3.7 after t = 40 although this would not be able to continue indefinitely
due to boundary effects. It is at the point where the free space reaches that
the total amount of cancer cells reaches a linear increase of approx. 1 per 12.5t
matched by an equal decrease in total ECM component density.
In the plot of Figure 4.17 B, it is abundantly clear that the bulk of degradation
of the ECM over the considered timeframe is due to the soluble MMP-2 where
degradation by either of the MMPs increases quadratically. This is due to the
ability of MMP-2 to diffuse beyond the cancer cell boundary into regions where
there is a higher amount of intact ECM components.
Data which is not be immediately clear from the figures in this subsection of
Section 4.3 is shown in Table 4.6 where ∅ represents the empty space of 1− c− v
and ∆vtotal,∆vms and ∆vmt represent the amounts of of ECM degraded in total,
by MMP-2 and by MT1-MMP, respectively.
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Figure 4.13: Invasion Scenario 0B. Plots A & B show the profiles of the initial
conditions for the cancer cell density and ECM density. Plots C-E show the time
evolution of the profile of cancer cell density at t = 10, 50 and 100 (corresponding to
∼1.15, 5.75 and 11.5 days, respectively). Plots F-H show the profiles of the ECM
density at t = 10, 50 and 100. Simulations are performed using the baseline parameter
set of Table4.4.
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Figure 4.14: Invasion Scenario 0B. Plots A-C show the profiles of MMP-2 concen-
tration, while plots D-F show the profiles of MT1-MMP concentration at t = 10, 50 and
100 (corresponding to ∼1.15, 5.75 and 11.5 days, respectively). The white contour line
in plots A, B, D & E and the black contour line in plots C & F shows the cancer cell
density at level 0.01 chosen to represent the maximum extent of invasion. Simulations
are performed using the baseline parameter set of Table4.4.
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Figure 4.15: Invasion Scenario 0B. Plots A-C show the profiles of the complex func-
tion f (where f is MT1-MMP:TIMP2:proMMP-2) concentration, while plots D-F show
the profiles of TIMP2 concentration at t = 10, 50 and 100 (corresponding to ∼1.15, 5.75
and 11.5 days, respectively). The white contour line in plots A-F shows the cancer cell
density at level 0.01 chosen to represent the maximum extent of invasion. Simulations
are performed using the baseline parameter set of Table4.4.
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Figure 4.16: Invasion Scenario 0B. Plots A-C show the profiles of the density of
ECM degraded solely by ms, while plots D-F show the profiles of the density of ECM
degraded solely by mt at t = 10, 50 and 100 (corresponding to ∼1.15, 5.75 and 11.5 days,
respectively). The white contour line in plots C-F and black contour line in plots A &B
shows the cancer cell density at level 0.01 chosen to represent the maximum extent of
invasion. Simulations are performed using the baseline parameter set of Table4.4.
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Figure 4.17: Invasion Scenario 0B. Plot A shows the subdomain integration of the
density of ECM (green), cancer (red) and empty space (blue) over the full time range
considered (t=0-100). Plot B shows the subdomain integration of the amount of ECM
degraded in total (black), solely by ms (blue) and solely by mt (red). Simulations are
performed using the baseline parameter set of Table4.4.
t c v ∅ ms mt T f ∆vtotal ∆vms ∆vmt
0 2.00 14.00 0 2.00 2.00 2.00 2.00 0 0 0
10 3.03 11.16 1.81 31.55 34.79 0.10 4.96 5.36 2.89 2.47
50 6.32 6.23 3.45 113.82 107.82 0.09 6.38 34.20 29.18 5.02
100 10.44 2.16 3.4 201.07 187.57 0.13 9.75 72.73 64.56 8.17
Table 4.6: Invasion Scenario 0B. Table showing the subdomain integration at t =
0, 10, 50 and 100 (corresponding to 0 days, ∼1.15 days, ∼5.75 days and ∼11.5 days) of
the model variables in addition to the inclusion of how much degradation has occurred
due to each and both of the MMPs considered.
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4.3.1 Parameter Sensitivity
In order to determine the sensitivity of the result dependent on the individual
parameters of the model, we perform additional simulations almost identical to
Invasion Scenario 0A where the only change is a single parameter by an increase
of 50%. We record the value of the subdomain integral of c (
∫
c dx) at t = 25
and present this data in Figure 4.18 where we consider how much each parameter
change has affected the result of
∫
c dx as a proportion of the maximum change
achieved by a single parameter change (φ53 has an 83% decrease in
∫
c dx at
t = 25).
By showing the sensitivity to each parameter we have performed a partial math-
ematical parameter sensitivity of the total amount of c at t = 25 to an increase
of 50% to the parameters of the model but to consider biological concerns where
we consider the sensitivity of the model to the sources of the parameters, we
have to consider the cases where we not only have caused a 50% increase to the
individual parameters but also to certain groupings of parameters. We define the
specified groupings of parameters to be where parameters are linked by either
having the same source or where one is defined in terms of the other. Included
at the bottom right of Figure 4.18 are the 5 cases where we have considered
changes to multiple, grouped parameters at once. Namely, φ31&φ51, φ32&φ62,
φ41&φ52&φ61, φ42&φ53&φ63 and δ1 (where δ1δ2 unchanged). By performing this
additional sensitivity analysis we have found that while there was a large decrease
in the total amount of cancer cells at t = 25 by the parameters of φ41 and φ53,
when the coupled sets of biological parameters of φ41, φ52, φ61 and φ42, φ53, φ63 are
each increased by 50%, there is in fact an increase in total amount of cancer cells
at t = 25.
The parameters that have the biggest affect on an increase in the overall number
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of cancer cells when they are increased by 50% are µc and Dc. While the cancer
cell production rate is unsurprisingly the parameter with the largest effect, we
note that the increase in diffusion rate of cancer cells having a larger effect than
the increase in haptotaxis is likely due to the volume filling that exists for the
haptotaxis but not diffusion of cancer cells where the diffusion allow cancer cells
to travel through regions where 1 − c − v =  for some 0 ≤  << 1 which
would act as a barrier or significant reduction factor to the haptotaxis mediated
displacement of cancer cells.
We note that an increase in δ1 where δ1δ2 is unchanged causes a higher increase in
total cancer cells than an increase in δ2. This is unsurprising as MMP-2 is found
to be responsible for the bulk of collagenolysis when compared with MT1-MMP.
We therefore identify the parameters of µv and αT as being the most relevant
parameters that cause an decrease in the total amount of cancer cells at t = 25
when they are increased by 50%. While these parameters for ECM remodelling
and TIMP2 production would reasonably be expected to fulfil this described role,
we note that the parameter αT actually has a much more complicated relationship
with the progression of cancer. We expand on this by showing the effect of
changing αT in Figures 4.19 and 4.20 on the steady state values of ms,mt, f and
T by representing the percentage change from the values obtained when αT = 4,
the rate of TIMP2 production found in Table 4.4. As we note that the amount
of free TIMP2 plays a significant role in determining whether there is MMP-2
activated and in how much free MT1-MMP or MMP-2 are able to degrade the
ECM.
Figure 4.19 shows that for too small or too high a value of αT , there is a decrease
in the total amount of active MMP-2 and that the total amount of active MT1-
MMP is strictly decreasing for an increasing TIMP2 production. This is line
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Figure 4.18: We show how much of a change there is in
∫
c dx at t = 25 when each
individual parameter listed in Table4.4 is increased by 50%. The black bars indicate the
amount of increase while the red bars indicate the amount of decrease. We scale each
result by the maximum decrease of 83% that was achieved by φ53
with the numerical study of the activation system of MMP-2 by Karagiannis
and Popel (2004) where they find the same relation when considering a system of
ODEs that lack production of enzymes but have that there is a value for the initial
concentration of TIMP2 that provides a maximum rate of MMP-2 activation from
proMMP-2 and which a lower or higher concentration of TIMP2 reduces this rate.
4.4 Discussion
In this chapter we established a PDE model for cancer invasion of tissue, focussing
on the roles of the soluble MMP, MMP-2 and the bound MMP, MT1-MMP. We
also considered their interactions with one another where MT1-MMP plays a
role in the activation of MMP-2 from its proenzyme state. This advanced upon
previous mathematical models of cancer cell invasion that used either generic
matrix degrading enzymes and could be considered to be parallel to works that
focus on the uPA system in cancer cell invasion. The presented work also furthers
mathematical modelling of MMP-2 activation that has thus far tended to focus
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Figure 4.19: The percentage increase or decrease in the steady state values of the
variables ms and mt from the steady state values obtained from Table 4.4 when the
parameter αT is increased or decreased by a unit amount from the initial value of
αT = 4 to a minimum of 1 and maximum of 9. We represent the change in active
MMP-2 by the red line and the change in active MT1-MMP by the yellow line.
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Figure 4.20: The percentage increase or decrease in the steady state values of the
variables T and f from the steady state values obtained from Table 4.4 when the pa-
rameter αT is increased or decreased by a unit amount from the initial value of αT = 4
to a minimum of 1 and maximum of 9. We represent the change in the intermediate
function f by the red line and the change in TIMP2 by the yellow line.
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upon ODE models. The potential of the presented model to consider rich ECM
environments is examined in the following chapter.
We determined the appropriate forms of functions as defined by the background
biology that would cause an increase to the cancer cell and ECM component
populations while showing functions that previously pubished models have chosen
to use. This incorporated the key biological rules of mitosis in cancer cells and the
remodelling of ECM by fibroblasts not being reliant on the presence of ECM while
also incorporating the competition for space in these inter- and intra- cancer cells
and ECM reactions. The paradigms of a volume filling model of two variables
were established to be 1− c− v ≥ 0, c ≥ 0 and v ≥ 0.
To formulate our model, we first had to establish which dynamics of the MMP-2
activation system would be incorporated into our model and settled on a reduced
version of the system as outlined in Figure 4.2. We then presented the model
in dimensionalised and non-dimensionalised forms before determining the best
parameters for the model from either previous mathematical models or the bio-
logical literature. Where parameters were not directly obtainable, we presented
two smaller mathematical models of the MMP-2 activation system to determine
appropriate estimations of the parameters.
A steady state analysis was performed to find that there exists one stable, spa-
tially homogeneous steady state that the solution of the model will tend to as
t → ∞. This solution represented the case where cancer has fully invaded the
domain and no ECM was present. With the baseline parameter set of Table 4.4,
values for the steady state approximation of the concentration of MMP-2 was
found to be 21.25nM and for MT1-MMP this was found to be 19.37nM. The con-
centrations of TIMP2 and the intermediate complex of TIMP2:MT1-MMP were
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noticeably lower at 0.01nM and 0.81nM, respectively. This lower value is deter-
mined to be due to the relation of the production of TIMP2 and the unbinding
of TIMP2 from the interim complex being outstripped by the binding of TIMP2
to MT1-MMP and MMP-2.
We noted that the variables were able to breach the volume filling criterion of
1− c− v ≥ 0 and found that this could be the result of either of the flux terms
of diffusion or haptotaxis and found that such a breach did not facilitate the
breaking of the remaining volume filling criteria of c ≥ 0 and v ≥ 0. We found
that the inclusion of volume filling in the terms representing haptotaxis, cancer
cell production and ECM remodelling decreased the likelihood of finite time blow-
up solutions occurring. In the event that finite time blow-up solutions are found
for parameter values not yet examined or for small modifications to the model, we
note that the inclusion of a non-local volume filling in the haptotaxis term would
allow for a sensing radius and would would limit the breach of the volume filling
criterion of 1− c− v ≥ 0 to that from diffusion. It can be trivially shown that a
breach due to diffusion would not break the remaining volume filling criteria of
c ≥ 0 and v ≥ 0 as diffusion cannot increase c above the value of 1 and so the
production term for the cancer cells and the remodelling term for the ECM will
both cause a decrease when 1− c− v ≤ 0 however they will allow v to approach
but not pass zero. As such, the consideration of integro-PDE models in the future
(as considered in Gerisch and Chaplain (2008), Andasari et al. (2011), Domschke
et al. (2014) and others) may be of use.
We considered two scenarios of initial conditions to examine cancer growth and
spread of Invasion Scenario 0A and 0B which were shown to have quadratic and
linear growth, respectively. In Invasion Scenario 0A, we considered a central
mass of cancer cells invading radially outwards as may be seen in some in vivo
experiments or cases where a cancerous mass is surrounded by ECM and detailed
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the variables through a progression of time in Figures 4.8–4.12 and Table 4.5. For
Invasion Scenario 0B, we considered a second set of initial conditions to create
a situation similar to what may appear in some in vitro experiments where the
cancer cell mass forms a strip along the LHS of the domain and invades an ECM
construct from left to right as seen in Figures 4.13–4.17 and Table 4.6.
We find that MMP-2 and TIMP2 are able to diffuse past the boundary of the
cancer cell mass in contrast to the intermediate complex f and MT1-MMP, and
that the MMP-2 profile has a less steep front than that of MT1-MMP. As such, all
matrix degradation in advance of the cancer invasion boundary is the sole domain
of MMP-2 while the degradation of ECM components within this cancer invasion
front is shared by both MMP-2 and MT1-MMP. In addition, the majority of
bulk ECM degradation was due to MMP-2 over the considered timeframe where
the role of MT1-MMP mediated degradation was diminished in comparison to
that of MMP-2 over time (cf. Figure 4.12 and Figure 4.17). This relationship
between MMP-2 and MT1-MMP when it comes to bulk degradation supports
the paradigm proposed by Sabeh, Li, Saunders, Rowe and Weiss (2009) of se-
creted MMPs being functionally limited to bulk collagenolytic processes whereas
MT1-MMP is capable of acting in a focussed manner that supports subsequent
collagenolysis and therefore invasion.
Where we considered the cancer-ECM interface to be defined as the region be-
tween c=0.01 and v=0.01, we were able to provide approximations for the concen-
trations of MMP-2 (0A: 1-4nM, 0B:1-5.5nM) and MT1-MMP (0A&OB: 0.1-5nM)
within this region, then we can provide further approximations for these concen-
trations to the spatially homogeneous steady state and can compare favourably
with biological data found in serum from various forms of cancer of MMP-2 =
2.81nM, 7.89nM, 7.91-10.03nM and MT1-MMP= 0.04nM, 0.38nM.
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Near the leading front of the cell invasion boundary (though not directly upon
the boundary) there is an increase in both the concentrations of the intermediate
complex f and TIMP2 from the concentration where the cancer population has
stabilised at the maximum non-dimensionalised value of 1. This increase in the
intermediate complex, f , was shown to not be due to the initial condition being
higher than this increased amount where in Invasion Scenario 0B f began near
its steady state and reached a maximum of almost twice this value.
A parameter sensitivity analysis finds that an increase in Dc has a larger impact
upon invasion than χ where we assume this to be due to the volume filling term
in the haptotactic sensitivity function limiting the movement of cancer cells in
the cancer-ECM interface. Additionally, we find that there is a value for αT at
which the steady state value of MMP-2 is at a maximum where either an increase
or decrease to this value reduces the value of MMP-2.
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Chapter 5
The Restructuring of ECM by
MT1-MMP in a PDE Model of
Cancer Invasion
5.1 Introduction
In the previous chapter, MT1-MMP was seen to be important in the early stages
of invasion where it outperformed MMP-2 in ECM degradation. However its
primary significance appeared to be due to its activation of MMP-2 which was
then able to diffuse into and degrade the bulk of the ECM (cf. Figure 4.12 A
and Figure 4.17). Although this corresponds to some of the known properties
of MT1-MMP proteins in cancer cell invasion (Sato et al., 1994), it lacks insight
into other roles of MT1-MMP which have been found to be of particular signifi-
cance in cancer invasion. For example, Hotary et al. (2003) consider MT1-MMP
to be a growth factor for cancer cells in a 3D ECM made up of collagen type-I,
both in vivo and in vitro due to its effect of enabling cancer cells to modify their
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shape. In this chapter we will examine MT1-MMP in its role of modifying the
local environment of cancer cells in ways that MMP-2 cannot. This will be done
through the inclusion of the effect the ECM architecture may have when applied
to a model of cancer invasion developed in the previous chapter. Elements of the
ECM architecture to be investigated include the pore size of the matrix and the
crosslinking of collagen fibres. We note that in some highly dense collagen struc-
tures such as breast tissue, the cancer cells are unable to physically fit through
a porous region. In this chapter we consider some cases where cancer cells are
reliant upon their attached MT1-MMP proteins to either forge a path or modify
the cell shape so that it can pass through an otherwise impassable ECM region al-
lowing degradation by either MT1-MMP or MMP-2 to take place and permitting
movement of cancer cells otherwise impossible.
The ECM will therefore need to be examined in greater detail than has been done
so far in the presented work where the architecture of the ECM plays a pivotal
role in cancer cell invasion (Kumar and Weaver, 2009; Friedl and Wolf, 2008; Lu
et al., 2012). Type I collagen fibres are non-branching, fibrous proteins that resist
tensile stresses and are the most common fibres found in the connective tissue
of almost all organs, as well as tendons, ligaments, fasciae, fibrocartilage and
bone (Eroschenko and Di Fiore, 2013). MMP-2 can degrade type-I collagen in
bulk, albeit at a rate 8 times slower than MT1-MMP. However Sabeh, Shimizu-
Hirota and Weiss (2009); Li et al. (2008) investigated embedding multicellular
spheroids of HT-1080 fibrosarcoma cells within gels of cross-linked native type I
collagen and found that MT1-MMP silencing blocks virtually all collagenolytic
and invasive activity. As such, Sabeh, Li, Saunders, Rowe and Weiss (2009)
proposed the paradigm that secreted MMPs are responsible for, but ultimately
limited to, bulk collagenolytic processes whereas MT1-MMP can cause focalised
degradation of ECM through which cancerous cells can then move and further
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Figure 5.1: Invasion of cancer cells through a 3 dimensional, in vivo generated net-
work of collagen type-I. Reproduced from Sabeh, Shimizu-Hirota and Weiss (2009) un-
der a Creative Commons license.
degradation by other MMPs can take place. Connective tissue is mainly formed
of collagen type-I whereas the stability of the basement membrane is determined
primarily by collagen type IV (Ku¨hn, 1995).
While MMPs can collectively degrade virtually all components of the ECM (Kleiner
and Stetler-Stevenson, 1999), when considering an environment of mainly type
I collagen, we must consider the substrates of MMP-2 and MT1-MMP, since
MMP-2 may not be able to degrade fully-formed collagen in vivo. Further, 3-D
collagen-induced surface localization of MT1-MMP leads to MMP-2 activation
(Sakai et al., 2011). There is also uncertainty over the ability of MMP-2 proteins
to degrade collagen type-IV in vivo (Barrett et al., 2012). Zhang et al. (2013)
suggest that MMP-2 is unable to degrade cross-linked forms of collagen type -I
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and -IV.
As more expansively discussed in Chapter 2 of the presented work, collagen fibres
are cross-linked collagen molecules, where collagen molecules are formed from
three strands of collagen proteins. In the case of type I collagen, the three proteins
involved are of two types termed α-1 type I collagen and α-2 type I collagen. The
standard construction of type I collagen is formed from two α-1 type I collagens
and a single α-2 type I collagen, although some variants are formed of three
identical proteins of α-1 type I collagen (Chang et al., 2012). Gioia et al. (2007)
show (in vivo) that MT1-MMP proteins and MMP-2 proteins have functionally
different ways of degrading type I collagen where the ectodomain of MT1-MMP
can bind to either α-1 or α-2 followed by their degradation whereas MMP-2 binds
preferentially to the α-1 chain from which it degrades the α-2 chain. However,
3D in vivo models of collagen type-I have found MT1-MMP proteins and not
MMP-2 proteins modulating cancer cell invasion (Hotary et al., 2000; Sabeh,
Shimizu-Hirota and Weiss, 2009).
Monaco et al. (2006) found that the rate that MMP-2 proteins degrade type IV
collagen to be 1.2 × 104M−1s−1 at 42 and 5 × 103M−1s−1 at 37, while Inada
et al. (2004) found that at 25, MMP-2 degradation of collagen type I is virtually
non-existent. Thus it may be that the partial unwinding of type IV collagen that
happens at increased temperatures (Do¨lz et al., 1988) is what deforms the cross-
linked collagen fibrils into a form that MMP-2 can degrade. Further, Kuznetsova
et al. (2003) find in vitro that homotrimeric type I collagen denaturates 100 times
slower than heterotrimeric collagen when experiments are performed at the same
temperature.
We operate under the assumption that in vitro models of MMP-2 degrading col-
lagen either make use of uncross-linked variants of collagen that do not resemble
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the makeup of collagen in vivo, have MT1-MMP causing partial unwinding of
the collagen before degradation or are performed at temperatures such that the
collagen has become at least partially unwound. As such, we consider the ECM
to be, at times, “protected” from degradation by MMP-2 until remodelled into
an appropriate form by MT1-MMP.
5.1.1 Suitability Modifier: The Means by which Biologi-
cal Traits of the ECM are Modelled
In our model we denote by s(x, t) the suitability modifier as introduced in Deakin
and Chaplain (2013). The suitability modifier acts as an environmental factor by
reducing the proportion of a cell population that can physically move through the
matrix by attempting to take into account the pore size of the collagen substrate
along with reducing the amount of matrix that is considered available to be
degraded.
The two main motivations we consider as means by which the suitability of the
ECM can be changed is:
• regions of smaller pore size can be traversed by cancer cell that have had
their shape adapted; a process that can be achieved by MT1-MMP proteins
(Hotary et al., 2003).
• degradation of cross-linked type I collagen fibrils by MMP-2 proteins may
only be possible once partial degradation by MT1-MMP has occurred.
While we acknowledge that there are other ways of modelling the effects that have
been used to illustrate why the suitability modifier may be used (e.g. multiple
ECM populations), we believe that the consideration of the suitability of the
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matrix may allow for quantifiable comparisons of tissues that will allow for simpler
models and faster computational results. Further, we find that this method offers
a simplified means of considering any combination of these effects, as well as
further effects that may be as of yet uncharacterised, while using the same model.
The combination of these effects would require extensive quantifying of tissues
before allowing for an individual analysis of imaging as input for a patient-specific
approach that is as of yet undeveloped. This would include properties such as the
effects of differing pore sizes on promotion or retardation of cancer cell movement,
specifically in bulk. Once imaging data has been obtained and quantified into a
form compatible with the suitability modifier for s(t = 0), a quicker calculation of
many complicating factors is possible than a more expansive model of split ECM
variables for each component with a more complex initial ECM distribution with
unique properties.
While MMP-2 may not be able to degrade type I collagen in vitro, it is able
to degrade gelatin in vitro and unwound collagen in vivo and we know that
MT1-MMP can degrade collagen into gelatin in vivo, can degrade gelatin in vitro
and can cause the partial unwinding of collagen in vitro. We therefore have
a justification for a suitability matrix that is remodelled by MT1-MMP into a
neural state.
What we do not have is a perfect biologically representative treatment of the
various interactions of ECM constituent parts and the cancer cells, since they are
grouped together into a single term (suitability modifier). However we note that
we do have a simplified presentation of many features that can now be implicitly
incorporated into the model without adding significant complication to the model
equations and therefore computational cost.
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5.2 A PDE Model of Cancer Invasion Including
Further Biological Effects of the ECM
We define a matrix environment with a neutral/no affect on cancer cell invasion
to have a suitability modifier value of 1. This represents a case where the results
of the model are identical to the reduced model where no consideration is placed
on the suitability of the environment, as presented in Chapter 4. A matrix en-
vironment containing difficult regions of ECM for cancer cells to invade will be
represented by a suitability modifier with a value 0 ≤ s < 1, with values towards
zero describing an environment that is more difficult for cancer cells to navigate
through the tissue, as well as a reduction in the amount of ECM that is available
to be degraded. A suitability modifier greater than 1 may be considered where
the environment is structured to encourage cell migration such as is the case in
a “follow the leader”/“Indian chain” dynamic (Schlu¨ter, 2013; Friedl and Wolf,
2003b), although this is not investigated in the present work.
We note that two spatial locations with the same value of ECM density, v, will
not necessarily present the same dynamics depending on the value of the suitabil-
ity modifier at these locations. In addition, an interpretation of the suitability
modifier can be made as follows: a value of s = 1
4
may represent a region that
contains a tissue where (i) 3
4
of the constituent parts of the ECM are cross-linked
collagen, (ii) 3
4
of the considered ECM has a pore size below a threshold α that
blocks invasion, (iii) more than 3
4
of the considered ECM has a pore size in the
range α−β that slows invasion or (iv) some combination of the factors presented
in (i)-(iii) that has the equivalent effect.
We present a modified PDE model of cancer invasion in equations (5.1)-(5.7)
where we have indicated through the functions gi(s, v) reactions that we feel
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further investigation into the effects of the ECM should be considered. We ensure
that there are appropriate functions of gi(s, v) where the model presented in
Chapter 4 can be recovered.
We highlight a minor difference in the way that the terms of ECM degradation are
presented where in the previous chapter, we considered there to be a degradation
rate of both MMP-2 and MT1-MMP which then experiences some scaling factor
of δ2 for the total degradative capability of MT1-MMP. This does not allow for
an examination of cases where MMP-2 is unable to degrade our chosen ECM
structures and so we modify the ECM degradation term of Chapter 4, from
−δ1v(ms + δ2mt) to −(δ1g2(s, v)ms + δ2g3(s, v)mt) where the parameter choices
for δ1 = 1 and δ2 = 1 in Table 4.4 are left unchanged and we note that the forms
of ECM degradation in both chapters are equivalent for this parameter choice.
The full non-dimensionalised model is therefore:
∂c
∂t
= ∇ · (Dc∇c− χcg1(s, v)(1− c− v)∇v) + µcc(1− c− v), (5.1)
∂v
∂t
= −(δ1g2(s, v)ms + δ2g3(s, v)mt) + µv(1− c− v), (5.2)
∂ms
∂t
= ∇ · (Dms∇ms)− φ31Tms + φ32mtf − βmsms, (5.3)
∂mt
∂t
= mt∇ · (Dc∇c− χcg1(s, v)(1− c− v)∇v)
−φ41Tmt + φ42f − βmtmt + αmtc(1 + v), (5.4)
∂T
∂t
= ∇ · (DT∇T )− φ51Tms − φ52Tmt + φ53f + αT c, (5.5)
∂f
∂t
= f∇ · (Dc∇c− χcg1(s, v)(1− c− v)∇v)
+φ61Tmt − φ62fmt − φ63f, (5.6)
∂s
∂t
= δsmt(1− s). (5.7)
We apply zero-flux boundary conditions to close the system. The initial condi-
tions imposed depend on the precise invasion scenario we are considering. In first
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three Invasion Scenarios (1A, 1B, 2) we have a cluster of cancer cells in the centre
of a homogeneous density ECM and suitability defined in the appropriate section
with a small amount of activated enzymes already released. The second grouping
of three Invasion Scenarios will be similar to the first three with the exception of
the layout where we consider a mass of cancer cells moving from left to right.
We simulate the model in 2 spatial dimensions and use the baseline parameters
outlined in Table 4.4, unless otherwise specified, along with the introduction of
δs which will have its value specified on a case by case basis. The key concepts of
the “suitability modifier” are dependent upon 3 dimensional effects such as the
pore sizes of the cross-linked collagen constituent of the ECM, which are then
represented by a numerical value that is applied as a modifier to interactions
involving the ECM. This means that the ECM density does not explicitly consider
these issues and, crucially, two ECM densities of value 0.5 will not necessarily
facilitate invasion in the same way if the corresponding “suitability matrix” values
are different at the two locations.
In Chapter 4, we considered the density of the ECM components to be the sole
factor of importance of the ECM when it came to the ability of MMPs to degrade
ECM components and cancer cells to move. As such, when the choice of g1(s, v) =
g2(s, v) = g3(s, v) = v is made, the model presented in Chapter 4 is recovered. In
this chapter, we now consider other characteristics of the ECM that may impact
on cancer cell growth and invasion before proposing alternative forms for the
functions g1(s, v), g2(s, v), g3(s, v).
Identifying appropriate functions (gi) by which the suitability modifier may be
modelled is done by first recognising that the choice of g1(s, v) = g2(s, v) =
g3(s, v) = v recovers the model presented in Chapter 4. This, however, completely
ignores the introduction of the suitability modifier but as we hope to extend the
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previous model, we impose the condition that where the suitability modifier is
neutral, i.e. s = 1, the previous model of equations (4.9)-(4.14) is recovered,
g1(1, v) = g2(1, v) = g3(1, v) = v. For example:
• s = 1 provides a neutral environment when g1(1, v) = g2(1, v) = g3(1, v) =
v.
• 0 ≤ s < 1 provides an environment that is less effective than the neutral
case.
• s > 1 provides an environment that actively facilitates invasion.
• if s1 < s2 then s2 is an environment that offers increased invasive potential.
There are many possible forms for the functions g1(s, v), g2(s, v), g3(s, v) that may
be appropriate. Some such forms are as follows: v, sv, sn−1+v, (s−1)n+v, s
n + a
a+ 1
.
In Figure 5.3 we plot the suitability modifier against the ECM density for the
examples where n = 1 and a = 1 of v, sv, s− 1 + v, s+ 1
2
v.
In Figure 5.3 A we have a case where the suitability modifier plays no role and
there is a linear increase in v. In plot B we have very small output from the
function unless v + s ≥ 1. In plot C we find have to incorporate the condition of
v+s ≥ 1 and so the function is not valid where this condition is not met. We have
contours of constant values along the line v = s. In plot D we have a stretched
version of plot B where we note that plot B would be the result of
sn + a
a+ 1
where
a = 0 and plot D is the case where a = 1. Notably from this representation of
gj(s, v) we have that when s = 1, we have a v that varies between
1
2
and 1. In all
four plots we have that v increases linearly from 0 to 1 when s = 1.
The precise form of g1(1, v), g2(1, v), g3(1, v) that we choose to use for the remain-
der of this chapter is g1(s, v) = g2(s, v) = g3(s, v) = −(1 − s − v). This is an
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Figure 5.2: Plot A shows the function gi(s, v) = v. Plot B shows the function
gi+1(s, v) = vs. Plot C shows the function gi+2(s, v) = −(1 − s − v) when consid-
ered with the condition of gi+3(s, v) = s+ v ≥ 1 and Plot D shows the function v s+12 .
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extension to the volume filling principles, though we note that s and v should
not be considered to be “in competition” with one another. The current form of
the model must also introduce further conditions that prevent the considering of
the feature of s > 1 promoting invasion through a “follow the leader”/“Indian
chain” dynamic (Schlu¨ter, 2013; Friedl and Wolf, 2003b). As such we impose the
conditions that s + v ≥ 1 and s ≤ 1, otherwise, instead of limiting movement
(g1(s, v)), movement would be encouraged in the opposite direction and instead
of limiting tissue degradation (g2(s, v) and g3(s, v)), the tissue degradation term
would cause the density of ECM to increase. Furthermore, we note that the
degradation of ECM term stops v from being degraded below s− 1 + v = 0 and
that the remodelling of ECM is only negative where c + v ≥ 1, therefore the
minimum v value that can be achieved is v = 1− s and we have the condition for
the model of v + s ≥ 1.
We consider the impact this has on the haptotactic sensitivity function where we
now have (s − 1 + v)(1 − c − v) by plotting in Figure 5.3 this function at four
values of c = 0, 0.25, 0.5, 0.75. Care must be taken when reading this figure to
ensure that the correct scale of the axis and value is read as we have imposed the
conditions of c+ v ≤ 1 and v + s ≥ 1.
5.3 Results
We consider the same dummy variables (∆vms and ∆vmt) and functions (∅ =
1 − c − v and ∆vtotal) as in the previous chapter in addition to the function
of γ = s + v − 1 which is used to show where there is potential tissue to be
degraded by MMP-2, as well as verifying that s + v ≥ 1 to ensure that ECM
degradation has a negative impact on total ECM density. The function γ also
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Figure 5.3: Plots A-D are of the function (s − 1 + v)(1 − c − v), which is the value
of haptotactic sensitivity function where g1 = s− 1 + v. Each plot (A-D) is the repre-
sentation of the function where c = 0, 0.25, 0.5 and 1, respectively. We draw particular
attention to the ranges of s and v in each plot and the value of the maximum as these
decrease from plot A → plot B → plot C → plot D.
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serves to illustrate how the suitability modifier affects the degradation of ECM or
movement of cancer cells. We also consider the function λ1 = mt(1− s) to show
where there is an overlap of MT1-MMP and suitability modifier of value < 1
which indicates the amount of suitability modifier that is in the process of being
remodelled back to the neutral state and indicates the regions that retard cancer
cell movement. The third and final function that we introduce is λ2 = ms(1− s)
which allows us to identify the regions in which MMP-2 degradation of ECM is
being impacted upon.
We now present the computational simulation results of our invasion model in
a 2-dimensional spatial domain (all parameter values are from the baseline set
found in Table 4.4). We consider 6 Invasion Scenarios formed from varying either
the initial conditions of the model or the parameter δs to identify characteristics
of results obtained by the model that may offer insight into either in vivo or in
vitro experiments.
We plot the time evolution of the various variables as well as noting some results
that are not immediately obvious from these plots, namely, the amount of tissue
degradaded by MMP-2 and MT1-MMP individually and offer a comparison of
these values.
The first grouping of scenarios (Invasion Scenarios 1A, 1B, 2) considers an initial
mass of cancer cells represented by a Gaussian distribution in the centre of a
two dimensional square domain along with two specific forms the surrounding
media can take (two initial condition data for s) along with v(0) = 1 − c(0),
ms(0) = mt(0) = T (0) = f(0) = 5c(0). These can be seen as comparable with
Invasion Scenario 0A. The second grouping of scenarios (Invasion Scenarios 3A-)
consider an initial strip of cancer cells on the left hand side of the domain and
how they proceed to invade through some varyingly heterogeneous surrounding
127
media along with v(0) = 1 − c(0), ms(0) = mt(0) = T (0) = f(0) = c(0). These
can be seen as comparable with Invasion Scenario 0B.
Invasion Scenario 1A is the first scenario we consider in which the tissue is consid-
ered to have a neutral effect on invasion in the top half of the domain by having a
matrix suitability modifier s = 1, with the lower half of the domain having mod-
erate characteristics limiting invasion by having the matrix suitability modifier of
s = 1
2
, as shown in Figure 5.4 C. This splits the domain into two regions where the
upper region, which has s(t = 0) = 1 and therefore has dynamics present in this
region that are identical to that of simulating the model presented in Chapter 4,
where the suitability modifier is not considered at all. The only minor difference
in comparing it with the previous model is that there is no zero flux boundary
across the line defined by y = 0 and therefore some movement of cancer cells
from the unrestricted upper region into the lower region is possible.
The lower region, on the other hand, is the first simulated result where the effects
of the suitability modifier are considered. This creates an asymmetric invasion
of the cancer cells as can be seen from the plots in Figure 5.4 with a reduced
invasion in the lower half of the domain (cf. Figure 5.4 D) and also an increased
overall ECM profile in the lower half of the domain (cf. Figure 5.4 E).
Figures 5.5 & 5.6 show the corresponding evolution of the various enzyme con-
centrations. The plots in Figures 5.5 F & 5.6 F show that any free TIMP2 that is
produced or released from a complex is quickly bound to either free MT1-MMP
or MMP-2. The plots in Figures 5.5 D & 5.6 D show that while MMP-2 can
freely diffuse throughout the environment, its profile is affected by the source
term coming from the asymmetric cancer cell invasion dynamics. The plots in
Figures 5.5 E & 5.6 E show how the degradative effect of MT1-MMP is limited
by its dependence on transport by the cancer cells. This is demonstrated by a
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reduced invasive profile in the bottom half of each plot.
In Figure 5.7 we note that there is a higher amount of degradation of tissue in
the upper half of the region where we have considered s(t = 0) = 1. This shows
the degree to which the suitability modifier has limited ECM degradation.
In Figure 5.8 we perform domain integrations of the variables v, c, ∅, λs, λt,
∆vtotal, ∆vms, ∆vmt, ms and mt to better examine the contributions of these
variables to the dynamics of the model across the considered timeframe of t =
0 − 40, corresponding to 4.6 days. We specifically note that while the domain
integration of ∆vtotal reaches ∼ 16 by t = 40, this should not be taken to mean
that the entirety of the ECM has been degraded as the ECM is remodelled (gained
density/recovered) over time. Indeed we note that the domain integration of v
at t = 40 is approximately 7
8
th the value of what it was initially. By plotting
the domain integrations of ms and mt we have shown that the difference between
∆vms and ∆vmt is not down to the relative concentrations of MMP-2 and MT1-
MMP (which are the same) but instead due to their relative locations (cf. Figure
5.4 and 5.5) where MMP-2 can diffuse past the boundary of the cancer cells,
which defines the full extent of MT1-MMP location, and gain access to ECM
that MT1-MMP cannot reach.
Finally, in Figure 5.9 we plot the location for the free space ∅ = 1−c−v and the
function s− 1 + v to gain insight into how the suitability modifier is influencing
cellular locomotion (g1 = s− 1 + v) and ECM degradation (g2 = g3 = s− 1 + v).
We note that degradation of ECM can only happen where s − 1 + v > 0 and
that haptotaxis of cancer cells to ECM gradients can only occur where both
1 − c − v > 0 and s − 1 + v > 0. While we refer the reader back to Figure 5.3
to see the plotting of (s − 1 + v)(1 − c − v) for s against v for various chosen
c to get an idea of what some of these values may be, we can use Figure 5.9 to
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Figure 5.4: Invasion Scenario 1A. Plots A-C show the initial values of the cancer cell
and ECM densities as well as the initial stucture of the matrix suitability modifier with
D-F showing their resultant profiles at t = 40 (corresponding to ∼4.6 days). Simulations
are performed using the baseline parameter set of Table 4.4 along with δs = 0.025.
see the locations where both 1 − c − v > 0 and s − 1 + v > 0 and can draw the
conclusion that the suitability modifier has blocked haptotaxis in the bottom half
of the domain where s− 1 + v = 0 at all points where c > 0 despite the volume
filling term not blocking haptotaxis at this location.
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Figure 5.5: Invasion Scenario 1A. The concentrations of MMP-2, MT1-MMP, the
intermediary complex f and TIMP2 are shown in plots A,B,C and F respectively at
t = 20 (corresponding to ∼2.3 days). Plots D, E show the MMP-2 and MT1-MMP
concentrations at t = 20 with appropriate thresholds near the invasive front of the
cancer cell invasion. The white contour line shows the cancer cell density at level 0.01
chosen to represent the maximum extent of invasion. Simulations are performed using
the baseline parameter set of Table 4.4 along with δs = 0.025.
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Figure 5.6: Invasion Scenario 1A. The concentrations of MMP-2, MT1-MMP, the
intermediary complex f and TIMP2 are shown in plots A,B,C and F respectively at
t = 40 (corresponding to ∼4.6 days). Plots D, E show the MMP-2 and MT1-MMP
concentrations at t = 40 with appropriate thresholds near the invasive front of the
cancer cell invasion. The white contour line shows the cancer cell density at level 0.01
chosen to represent the maximum extent of invasion. Simulations are performed using
the baseline parameter set of Table 4.4 along with δs = 0.025.
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Figure 5.7: Invasion Scenario 1A. Plots A & B show the profiles of the density of
ECM degraded solely by ms, while plots C & D show the profiles of the density of
ECM degraded solely by mt at t = 20 and 40 (corresponding to ∼2.3 and 4.6 days,
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Figure 5.8: Invasion Scenario 1A. Domain integrations of various variables and func-
tions where plot A features
∫
c,
∫
v and
∫
∅ =
∫
1−c−v representing the total amount of
cancer cell density (red), ECM density (green) and amount of free space (blue), respec-
tively. Plot B features
∫
λ2 =
∫
ms(1−s) and
∫
λ1 =
∫
mt(1−s) to represent the amount
of overlap between the suitability modifier with MMP-2 (magenta) and with MT1-MMP
(cyan), respectively. Plot C features
∫
∆vtotal,
∫
∆vms, and
∫
∆vmt, to represent the
total amount of ECM degraded (black), total ECM degraded by MMP-2 (blue) and total
ECM degraded by MT1-MMP (red). Plot D features
∫
ms and
∫
mt to represent the
total amount of MMP-2 (magenta) and MT1-MMP (cyan), respectively. Simulations
are performed using the baseline parameter set of Table 4.4 along with δs = 0.025.
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Figure 5.9: Invasion Scenario 1A. The function of ∅ = 1 − c − v is plotted in plots
A-C for the times of t = 0, 20 and 40 while the function of s − 1 + v is plotted in
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0.01 chosen to represent the maximum extent of invasion. Simulations are performed
using the baseline parameter set of Table 4.4 along with δs = 0.025.
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Invasion Scenario 1B follows on from Invasion Scenario 1A, which we note
offers a clear comparison between the dynamic of results obtained from the model
presented in Chapter 4 (cf. upper region of plots D, E and F in Figure 5.4) and
results obtained when the suitability modifier is actively impacting the spread of
cancer cells and the degradation of ECM (cf. lower region of plots D, E and F in
Figure 5.4). We now proceed to consider what impact having a considerably high
value of δs in a scenario that is otherwise the same as Invasion Scenario 1A. By
having such a high value for δs, we are representing the unfit matrix being very
quickly remodelled into a neutral state. By doing so, we will again be able to
compare the upper and lower regions (separated by the line y = 0) to determine
what effect a rapidly neutralised suitability modifier will have on the growth and
spread of cancer cells.
We offer only a minimal interpretation and presentation of the results of this In-
vasion Scenario as we note that this is only minimally varied from that of Invasion
Scenario 1A. As such, we have condensed the results presented into a singular fig-
ure of Figure 5.10 where we show the resultant profiles at t = 40 (corresponding to
∼ 4.6 days) of cancer cell density, ECM, suitability modifier and concentrations of
MMP-2, MT1-MMP, the intermediate complex of TIMP2:MT1-MMP:proMMP-2
and TIMP2 in the plots of A-F and I, respectively. We also consider the presence
of MMP-2 and MT1-MMP when within defined concentration ranges.
It can be seen from the plot in Figure 5.10 A that the cancer cells invade in an
almost symmetric manner (unlike the scenario in Figure 5.4 D). However, we can
also see from the plot in Figure 5.10 B that there is a reduced ECM profile in
the upper half of the domain compared with the lower half. This is due to a
limiting of ECM degradation beyond the cancer cell boundary in the lower half
of the domain which can only be due to a reduction in ECM degradation by
MMP-2. While the cancer cell profile is near symmetric and the ECM profile is
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asymmetric, we note that the remaining variable of ms,mt, T and f all appear
to be as symmetric as the cancer cell profile. This is due to the reliance of these
variables on cancer cells for production or activation depending on enzymes found
to cancer cells.
137
c(t=50)
A B C
D
s(t=40)
c(t=40)
-2
-1
0
1
2
-1 0 1 2-2
-2
-1
0
1
2
-1 0 1 2-2
-2
-1
0
1
2
-1 0 1 2-2
c(t=0)
-1 0 1 2-2
-2
-1
0
1
2
-2
-1
0
1
2
-1 0 1 2-2
-2
-1
0
1
2
-1 0 1 2-2
c(t=50)
E F
G H I
>1
<0.25
>1
1
≥ms≥
0.25
<0.25
ms(t=40)
T(t=40)
f(t=40)
1
≥mt≥
0.25
mt(t=40)ms(t=40)
1.6
1.2
0.8
0.4
0
2 f( 2 )
(t 2 ) 2
mt(t=20)
T(t 20)
0
0.01
0.02
0.03
0.04
0
2
4
6
8
10
12
14
16
0
2
4
6
8
10
12
14
16
T(t=40)
s(t 40) mt(t=40)
-1 0 1 2-2
-2
-1
0
1
2
-2
-1
0
1
2
-1 0 1 2-2
-2
-1
0
1
2
-1 0 1 2-2
s(t=40)v(t=40) 1
0.8
0.6
0.4
0.2
0
1
0.8
0.6
0.4
0.2
0
1
0.8
0.6
0.4
0.2
0
s(t )(t )
s(t ) t(t 4 )
(t ) ( )
Figure 5.10: Invasion Scenario 1B. Simulations are performed using the baseline
parameter set of Table 4.4 along with the key constant of δs = 10. Plots A-C show
the values of the cancer cell and ECM densities as well as the initial layout of the
matrix suitability modifier at t = 40 (corresponding to ∼4.6 days). Plots D-G show
the concentrations of MMP-2, MT1-MMP, the intermediary complex f and TIMP2 at
t = 40 (corresponding to ∼4.6 days). Plots H, I show the MMP-2 and MT1-MMP
concentrations at t = 40 with appropriate thresholds near the invasive front of the
cancer cell invasion. The black contour line shows the cancer cell density at level 0.01
chosen to represent the maximum extent of invasion.
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Invasion Scenario 2 considers the tissue to have neutral effects on invasion in
a diagonal strip across the region by having a matrix suitability modifier s = 1,
while the remaining domain is considered to have characteristics that strongly
limit invasion by having the matrix suitability modifier of s = 1
4
, as shown in
Figure 5.11 C. All parameters are kept at the baseline values and we use the same
initial conditions as Invasion Scenario 1A, with the exception of s(t = 0) defined
above. As can be seen from the plots in Figure 5.11 we observe an asymmetric
invasion by the cancer cells, with a reduced invasion in the region where s was
originally s = 1
4
(cf. Figure 5.11 D) and also a reduced degradation of ECM in
this region (cf. Figure 5.11 E).
Figures 5.12 & 5.13 show the corresponding evolution of the various enzyme
concentrations using the baseline parameter set. The plots in Figures 5.12 F &
5.12 F show that we retain the characteristic of any free TIMP2 that is produced
or released from a complex is quickly bound to either free MT1-MMP or MMP-
2. In comparing these two plots, it can be seen that there is a higher TIMP2
concentration in the invading front when there is a more suitable matrix to be
invaded, i.e. where s = 1. Evaluation of the other enzyme concentrations shown
in Figures 5.12 A–E & 5.12 A–E shows similar insight as was obtained from
Invasion Scenario 1A.
Plots showing the simulation results obtained in a two-dimensional domain where
asymmetric invasion of the ECM is achieved by the cancer cells. We use the
matrix suitability modifier s to represent a medium with neutral abilities in the
upper half of the region (s = 1; red) and with a reduced, moderate, suitability
for invasion in the lower half (s = 0.5; green).
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Figure 5.11: Invasion Scenario 2. Plots A-C show the initial values of the cancer cell
and ECM densities as well as the initial layout of the matrix suitability modifier with D-
F showing their resultant profiles at t = 80 (corresponding to ∼9.2 days). Simulations
are performed using the baseline parameter set of Table 4.4 along with the key constant
of δs = 0.025.
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Figure 5.12: Invasion Scenario 2. Plots A-C show the initial values of the cancer cell
and ECM densities as well as the initial layout of the matrix suitability modifier with D-
F showing their resultant profiles at t = 40 (corresponding to ∼4.6 days). Simulations
are performed using the baseline parameter set of Table 4.4 along with the key constant
of δs = 0.025.
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Figure 5.13: Invasion Scenario 2. Plots A-C show the initial values of the cancer cell
and ECM densities as well as the initial layout of the matrix suitability modifier with D-
F showing their resultant profiles at t = 40 (corresponding to ∼4.6 days). Simulations
are performed using the baseline parameter set of Table 4.4 along with the key constant
of δs = 0.025.
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Figure 5.14: Invasion Scenario 2. Plots A & B show the profiles of the density of
ECM degraded solely by ms, while plots C & D show the profiles of the density of
ECM degraded solely by mt at t = 20 and 40 (corresponding to ∼2.3 and 4.6 days,
respectively). The white contour line in plots C & D and black contour line in plots A
& B shows the cancer cell density at level 0.01 chosen to represent the maximum extent
of invasion. Simulations are performed using the baseline parameter set of Table 4.4
along with the key constant of δs = 0.025.
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Comparison of Invasion Scenarios 0A, 1A, 1B, 2 is offered up here where in recog-
nising that the six Invasion Scenarios proposed in this chapter can be separated
into two groups that bear similarities to the Invasion Scenarios of the previous
chapter, we compare the results obtained from each to see what conclusions we
can draw from the results. Here, we consider the first three Invasion Scenarios
proposed in this chapter of 1A, 1B and 2 with the first Invasion Scenario proposed
in the previous chapter of 0A.
We can compare Invasion Scenarios 1A and 1B in order to examine the effect of
the parameter δs on cancer cell invasion. Invasion Scenarios 0A and 1B can
be compared to establish the connection between no consideration of a suit-
ability modifier (s(t = 0) = 1) and the case where the suitability modifier is
quickly remodelled by MT1-MMP (δs >> 0). In comparing the initial overlap of
c(0)(1−s(0)) for IS1A & 1B with IS2, we find that they begin at different values.
This means that we cannot directly compare IS2 with either IS1A or IS1B to
obtain precise results for the effect of the parameter δs, however some general
trends may be commented on, such as the effect of s(0) on later time cancer cell
invasion. Further, IS2 can be compared with IS0A to understand the effects that
the suitability modifier has had on cancer cell invasion when presented with the
scenario of s(t = 0) and δs in IS2.
We present three tables; Tables (5.1, 5.2) and (5.3), to show domain integra-
tion data and some functions thereof obtained from the model presented in this
chapter of equations (5.1)-(5.7) when solved with the parameters defined in the
previous chapter in Table 4.4. This has been done so that there is able to be a
meaningful comparison with the results obtained in the previous chapter for In-
vasion Scenarios 0A&B. One such method for comparing total amount of MMPs
present at various time steps is to scale the subdomain integration over a suit-
able domain or other term. We have decided to scale it against the subdomain
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integration of c here. We also consider the proportion of ECM that has been
degraded by the two functionally different MMPs and how much the suitability
matrix has changed.
We label the functions identified in Table 5.3 as the following: α = ms
c
, β =
mt
c
, γ = ms
mt+ms
, δ = mt
mt+ms
,  = ∆vms
∆vmtotal
, ζ =
∆vmt
∆vmtotal
, η = s
s(t=0)
, θ = s − s(t =
0), ι = T
c
While a parameter sensitivity is offered in the previous chapter, the inclusion of
the suitability matrix incorporates a new parameter (δs) and more importantly,
further consequences that can be discussed. As we note that Invasion Scenarios
1A&B are identical with the exception of the parameter δs, we choose to consider
the impact of the parameter δs on cancer cell invasion by varying it and in doing
so we can view Invasion Scenarios 1A&B.
We explore the following functions in Table (5.4): A = [
∫
s(25) dx]δs=ψ−∫ s(0) dx,
B = [
∫
c dx]δs=ψ − [∫ c dx]δs=0.025, C = [∫∆vtotal]δs=ψ − [∫∆vtotal]δs=0.025, D =
[
∫
∆vmt∫
∆vtotal
]δs=ψ − [
∫
∆vmt∫
∆vtotal
]δs=0.025, E = tc.
We consider 8 possible parameter values for δs of 0, 0.005, 0.015, 0.025, 0.05, 0.1,
1, 10 and record various data from each simulation. We first show in Table 5.4
(A) the amount that the suitability modifier has changed by where it logically
proceeds that we consider the minimum to be 0 where δs = 0 and record the
changes from this choice of δs instead of from δs = 0.025, (B) the amount specific
results change from the values obtained for the choice of δs = 0.025 for the
results of the total cancer cell density, (C) the total ECM degradation and (D)
the proportion of the ECM degradation that has been achieved by MT1-MMP.
We note that the values of [
∫
c dx]δs=0.025 = 0.64, [
∫
∆vtotal]
δs=0.025 = 6.98 and
[
∫
∆vmt∫
∆vtotal
]δs=0.025 = 0.28 were recorded to provide the values that the other choices
for δs are recorded to deviate from. As a final result (E), we consider the time,
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IS t c v ∅ ms mt T f s
0A 0 0.06 15.94 0 0.31 0.31 0.31 0.31
1A 0 0.06 15.94 0 0.31 0.31 0.31 0.31
1B 0 0.06 15.94 0 0.31 0.31 0.31 0.31
2 0 0.06 15.94 0 0.31 0.31 0.31 0.31
0A 20 0.57 13.14 2.29 5.29 6.02 0.04 1.19 NA
1A 20 0.44 14.14 1.42 2.41 2.69 0.08 1.69 12.10
1B 20 0.57 13.51 1.92 5.22 5.88 0.04 1.24 12.38
2 20 0.53 14.48 0.99 2.62 2.95 0.08 1.91 6.87
0A 40 2.01 9.11 4.88 24.75 25.69 0.07 3.14 NA
1A 40 1.51 11.79 2.70 8.84 8.62 0.16 4.81 12.30
1B 40 1.97 10.01 4.02 24.32 25.24 0.07 3.08 12.90
2 40 1.39 12.99 1.62 9.08 8.36 0.13 4.26 7.18
Table 5.1: Invasion Scenarios 0A, 1A&B, 2. The domain integration of the model
variables at t = 0, 20 and t = 40 (corresponding to 0 days, ∼2.3 days and ∼4.6 days).
We note that all the Invasion Scenarios detailed here have the same initial conditions
with the exception of s and therefore identical domain integration values at t = 0 for
the remaining variables.
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IS t ∆vtotal ∆vms ∆vmt
0A 0 0 0 0
1A 0 0 0 0
1B 0 0 0 0
2 0 0 0 0
0A 20 7.29 6.21 1.08
1A 20 4.83 3.43 1.40
1B 20 6.25 5.18 1.07
2 20 4.06 2.56 1.50
0A 40 25.72 23.04 2.68
1A 40 15.45 11.55 3.94
1B 40 21.66 19.01 2.65
2 40 10.80 7.46 3.34
Table 5.2: Invasion Scenarios 0A, 1A&B, 2. The domain integration of how much
degradation has occurred due to each and both of the MMPs considered at t = 0, 20
and t = 40 (corresponding to 0 days, ∼2.3 days and ∼4.6 days). We note that all the
Invasion Scenarios detailed here have the same initial conditions with the exception of
s and therefore identical domain integration values at t = 0 for the remaining variables.
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α β γ δ  ζ η θ ι
Scenario0A 12.31 12.78 0.49 0.51 0.90 0.10 NA NA 0.03
Scenario1A 5.85 5.71 0.51 0.49 0.75 0.25 1.02 0.27 0.11
Scenario1B 12.35 12.81 0.49 0.51 0.88 0.12 1.07 0.87 0.04
Scenario2 6.53 6.01 0.52 0.48 0.69 0.31 1.05 0.37 0.09
Table 5.3: Comparison of Invasion Scenarios 0A–2. The subdomain integration of
functions of the model variables where we define these functions (α–$ι) in the text.
Results are found at t = 40 unless otherwise specified. The values of the subdomain
integration for specific variables for Invasion Scenario 0A, 1A, 1B, 2 can be found in
Tables 5.1 and 5.2.
tc, when the switch from more degradation being due to MT1-MMP to more
degradation from MMP-2.
From columns A–C we can determine that an increase in parameter δs causes an
increase in the amount of suitability modifier that has been remodelled, an in-
crease in the amount of total cancer cells and an increase in the total degradation
of ECM.
Additionally, we find from these data is that the proportion of ECM that is
degraded by MT1-MMP is reduced for the cases where δs is reduced and increased
for when we have an increased δs. This result appears paradoxical at first as we
would expect that by decreasing δs we would increase the amount of time that
certain ECM is considered unavailable to be degraded by MMP-2. Indeed, when
we compare the results obtained from Table 5.3 for proportion of degradation by
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MT1-MMP between Invasion Scenario 1A and 1B at t = 50, we find that there is
a marked reduction in the amount of degradation of ECM by MT1-MMP in IS1B
from 1A (25% to 12%) where the parameter δs has increased from δs = 0.025
to δs = 10. This results in a contradiction that requires further examination
and so we consider the plots of
∫
∆vms and
∫
∆vmt to find some clarity. We
find that for early times we have more than half of the degradation being done
by MT1-MMP with a switch occurring at t = tc where more than half of the
degradation is being done by MMP-2. We note that as degradation by MMP-2
increases at a quadratic rate of a higher power, the proportion of degradation as a
result of MT1-MMP decreases as the time progresses. In comparing the amount
of degradation by MMP-2 for each δs, we do find that there is an increase as δs
increases however this is balanced at lower timeframes by the increase in tc for
increasing δs. As such we have identified that for lower timeframes, there is an
increase in the proportion of degradation of ECM by MT1-MMP for increasing
δs whereas for longer timeframes, there is the reverse where an a decrease in the
proportion of degradation of ECM by MT1-MMP for increasing δs
We compare the data obtained for Invasion Scenario 0A and 1B in Tables 5.1 and
5.2 and find that having a high δs is almost analogous to having no suitability
modifier considered with the exception of a reduced degradation of ECM in ad-
vance of the cancer invasion boundary where s < 1 (cf. Figure 4.8 E and Figure
5.4 E). We show in Figure 5.15 that the amount of overlap between cancer cells
and the suitability matrix, that is to say the value of c(1 − s), increases for a
decreasing δs where there is virtually no overlap across the considered timeframe
for the case where δs = 10.
We note that for the case where there is a high δs, which is understood as a
case where the suitability modifier is rapidly remodelled upon contact with the
MT1-MMP attached to cancer cells, we recover many of the details, though not
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Figure 5.15: Invasion Scenario 1A. We show the values of c(1−s) across a timescale
of t = 0− 25 for varying values of the parameter that represents the remodelling of the
suitability of the matrix, δs = 0, 0.005, 0.015, 0.025, 0.05, 0.1, 1 and 10. Simulations are
performed using the baseline parameter set of Table 4.4 along with the indicated values
of δs.
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ψ A B C D E
0 0 -0.08 -0.24 -0.01 -0.06
0.005 0.03 -0.06 -0.18 -0.01 -0.04
0.015 0.08 -0.03 -0.07 -0.01 -0.02
0.025 0.11 0 0 0 0
0.05 0.17 0.04 0.11 0 0.05
0.1 0.22 0.08 0.24 0.01 0.14
1 0.44 0.16 0.65 0.03 0.89
10 0.57 0.19 1.05 0.04 0.90
Table 5.4: The amount that functions A–E, defined in the text, have increased or
decreased at t=25 for when the parameter δs has a range of values 0-10 where we
measure the variation from δs = 0 in A and δs = 0.025 for B-E.
all, that are representative of the model from the previous chapter. The reason
for the similarity, though not replication, is that as MT1-MMP rapidly remodels
the suitability modifier, g1 = g2 = g3 = v where c > 0. As g1 and g3 would
only matter where there already exists either cancer cells or MT1-MMP attached
to cancer cells, it is only g2 that offers meaningful difference from the model of
the previous chapter where g2 = v. We have therefore determined that for cases
where δs is high, we have a model that is an extension from the previous model
only where MMP-2 is limited in its ability to degrade the ECM in advance of the
cancer cell boundary. By setting the diffusion rate of MMP-2 to 0, we would in
fact have the two models converging as δs →∞.
Invasion Scenario 2 can be seen as an alternative exploration from that of Invasion
Scenario 1A of the effects of the suitability modifier where the two scenarios have
the same parameters and initial conditions with the exception of
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We note that there appears to be two classifications of results where Scenario
0A and 1B exist as one such classification while Scenario 1A and 2 represent
the other. More specifically, we note that for Invasion Scenarios 0A and 1B we
have that invasion has not been significantly hampered by the suitability matrix
(where Invasion Scenario 0A is equivalent to a neutral s(t = 0) = 1 and as such
is the scenario the others are compared to to measure the effect of the suitability
modifier).
When examining Table 5.3, we make the following remarks:
(i) the ratio of total MT1-MMP to MMP-2 across the entire domain is approxi-
mately equal for all scenarios (ii) in the scenarios where MT1-MMP is less signif-
icant than MMP-2 (Invasion Scenarios 0A and 1B: where there is comparatively
less a proportion of ECM degraded by MT1-MMP when compared to MMP-2 and
there is either no suitability modifier to remodel or a high value of δs) we have
that there is a higher proportion of MT1-MMP than MMP-2 despite the previ-
ously shown results of the MMP-2 being freely diffusive and as such being able
to extend past the cancer cell invasive boundary while MT1-MMP is restricted
by the movement of the cancer cells and cannot extend beyond the cancer cell
invasive boundary.
The subdomain integration of TIMP2 concentration divided by the cancer cell
density is either ∼ 0.03 − 0.04 (Scenarios 0A, 1B) or ∼ 0.09 − 0.11 (Scenarios
1A, 2) at t = 40 where we note that the stable steady state would provide
a TIMP2 concentration of 0.01nM and a cancer cell density of 1 across the 4
by 4 domain providing a TIMP2 concentration scaled by the cancer density of
0.01, a value below either result obtained from the dynamically evolving results.
The approximately threefold results for TIMP2 concentration scaled by cancer
cell density in the second grouping of scenarios correlates with the the scenarios
152
where the cancer cells have been the least successful in growing and spreading.
We further note that as the function of the domain integrals T
c
reduces (Invasion
Scenario 1A and 2 → 1B and 0A) we see am increase in total cancer cell density
(1.51 and 1.39 →1.97 and 2.01). From this we may suspect that an increase
in TIMP2 concentration may lead to a decrease in invasion from the ability of
TIMP2 to inhibit the matrix degrading capabilities of MMP-2 however upon
inspection of the spatial layout of TIMP2 in Invasion Scenario 1A in Figures
5.5 F & 5.6 F we see the increase in TIMP2 concentration is in the top half of
the domain where we have an increased and active invasion. This paradoxical
definition of an increased invasion where there is an increased concentration of
TIMP2 while a lower overall TIMP-2 concentration benefits invasion means that
TIMP2 cannot be an effective indicator of tumour invasiveness on its own.
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t c v ms mt T f s ∆vtotal ∆vms ∆vmt
0 2.00 14.00 2.00 2.00 2.00 2.00 9.00 0 0 0
100 7.26 6.74 147.60 147.90 0.09 6.71 11.30 43.24 36.02 7.22
Table 5.5: Invasion Scenario 3A. Table showing the subdomain integration at t = 0
and t = 100 (corresponding to 0 days and ∼11.5 days) of the model variables in addition
to the inclusion of how much degradation has occurred due to each and both of the MMPs
considered.
Invasion Scenario 3A examines computational simulation results of cancer
cell invasion in a more heterogeneous environment such as would be expected in
certain in vitro experiments (and also in vivo). For this scenario, we used the
baseline parameter set, except for the parameter δs which is reduced by a factor
of ten to a value of 0.0025. The plots in Figures 5.16 D–F show that the cancer
cells take a longer time to invade the less suitable regions of ECM resulting in
a heterogeneous invasion pattern. In Figure 5.16 F, we can see that there are
regions of higher cancer cell density (small red zones) in advance of regions of
lower cancer cell density (small green zones) but without having broken off from
the main mass entirely. The corresponding plots of the concentrations of MMP-2
and MT1-MMP at t = 10, 50, 100.
Figure 5.17 shows the plots of the corresponding MMP-2 and MT1-MMP con-
centrations. Plots A-C show the MMP-2 concentration at t = 10, 50 and 100
(corresponding to ∼1.15, 5.75 and 11.5 days, respectively), while plots D–F show
the MT1-MMP concentration at t = 10, 50 and 100 respectively.
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Figure 5.16: Invasion Scenario 3A. Plots showing the simulation results obtained in a
two-dimensional domain with a spatially complex matrix suitability modifier s to more
accurately depict the observations of certain in vivo experiments. Plots A-C show the
initial values of the cancer cell and ECM densities as well as the initial structure of the
matrix suitability modifier. Plots D-F show the resultant profiles of cancer cell density
at t = 10, 50 and 100 (corresponding to ∼1.15, 5.75 and 11.5 days, respectively). The
white contour line shows the cancer cell density at level 0.01 chosen to represent the
maximum extent of invasion. Plots G-I show the resultant profiles of ECM density at
t = 10, 50 and 100. The simulations were performed using the baseline parameter set
with the exception of the parameter δs = 0.0025.
155
-2
-1
0
1
2
-1 0 1 2-2
-2
-1
0
1
2
-1 0 1 2-2
-2
-1
0
1
2
-1 0 1 2-2
-1 0 1 2-2
-2
-1
0
1
2
-2
-1
0
1
2
-1 0 1 2-2
-2
-1
0
1
2
-1 0 1 2-2
c(t=50)
c(t=50)
A B C
D FE
ms(t=10)
v(t=10) v(t=50)
ms(t=50) ms(t=100)
ms 1 mt(t=50) mt(t=100)mt(t=10)
0
5
10
15
20
Figure 5.17: Invasion Scenario 3A. Plots showing the simulation results obtained
in a two-dimensional domain with a spatially complex matrix suitability modifier s to
more accurately depict the observations of in vivo experiments. Plots A-C show the
evolution of MMP-2 concentration at t = 10, 50 and 100 (corresponding to ∼1.15, 5.75
and 11.5 days, respectively). Plots D-F show the evolution of MT1-MMP concentration
at t = 10, 50 and 100 respectively. The white contour line shows the cancer cell density
at level 0.01 chosen to represent the maximum extent of invasion. Simulations are
performed using the baseline parameter set with the exception of δs = 0.0025.
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Figure 5.18: Invasion Scenario 3A. Plots showing the simulation results obtained
in a two-dimensional domain with a spatially complex matrix suitability modifier s to
more accurately depict the observations of in vivo experiments. Plots A-C show the
profiles of the density of ECM degraded solely by ms, while plots D-F show the profiles
of the density of ECM degraded solely by mt at t = 10, 50 and 100 (corresponding to
∼1.15, 5.75 and 11.5 days, respectively). The white contour line shows the cancer cell
density at level 0.01 chosen to represent the maximum extent of invasion. Simulations
are performed using the baseline parameter set with the inclusion of δsu = 0.025.
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Invasion Scenarios 3B-E are variations of Invasion Scenario 3A where by
considering different initial distributions of the suitability modifier (s(t = 0))
while imposing
∫
sdΩtotal remaining the same (Ω represents the entire domain)
with the additional constraints of
∫
sdΩi remaining the same for defined smaller
regions Ωi. We note that the initial condition for Invasion Scenario 3A was
determined in part by the term 0.5cos(4pix
2
)cos(kpiy2 where k = 4, for information
in the final 3
4
of the domain. As such, the natural division is for 26 Ωi where,∫
sdΩ1 = P,
∫
sdΩ2 = Q,
∫
sdΩ3 = R, (5.8)∫
sdΩ4 = S,
∫
sdΩj = T (5.9)
For positive k and some constants P,Q,R, S and T where j = 5, ..., 16
Therefore, we choose to consider the cases where k = 0, 2, 6, 8 as Invasion Sce-
narios 3B-E, respectively. In considering the case where k = 0, we note that we
no longer have the condition of
∫
sdΩj = T for j = 5, ..., 16 but instead have∫
sdΩk = U(k) for k = 1, ..., 8 and U(k) = (P +Q,R + S, 2T, 2T, 2T, 2T, 2T )
T .
As the results of each of these Invasion Scenarios of 3C-F will be qualitatively the
same as those obtained in Invasion Scenario 3A and Invasion Scenario 3B will be
qualitatively similar to Invasion Scenario 0B, we present only the initial condition
for s(t = 0) for each scenario while the results of the domain integration of c will
be presented in the next subsection in Figure 5.20.
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Figure 5.19: Plots of the initial condition s(t = 0) for Invasion Scenarios 3B-E
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Figure 5.20: Plot of the domain integration of cancer cells,
∫
cdΩtotal, for Invasion
Scenarios 3A-E
Comparison of Invasion Scenarios 3A-E enables considering the effect of
changing the distribution of the initial condition for s(t = 0) while maintaining
the properties of
∫
sdΩtotal and
∫
sdΩi for i = 1, ..., 16 remaining the same for all
of the Invasion Scenarios 3A-E.
In comparing the domain integrations of cancer cells in Figure 5.20, we find that
the results are the same for t < 35 for Invasion Scenarios where k > 0. After this
time, however, there is a breaking of the fellowship where the domain integration
of the cancer cells becomes stratified where the Invasion Scenarios with higher
k values show increased total cancer cell density. This suggests that a location
with a suitability modifier value that is twice as restrictive as another location
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will have less than twice the impact on cancer invasion over time. This can be
understood as the remodelling term of the suitability modifier of δsmt(1 − s)
will not provide a linear rate of remodelling over the time period it will take to
obtain a value of s = 1 as there will be an increase in the amount of MT1-MMP
present as more cancer cells reach the location of overlap. This affect will be
even more pronounced for a lower δs, higher cancer diffusion or higher haptotaxis
rate. This highlights the importance of effectively modelling the spatial aspect
of the suitability modifier as even though we have subdomain integrations over
each subdomain, Ωi being the same between the Invasion Scenarios, there is still
a difference in the total amount of cancer cells present at later times.
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5.4 Discussion
By including a suitability modifier in the model considered in the previous chap-
ter, we have found that this modification can provide a wide range of new results
as well as providing an additional function for MT1-MMP which has now become
much more significant to cancer cell invasion for specific types of tissue that may
be considered to be closer to 3D in vitro models as well in vivo models.
Additionally we introduced the concept of “matrix suitability”, governed by the
variable s in our model. By considering the suitability of the matrix as a factor
affecting ECM degradation and the movement of enzymes and cancer cells, we
were able to generate heterogeneity in the ECM caused solely by matrix degrada-
tion. This meant we were able to focus on the effects of these gradients explicitly
caused by matrix degradation rather than ECM density gradients due to some
intrinsic tissue heterogeneity. This also allows for the consideration of stable spa-
tially heterogeneous conditions in the initial ECM layout (while v(t = 0) = 1)
where the ECM remodelling term of µv(1− c− v) will not affect this initial het-
erogeneous condition over time. More specifically, if we were to not include the
suitability modifier at all and wanted to have an initially heterogeneous ECM, we
would have to have a spatially heterogeneous v(t = 0). ECM that is not in the
cancer-ECM interface would then be remodelled by the term µv(1− c− v) to the
non-spatially heterogeneous value of 1 before cancer cells have come into contact
with the region. The only 3 ways of preventing this would be to (i) consider a
small enough domain that the remodelling of ECM has not fully taken place by
the time cancer cells have reached the specified region, (ii) have a low enough
parameter value µv (down to the point of being zero) for the same reason as in
the first case and (iii) have the ECM remodelling term by dependent upon the
spatially significant initial condition of v.
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We found the parameter δs to be significant in determining the morphology of
the cancer mass as evidenced by the comparison between Invasion Scenario 1A
and 1B where the only difference was the increase in the parameter δs. We found
that for a high enough δs, the results of the model are similar to, but do not tend
to, those obtained for when there is no suitability modifier considered (Invasion
Scenario 0A), unless there is a lack of diffusion for the MMP-2 proteins.
An increase in parameter δs causes an increase in the amount of suitability modi-
fier that has been remodelled, an increase in the amount of total cancer cells and
an increase in the total degradation of ECM.
We observed the time dependence on the effect of the parameter δs where when
we compared the proportion of degradation of ECM by MT1-MMP for varying
values of δs, we found that at t = 25 the relation was an increase for increasing
δs whereas at t = 50 the relation was reversed with a decrease for increasing
δs. This was due to the effect on the point measured as tc which measured the
time where the switch from more degradation occurring due to MMP-2 instead of
MT1-MMP occurs where as t increases further, we will maintain this relation of
an increase in δs will further reduce the proportion of ECM degradation caused
by MT1-MMP.
Further, we have found that the ratio of MT1-MMP to MMP-2 is unaffected
by either the suitability modifier or the rate at which it is remodelled, however,
when there is a need for the suitability to be remodelled (s(t = 0) < 1), there
is a higher proportion of total ECM degraded by MT1-MMP. We find that the
total amount of TIMP2 when scaled by total cancer cell population is markedly
increased to threefold in Invasion Scenarios 1A and 2 when compared to Invasion
Scenarios 0A and 1B. This overall increase in relative TIMP2 concentration can
be seen to be a result of an increase in TIMP2 at areas where there is active
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degradation of ECM and a stabilised, reduced TIMP2 concentration at the area
where cancer cell invasion has been completely successful (c = 1).
We formulated Invasion Scenarios 3A-E in such a way as to investigate the effect
of a changing initial condition for the suitability modifier while maintaining 16
regions of constant total suitability modifier. We find that the initial spatial
layout of the suitability modifier is important as while a location with a suitability
value of 1− 2β will have twice the impact as a suitability value of 1− β for some
constant β, when it comes to remodelling these locations to the value of 1, it
will take t1 for the first case and t2 for the second case where t2 ≤ t1 ≤ 2t2
due to the increase in MT1-MMP that is moved to the location that is being
remodelled. This effect will therefore become more significant for an increase in
the parameters of Dc, χ and a decrease in the parameter δs.
In summation, the computational simulation results showed that the matrix suit-
ability modifier and its regulation played an important role in determining the
precise pattern of invasion. As has been observed in the experimental data of
Sabeh, Shimizu-Hirota and Weiss (2009) and Li et al. (2008), we have shown
that the architecture of the tissue can negatively impact invasion under circum-
stances of pore-size being below on optimal level or in environments of cross-linked
collagen type I and IV, with both of these conditions requiring tissue remodelling
specifically by MT1-MMP. In addition to this, invasion is reduced where TIMP2
is over or under produced. To investigate the matrix suitability modifier from a
biological perspective, experiments would need to be carried out to obtain the
initial layout of the suitability modifier as well as the parameter δs. The first
step in doing this would be to find out the effects of different tissue pore size on
cancer cell migration to establish what range of pore sizes would be considered
a neutral modifier, what range of pore sizes allow migration at reduced levels
and what range of pore sizes completely block migration. This could be done by
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using the approaches of Nystro¨m et al. (2005) and Martins et al. (2009) where
they performed in vitro experiments using a collagen:matrigel assay to investi-
gate the invasiveness of cancer cells to establish a quantitative “invasive index” in
organotypic cultures. Once there is quantitative data for these effects, obtaining
data on the structure of the tissue through effective imaging techniques such as
those described in Wolf et al. (2009) would allow one to generate realistic initial
conditions of the matrix suitability modifier. An estimate of the parameter δs
could then be obtained by validating the model against experiments similar to
those found in Sabeh, Shimizu-Hirota and Weiss (2009) or Li et al. (2008), who
performed in vitro experiments using a cross-linked native type I collagen assay
to investigate the importance of MT1-MMP in cancer invasion.
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Chapter 6
Stochastic Modelling of the
MMP-2 Activation System at
Invadopodia
6.1 Introduction
In this chapter we move from the much larger spatial scale considered in the
previous two chapters to discuss MMP-2 activation by MT1-MMP proteins at
the smaller subcellular scale of invadopodia (of volume 2× 10−15 L Murphy and
Courtneidge, 2011). While MMP-2, with its relatively high diffusion rate, is
not responsible for localised ECM degradation at invadopodia, it is capable of
degrading many components of the ECM, including type IV collagen. Type IV
collagen is the main component of the basement membrane, a cellular barrier
which cannot be degraded by MT1-MMP. Initially, we present a model of an
invadopodium in isolation before analysing this model with simulations to show
the affect an invadopodium has in the context of its surroundings, as well as the
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Cube of length (cm) Volume (L) Maximum number of
cancer cells in domain
1 1× 10−3 67, 000, 000
0.1 1× 10−6 67, 000
0.01 1× 10−9 67
0.0025 1.59× 10−11 1
a fraction equal to the
0.000126 2× 10−15 volume of an invadopodia
Murphy and Courtneidge (2011)
Table 6.1: A clarification on the scales involved at various spatial scales in regards
to the amount of cancer cells that can fill the volume. The values are based off of the
cancer cell volume filling value in the previous two chapters of 6.7× 107cells cm−3.
affect that the surroundings have on the invadopodia.
Invadopodia are actin-rich membrane protrusions from a cell that form adhesion
sites with the ECM and propagate ECM degradation by the releases of matrix
degrading enzymes (Chen, 1989; Kelly et al., 1994). As such, they are of particular
significance when it comes to cancer cell invasion (Basbaum and Werb, 1996;
Weaver, 2006; Yamaguchi and Condeelis, 2007). This ECM degradation fuels
migration of the cell through the ECM (Chen and Wand, 1999). Invadopodia are
distinct from other cell protrusions (e.g. filopodia, lamellipodia, podosomes) in
size and function (Chen and Wand, 1999; Murphy and Courtneidge, 2011). The
maximum number of cancer cells that is capable of filling various volumes is listed
in Table 6.1 to illustrate the spatial scale involved.
MT1-MMP is found to be the most critical of the matrix degrading enzymes
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Figure 6.1: Image showing focalised ECM degradation as a result of invadopodia.
Reproduced from Yamaguchi et al. (2005), published under a creative commons licence.
at invadopodia where they are not required for invadopodia formation but are
essential for invadopodia function (Artym et al., 2006). A single carcinoma cell
may feature 1–10 invadopodia at one time and these are generally formed in a
cluster (Linder, 2007). This clustering causes focalised degradation of ECM as can
be seen in Figure 6.1. MT1-MMP shuttling to invadopodia is essential for cancer
cell invasion (Nakahara et al., 1997) and causes increased MMP-2 activation.
Kwiatkowska et al. (2011) found that blocking this shuttling to lamellipodia can
downregulate MMP-2 expression.
The precise number of MMP-2 proteins that can be activated at invadopodia must
be estimated from the total amount produced by an entire cell. Here, we provide
three methods of estimating this value using the property that a cell may produce
MMP-2 at a rate of 100,000–1,000,000 h−1. In all three methods, we will assume
that the volume of a cell is 1.59 × 10−11L and the volume of an invadopodium
is 2 × 10−15L, as in Table 6.1. Further, we will consider a cancer cell without
invadopodia to be a sphere of radius 15.6µm and a single invadopodium to be a
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r(cell)
5 µm
Figure 6.2: Schematic diagram illustrating a cell with an invadopodium used to ap-
proximate the amount of MMP-2 proteins that can be activated at an invadopodium.
Scale bar = 5µm.
cone of radius 0.5µm and height 7.5µm where we note that these values maintain
the volumes defined previously.
A method based off dividing the volume of the cell by that of the invadopodium
provides an estimate of 12–126 proteins per hour. A method based off comparing
the relative surface areas of the cell and invadopodium provides an estimate
of 380–3800 proteins per hour. A third method, where additional details are
provided below, provides an estimate of 2–30 proteins per hour.
The region defined as that in which enzyme reactions between membrane bound
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and freely diffusive proteins can take place is termed the active region. The active
regions of invadopodia is referred to as the invadopodial regions.
If we consider this active region to be up to a cm from the cell membrane then
the volume of the active region for a cell without invadopodia would be Vac =
4
3
pi((r + a)3 − r3) = 4
3
pi(3r2a + 3ra2 + a3)cm3. For simplicity, we neglect the
minor difference as would be caused by the overlap of the active region of the
cell and the invadopodia. The volume of the active region of the invadopodia is
Vai = pi(r + a)
2h+ a
3
− pir2h
3
=
4pi
3
(
r2
4
+
ar(h+ a)
2
+
a2(h+ a)
4
). Therefore, the
amount of MMP-2 proteins that can be produced at invadopodia is estimated
to be (
Vai
Vac
× 100)% of 100,000–1,000,000h−1. We plot Vai
Vac
× 100 in Figure 6.3.
Therefore, the number of MMP-2 proteins that can be produced at invadopodia
is estimated to be 0.0025 − 0.003% of the range 100,000–1,000,000h−1, or, 2-30
proteins per hour.
Taking the three methods into account, we choose to consider a default range
for the amount of MMP-2 proteins to be activated of 0–216 proteins (0–180nM)
per hour. This can be achieved by simulating the invadopodial region with zero
flux boundary conditions with a corresponding initial proMMP-2 concentration
of 0–180nM and no production.
Stochastic simulations are widely used for intracellular dynamics in computa-
tional cell biology (Cai and Wang, 2007; Bressloff and Newby, 2013; Sturrock,
2013). Traditionally, intracellular chemical reactions have been modelled with
deterministic reaction rate equations (RREs), namely ordinary differential equa-
tions (ODEs). The justification for modelling these reactions stochastically lies in
the low population number of mRNAs as well as the fact that small fluctuations
in their levels have a knock-on effect where each mRNA may produce 1000s of
active proteins.
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Figure 6.3: Identifying the proportion of MMP-2 proteins that are produced by an
invadopodium is achieved by plotting the function VaiVac × 100 for various values of the
radius defining the invadopodial region, a, where h=7.5µm and r=0.5µm. The minimum
value of a is considered to be 0.001µm with a maximum a of 0.1µm, which we note is
one fifth the radius of the invadopodium.
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At invadopodia, only a small number of proteins (0-432) comes into play in a
relatively short time (1-2 hours). The knock-on effect from a localised increase in
the activation of MMP-2 increases the degradation of ECM across the considered
domain. However the most significant knock-on effect is that the increased ECM
degradation occurring at invadopodia as a result of MT1-MMP activity can fuel
locomotion of the entire cell through a medium (Chen and Wand, 1999). We
therefore apply stochastic methods when considering the activation system of
MMP-2 by MT1-MMP and TIMP2 at invadopodia.
We formulate our model based on the Gillespie Algorithm (SSA: stochastic sim-
ulation algorithm Gillespie, 1977), which is explained in detail in Higham (2008).
We will use this approach to model the system of activation of MMP-2 by MT1-
MMP as outlined in Figure 6.4.
We will therefore be simulating a similar scenario to that which is considered in
a deterministic way with a system of ODEs in Karagiannis and Popel (2004),
which was later developed to consider the tip endothelial cell in sprouting angio-
genesis in Karagiannis and Popel (2006). We note that continuum modelling is
an appropriate method of modelling the protein interactions considered in this
chapter when applied to a domain considering one or more cancer cells as the
larger spatial and temporal scales results in a large amount of proteins and less
consequences in fluctuations of their populations.
The other notable attempt at modelling MT1-MMP mediated MMP-2 activation
along with related interactions in regards to cancer cell invasion is that of Hoshino
et al. (2012). The focus of their work is an invadopodium of size ∼ 1.39µm3
with a total domain of size ∼ 73.61µm3. They modelled the invadopodium and
surrounding environment as a 3D discretised space of 2601 compartments of di-
mensions 0.0973µm × 0.0973µm × 3µm where the invadopodium consisted of
172
49 clustered compartments. The freely diffusive proteins and protein complexes
were modelled with reaction diffusion equations while the interactions of pro-
teins within the invadopodium were modelled by a systems of 39 ODEs in ACell
(Ichikawa, 2001). The main finding of their work is that the rapid turnover of
MT1-MMP is responsible for the increased degradation of ECM at invadopo-
dia. This was determined from both of their in silico and in vitro modelling
approaches where the blocking of vesicle transport blocked ECM degradation.
6.2 Model Development
A schematic diagram of the MMP-2 activation system from its pro-enzyme form
is shown in Figure 6.4. The N-terminal inhibitory domain of a freely diffu-
sive TIMP2 protein binds to the active site (catalytic region) of the membrane
bound MT1-MMP. This blocks catalytic activity on the part of MT1-MMP.
The C-terminal domain that remains free on TIMP2 binds with the C-terminal
hemopexin domain of proMMP-2. This stochiometric trimer of form 1:1:1 is
then split by a free MT1-MMP protein concluding the activation of MMP-2 from
its proenzyme form. Additionally, we consider an alternative route by which the
trimer of MT1-MMP:TIMP2:proMMP-2 can be formed by the initial formation of
the complex TIMP2:proMMP-2 that can then bind to a free MT1-MMP protein.
As both proMMP-2 and MMP-2 bind to TIMP2 with a high rate in comparison
to the dissociation rate (Olson et al., 1997), we consider this reaction to be irre-
versible. Before we present the reaction equations, we must define the notation
involved.
Notation for the stochastic model largely follows the mathematical literature
(Higham, 2008):
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MT1
T2
MT1:T2
MT1:T2:pM2:MT1pM2
MT1:T2:pM2
MT1
M2
Stage 1 Stage 3
Stage 2 Stage 4
MT1:T2
MT1
cell
MT1
T2pM2 M2
pM2
T2
T2:pM2
MT1
MT1:T2:pM2
Alternative stage 1
Alternative stage 2
A
B
C
Figure 6.4: The schematic diagram of MMP-2 activation. Plot A indicates whether
a protein or complex is bound to the membrane of the cell or capable freely diffusing
throughout the domain. Plot B illustrates the first pathway by which proMMP-2 can
become activated while plot C illustrates the alternative route by which proMMP-2 can
become activated. In all plots, ‘MT1’ represents MT1-MMP, ‘T2’ represents TIMP2,
pM2 represents proMMP-2 and M2 represents MMP-2, while in plots B and C, a pro-
tein/complex is in a blue box if it is directly produced by a cancer cell and black if it is
formed from later reactions.
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N : the number of chemical species.
M : the number of chemical reactions or reaction channels that the chemical
species partake in.
X(t) : the state vector, elements of which are defined below.
Xi(t) : elements of the state vector represent the number of elements of chemical
species i, where i = 1, ..., N .
νj : the stochiometric vector, also known as the state-change vector, details how
the state vector is modified by chemical reaction j where j = 1, ...,M .
A: the stochiometric matrix is a matrix whose columns are made up of the
stochiometric vectors, i.e., A = [ν1, ..., νM ].
We define the state vector of our model as follows:
X(t) =

X1(t)
X2(t)
X3(t)
X4(t)
X5(t)
X6(t)
X7(t)
X8(t)
X9(t)

=

proMMP-2
MMP-2
MT1-MMP
TIMP2
MT1-MMP:TIMP2
MT1-MMP:TIMP2:proMMP-2
MT1-MMP:TIMP2:proMMP-2:MT1-MMP
MMP-2:TIMP2
proMMP-2:TIMP2

, (6.1)
and we can proceed to write out the chemical reactions outlined above in a manner
that will be easier for our modelling efforts.
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Stage 1: X3 +X4
c1→ X5 (6.2)
X5
c2→ X3 +X4 (6.3)
Stage 2: X5 +X1
c3→ X6 (6.4)
Stage 3: X6 +X3
c5→ X7 (6.5)
X7
c6→ X6 +X3 (6.6)
Stage 4: X7
c7→ X5 +X2 +X3 (6.7)
Alternative stage 1: X1 +X4
c8→ X9 (6.8)
Alternative stage 2: X3 +X9
c1→ X6 (6.9)
X6
c2→ X3 +X9 (6.10)
X2 +X4
c8→ X8 (6.11)
Now that we have formulated the system in this way, it is easier to see what each
of the reactions defined by equations (6.2)–(6.11) does to the state vector X(t).
For example, for one reaction taking us from t = t1 to t = t2 of equation (6.7)
to occur we require an X7(t1) ≥ 1 with the result being X7(t2) = X7(t1) − 1,
X9(t2) = X9(t1) + 1, X2(t2) = X2(t1) + 1, X3(t2) = X3(t1) + 1 with the remaining
Xj(t2) = Xj(t1) for j = 1, 4, 5, 6, 8. In formalising this, X(t1 + τ) = X(t1) + νj
where τ is the adaptively determined timestep for the chemical reaction j to occur
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and νj are defined as the columns of the stochiometric matrix A where:
A =

0 0 −1 1 0 0 0 −1 0 0 0
0 0 0 0 0 0 1 0 0 0 −1
−1 1 0 0 −1 1 1 0 −1 1 0
−1 1 0 0 0 0 0 −1 0 0 −1
1 −1 −1 1 0 0 1 0 0 0 0
0 0 1 −1 −1 1 0 0 1 −1 0
0 0 0 0 1 −1 −1 0 0 0 0
0 0 0 0 0 0 0 0 0 0 1
0 0 0 0 0 0 0 1 −1 1 0

. (6.12)
We are left with two issues that need to be dealt with. Firstly, how we will choose
which of the chemical reactions takes place and secondly, in what manner will
we define their respective timesteps represented by τ . It is in both of these steps
that we will find our stochasticity. By using the Gillespie Algorithm, we obtain
the following iterative method of identifying which reaction will next take place
and what the time length, τ , for this reaction to take place will be where we use
the function rand in Matlab to generate a random number, r, from a uniform
distribution in the interval (0,1). The reaction rates determined in units involving
concentrations (c1, ..., c8) are transformed into appropriate form (a1, ..., a11) where
the probability of a reaction, j, to take place is determined by
aj
11∑
i=1
ai
.
A minimal form of one iteration of our model is presented below in equations
(6.13)–(6.29) where the probability of which reaction takes place is initially de-
fined before the reaction that is chosen to take place and the time that this takes
is determined. The molecule population and the probability of which reaction
would take place would therefore be updated in the next iteration.
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a1 =
c1
NAv
×X3 ×X4 (6.13)
a2 = c2 ×X5 (6.14)
a3 =
c3
NAv
×X1 ×X5 (6.15)
a4 = c4 ×X6 (6.16)
a5 =
c5
NAv
×X6 ×X3 (6.17)
a6 = c6 ×X7 (6.18)
a7 = c7 ×X7 (6.19)
a8 =
c8
NAv
×X1 ×X7 (6.20)
a9 =
c1
NAv
×X3 ×X9 (6.21)
a10 = c2 ×X6 (6.22)
a11 =
c8
NAv
×X2 ×X4 (6.23)
α =
11∑
i=1
ai (6.24)
βk =
k∑
i=1
ai
α
(6.25)
j = min(k) s.t. r < βk (6.26)
τ =
1
α
ln(
1
r
) (6.27)
X = X + νj (6.28)
t = t+ τ (6.29)
Rate constants for the model are established by collecting those that were used
in previous chapters as well as the biological literature and are presented in Table
6.2. We note that there is a high level of uncertainty when it comes to parameter
c5 which can be fitted to the experimental results of English et al. (2001) and
Butler et al. (1998), similarly done in the ODE model considered in Karagiannis
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and Popel (2004) to obtain a value of ∼ 4.3 × 103M−1. Indeed, we show how
the proposed stochastic model can obtain a similar approximation to this value
in Figure 6.5. This is, however, significantly lower than the parameter value of
2× 106M−1 used in Hoshino et al. (2012) and 4.3× 104M−1 used in the previous
chapters of this work and that of Deakin and Chaplain (2013). As such, while we
continue to use the value of 4.3× 104M−1, we acknowledge that a more accurate,
biologically obtained, estimate for this parameter is required.
We examine the activation system of MMP-2 mediated by MT1-MMP and TIMP2
and as such consider a spatial region around the external boundary of invadopo-
dia. We define this spatial region of interest to be approximately the same
size as the invadopodia itself of 2 × 10−15L. This is equivalent to choosing a
value of a =∼ 0.3µm. As we lack significant data for the production rates of
proMMP-2, TIMP2 and MT1-MMP, we consider the system to be closed by set-
ting αpM2 = αMT1 = αT2 = 0.
We initially consider two cases with differing initial conditions, where we show the
results of the proposed schematic when run over 1 hour with zero-flux boundary
conditions. We present the cases concurrently, divided into two figures detailing
the population dynamics across the initial 60s (Figure 6.6) and then the entire
lifespan of the invadopodium, defined as 1 hour (Figure 6.7).
For the first case, we consider proMMP-2(t = 0) = 60nM, MT1-MMP(t = 0) =
70nM and TIMP2(t = 0) = 50nM, while all other enzymes and enzyme complexes
are assumed to be zero. In the second case, we consider proMMP-2(t = 0) =
60nM, MT1-MMP(t = 0) = 47.5nM and TIMP2(t = 0) = 50nM where, again,
all other enzymes and enzyme complexes are assumed to be zero. We note that
when we define the I.C.s to be of form pM2=z1, T2=z2 and T2:pM2=z3, we can
vary the initial conditions of these three proteins and complexes and maintain
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Figure 6.5: Plots showing comparisons of the stochastic model with the parameters of
Table 6.2 with the exception of c5 = 4.3×103M−1s−1. The experimental data of Butler
et al. (1998) is represented in plots A & B and English et al. (2001) in plot C.
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Parameter Dimensionalised value Source
c1 2.74× 106 M−1s−1 Toth et al. (2000)
c2 2× 10−4 s−1 Toth et al. (2000)
c3 1.406× 105 M−1s−1 Olson et al. (1997)
c4 4.7× 10−3 s−1 Olson et al. (1997)
c5 4.3× 104 M−1s−1 estimated
c6 9× 10−7 s−1 Karagiannis and Popel (2004)
c7 2× 10−2 s−1 Karagiannis and Popel (2004)
c8 3.26× 104 M−1s−1 Olson et al. (1997)
cshuttle
1
tshuttle
s−1 definition
αpM2 0
αMT1 0
αT2 0
NA 6.022× 1023 Perrin (1909)
volume (v) 2× 10−15L estimated
Table 6.2: List of parameter values used in this chapter (unless otherwise stated).
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qualitatively similar results provided the conditions of z1 + z2 + 2× z3 = C1 and
z1 + z3
z2 + z3
= C2 are met, for some constants C1 and C2.
We note that the plots of Figure 6.6 are qualitatively similar. However, there
are some noticeable differences where the first difference we remark upon is
one we have not found to be significant. In the first case, the complex MT1-
MMP:TIMP2:proMMP-2 (brown) is first formed at t =∼ 7s in comparison to
t =∼ 3s in the second case. Further, the number of TIMP2 proteins in the first
case has almost reached zero in half the timeframe while this number has not
dropped below 8 in the entire timeframe in the second case. This difference is
caused by the amount of TIMP2 binding to MT1-MMP where we remark that
MT1-MMP(t=60)=25 in the first case compared to the very low value of MT1-
MMP proteins in the second case by this time.
It is in the plots of Figure 6.7 that we notice a much more significant difference
between the two cases. Critically, there is minimal MMP-2 present by the end of
the simulation for the second case. This is the result of TIMP2 proteins binding
to every available MT1-MMP protein meaning that there is a lack of free MT1-
MMP proteins that are able to take place in the severing of the pro domain as
indicated in stages 3 and 4 of Figure 6.4. In fact, the only enzymes and enzyme
complexes larger than 10 in case ii are MT1-MMP:TIMP2:proMMP-2 (brown),
proMMP-2 (red) and MT1-MMP:TIMP2 (green).
We note that from 10 simulations (not shown) where there were the same initial
conditions as presented in case ii, the percentage of MMP-2 activated by t=3600s
varied between 0 and 15 with mean value ∼4.4% and standard deviation of ∼3.2.
This compares to the percentage of MMP-2 activated by t=3600s where we con-
sider the volume of the well-mixed system to be 2×10−11L, where Higham (2008)
showed that the Gillespie Method converges to the ODE model of the interactions
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Figure 6.6: Plots showing the short time dynamics (t=0-60s) of the MMP-
2 activation system. Plot A represents the first case while plot B repre-
sents the second case. proMMP-2 is presented in red, MT1-MMP in yellow,
TIMP2 in blue, MT1-MMP:TIMP2 in green, MT1-MMP:TIMP2:proMMP-2 in
brown, MT1-MMP:TIMP2:proMMP-2:MT1-MMP in dark blue, MMP-2 in black and
TIMP2:proMMP-2 in lavender.
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Figure 6.7: Full term dynamics (t=0-3600s) of the MMP-2 activation system where
no MT1-MMP shuttling takes place. Plot A represents the first case while plot
B represents the second case. proMMP-2 is presented in red, MT1-MMP in yel-
low, TIMP2 in blue, MT1-MMP:TIMP2 in green, MT1-MMP:TIMP2:proMMP-2 in
brown, MT1-MMP:TIMP2:proMMP-2:MT1-MMP in dark blue, MMP-2 in black and
TIMP2:proMMP-2 in lavender.
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at high volumes, of 6.0%.
The conclusions that we can draw from these observations are that when the
initial number of TIMP2 proteins is larger than the initial amount of MT1-MMP
proteins, rapid binding of MT1-MMP to TIMP2 can prevent there from being any
free MT1-MMP proteins to take place in the activation of MMP-2. However, we
can also conclude that stochastic effects allow for the production of some MMP-2
proteins despite this with the maximum of 11% of the proMMP-2 being activated
in the simulations run.
We have proposed a method of examining invadopodia in isolation from the cell
and the majority of the surrounding ECM by imposing zero-flux boundary con-
ditions on a domain defined as the invadopodial region (the difference between
the volume of one cone of radius, r, and height, h, and a larger cone of radius,
r+ a, and height, h+ a). While there may be experiments that can be set up to
study just such a scenario, we consider the additional dynamics of freely diffusive
proteins capable of diffusing into the invadopodial region to be more reflective
of the majority of potential in vivo and in vitro experiments. We note that due
to the relatively high diffusion rate of the freely-diffusive proteins (O(108cm2s−1)
Collier et al., 2011), this would not be an inconsequential amount. We must
therefore expand the model to capture the dynamics involved with the activation
process of MMP-2 in a more expansive set of biological considerations.
We define a scenario similar to the experimental results shown in Figure 6.1 by
using the schematic illustrated in Figure 6.8, where we consider a layer of ECM
constituent parts of dimensions 5×50× 50µm with a single cancer cell, placed on
top of this region with a cell-ECM interface of 5 × 10−6cm−2 and consider the
ECM degradation that would take place through both MT1-MMP and MMP-2.
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MT1-MMP shuttling to invadopodia is, by necessity, dependent on the consid-
eration of a region larger than an isolated invadopodium. As such, we can now
appropriately model MT1-MMP shuttling to invadopodia. MT1-MMP shuttling
to invadopodia is independent of all other reactions so we treat this separately
and we consider an additional MT1-MMP shuttled to the invadopodia after a
time tshuttle. To couple this with the SSA time steps, we consider a production
of a single MT1-MMP protein every tshuttle and apply the additional number of
MT1-MMP proteins after every cycle of the SSA. Note that this can be inter-
preted as adding νs to the state vector, X(t), where this adds one protein of
MT1-MMP, νs = (0, 0, 1, 0, 0, 0, 0, 0, 0)
T .
Reactions involving one or more membrane-bound proteins/complexes can take
place only within the active region defined by the sensing radius a and reactions
between two freely diffusive proteins can take place both outside and inside this
defined region. Once again we define the invadopodia to be a cone of radius
0.5µm and height 7.5µm.
Since the number of enzymes used to form complexes at invadopodia is much
lower than the total number of these enzymes in the domain, combined with the
high diffusion rate of these enzymes, we consider the concentration of proMMP-
2, TIMP2 and TIMP2:proMMP-2 to be constant within the invadopodial region
by considering a replacement protein to be instantly transported within the in-
vadopodial region when a complex is formed that would otherwise use them up.
Further, we define the separation of complexes to no longer release these proteins
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and we model these modified reactions within the invadopodial region as:
Stage 1: X3 +X4
c1→ X4 +X5, (6.30)
X5
c2→ X3, (6.31)
Stage 2: X5 +X1
c3→ X1 +X6, (6.32)
X6
c4→ X5, (6.33)
Stage 3: X6 +X3
c5→ X7, (6.34)
X7
c6→ X6 +X3, (6.35)
Stage 4: X7
c7→ X5 +X3 +X2, (6.36)
X3 +X9
c1→ X6 +X9, (6.37)
X6
c2→ X3, (6.38)
with a corresponding stochiometric matrix B of form:
B =

0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 1 0 0
−1 1 0 0 −1 1 1 −1 1
0 0 0 0 0 0 0 0 0
1 −1 −1 1 0 0 1 0 0
0 0 1 −1 −1 1 0 1 −1
0 0 0 0 1 −1 −1 0 0
0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 −1 1

. (6.39)
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We consider the amount of ECM to be degraded as a result of the invadopodium
to be the sum of degradation by MT1-MMP at the invadopodium and the degra-
dation of MMP-2 activated at the invadopodium. For simplicity, we consider the
amount of ECM degraded by either MT1-MMP or MMP-2 to be a linear rela-
tion to the sum of their respective lifespans. As such, the total amount of ECM
degradation is assumed to be of the form:
δ1
∫
X(3)dt+ δ2
∫
X(2)dt. (6.40)
In order to consider a simple method by which the dissolution of the invadopodia
is the result of MT1-MMP dissociating cortactin, we set
δ3
∫
X(3)dt, (6.41)
to be dissociation of cortactin and that the invadopodia lifespan ends when this
value passes some critical value χ.
While the total amount of degraded ECM will generally be unaffected by dif-
ferently defined sizes of regions of ECM in our formulation, the distribution of
the ECM degradation by MMP-2 will differ as we impose zero-flux boundary
conditions on this region of ECM.
Since we have insufficient data for the linked parameters of δ3, tshuttle and χ, we
simply leave δ3 undefined and determine δ3χ from running the default parameter
set indicated in Table 6.2 along with the chosen default value of MT1-MMP
shuttling of 1
tshuttle
= 0.18s−1 to obtain the amount of cortactin degraded over a 1
hour lifespan of δ3
∫ 3600
0
X(3) dt = χ. We then set the lifespan of an invadopodia
to be the lowest time, t, s.t. δ3
∫
X(3) dt ≥ χ. In doing so, we have uncoupled
the lifespan of invadopodia from being one hour and linked it to the amount of
cortactin that has been degraded. Finally, an estimate for the range of permissible
rates of MT1-MMP shuttling 1
tshuttle
is identified.
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In making these approximations, we make no quantitative predictions for the
levels of cortactin dissociated. However we are able to provide qualitative results
for the lifespan of invadopodia, how this is affected by MT1-MMP shuttling as
well as the resultant MMP-2 activation and ECM degradation across the lifespan
of an invadopodium.
While we have to consider the two regions of the invadopodial region and the
domain minus the invadopodial region, we formulate our model by considering the
domain minus the invadopodial region to be in stasis in terms of the population
concentrations of all enzymes with the exception of MMP-2 and the invadopodial
region is assumed to be in stasis for the populations of the freely diffusive proteins.
We assume that any MMP-2 proteins that are produced in the invadopodial
region are instantly transported to the region made up of the domain minus
invadopodial region. This allows us to calculate the lifespan of each active MMP-2
protein, defined as the time until it is inhibited by TIMP-2, by using the Gillespie
Algorithm to be τi =
log(1/rand)
2.5× 10−2 where rand is a function that generates a
random number uniformly distributed in the interval (0,1). We note that this is
not dependent on the volume of the region considered so will be unchanged by
the size of the region of ECM that we consider. Since τi is in the range 0–100s
and Dms = 1.29 × 108cm2s−1 (with a correspondingly high root mean squared
displacement), MMP-2 activated at invadopodia are active over a much larger
spatial scale than the invadopodia themselves. We have therefore shown that it
is appropriate to consider MMP-2 activated at invadopodia to be considered as
instantly acting over the larger well-mixed region. We note that the size of the
larger domain does not affect the production of MMP-2 or the lifespan of the
proteins and so does not need to be explicitly defined.
In order to identify suitable forms of initial conditions for a scenario where the
majority of ECM degradation happens at invadopodia and for the amount of
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Figure 6.8: Schematic diagram showing the location of the invadopodium and its
relative size when compared to a cell.
MT1-MMP shuttled to the invadopodium as determined by biologically realis-
tic approximations, we note that, as illustrated in Figure 6.7, we have found
that there are minor amounts of active MT1-MMP or MMP-2 proteins when
TIMP2(t = 0) >MT1-MMP(t = 0), and therefore a correspondingly minor
amount of ECM degradation. We therefore choose initial conditions for MT1-
MMP(t = 0) = 47nM and TIMP2(t = 0) = 50nM. Additionally, we choose to use
an initial concentration of proMMP-2 of 60nM.
In order to obtain an estimate for the default shuttling rate of MT1-MMP to
invadopodia, tshuttle, we define it to be the rate that allows for the production
of 60nM of MMP-2 after an hour from the initial conditions prescribed above.
We have done so as we note that this is also the fastest shuttling rate allowed
as the amount of activated MMP-2 after one hour is 10% the initial amount
of proMMP-2 proteins from simulations performed with the increased TIMP-2
concentration of 143nM. This follows as a limit from Artym et al. (2006) where
they note that complete inhibition of matrix degradation at invadopodia occurs
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when the TIMP2 concentration is 143nM (3 µg/ml). As such, we have identified
a default MT1-MMP shuttling rate of tshuttle = 5.56s.
In performing ten computational simulations with these defined initial conditions
and default shuttling rate, we obtain a mean value of
∫ 3600
0
X(3) dt of 7028.6
with standard deviation of 339.8. This means that we take χ to be equal to
δ3 × 7028.6 and assume that instead of invadopodia terminating at one hour,
they now terminate once
∫
X(3) ≥ 7028.6.
6.3 Results
In order to identify the permissible range of values for the MT1-MMP shuttling
rate, we note that the default rate is the fastest possible shuttling rate and pro-
ceed to identify the slowest MT1-MMP shuttling rate. We performed groups of
ten computational simulations for increasing tshuttle until we identified a limit of
tshuttle = 17.8s. This limit was determined as we have not observed invadopodia
having a lifespan of over 2 hours in the biological literature. We present these
findings in Table 6.3.
From the available data, presented in Table 6.3, we are now able to establish
a range of permissible rates of MT1-MMP shuttling to invadopodia of tshuttle =
5.56 − 17.8s. We note that decreasing the shuttling rate of MT1-MMP, 1
tshuttle
,
causes an increase in the lifespan of the invadopodium. Despite the increase in
invadopodium lifespan, the total amount of MT1-MMP proteins shuttled to the
invadopodium over the course of its lifespan is decreased with decreasing shuttling
rate of MT1-MMP.
The amount of ECM degraded by MT1-MMP at, and MMP-2 activated at, the
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Figure 6.9: Short time dynamics (t=0-60s) of the MMP-2 activation system. Plot
A has a shuttling rate of 5.56s while plot B has no MT1-MMP shuttling. proMMP-
2 is presented in red, MT1-MMP in yellow, TIMP2 in blue, MT1-MMP:TIMP2 in
green, MT1-MMP:TIMP2:proMMP-2 in brown, MT1-MMP:TIMP2:proMMP-2:MT1-
MMP in dark blue, MMP-2 in black and TIMP2:proMMP-2 in lavender.
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Figure 6.10: Full term dynamics (t=0-3600s) of the MMP-2 activation system. Plot
A has a shuttling rate of 5.56s while plot B has no MT1-MMP shuttling. proMMP-
2 is presented in red, MT1-MMP in yellow, TIMP2 in blue, MT1-MMP:TIMP2 in
green, MT1-MMP:TIMP2:proMMP-2 in brown, MT1-MMP:TIMP2:proMMP-2:MT1-
MMP in dark blue, MMP-2 in black and TIMP2:proMMP-2 in lavender.
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Invadopodium MT1-MMP Activated Sum of MMP-2
tshuttle Lifespan (s) Shuttled MMP-2 Lifespans
5.56 3527.2 ± 105.6 817 ± 30 68 ± 10 2640.0 ± 400.1
9 4915.4 ± 144.8 792 ± 26 68 ± 10 2722.1 ± 501.5
13 6110.0 ± 125.5 754 ± 19 68 ± 10 2887.9 ± 514.4
17.8 7276.1 ± 279.3 742 ± 34 62 ± 4 2444.1 ± 357.6
Table 6.3: Mean with standard deviation values for when the time between MT1-MMP
molecules shuttling to MT1-MMP is varied from 5.56s to 17.8s. Further, we note here
that the total amount of ECM degraded by MT1-MMP will remain near constant across
the computational simulations regardless of the lifespan of the invadopodia by definition.
invadopodium, as defined by δ3
∫
X(3) and δ3
∫
X(3), respectively, remains ap-
proximately the same (∼ 7028.6 and ∼ 2500) as the shuttling rate of MT1-MMP
to invadopodium changes. As the lifespan of invadopodium is strictly increasing
with decreasing shuttling rate of MT1-MMP, the rate of degradation by MT1-
MMP proteins at invadopodia decreases as well as the rate of ECM degradation
by MMP-2 proteins activated at the invadopodia. As such, we have found that
while the amount of ECM degraded by invadopodia is not linked to the MT1-
MMP shuttling rate, the rate of ECM degradation is directly linked to the MT1-
MMP shuttling rate. Further, from computational simulations where we assume
MT1-MMP shuttling to invadopodia has been blocked, 1
tshuttle
= 0, we find that
there is only minimal levels of ECM degraded by either MT1-MMP or MMP-2
proteins.
.
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6.4 Discussion
We have studied MMP-2 activation at the smaller spatial and temporal scales
that are relevant when considering invadopodia by formulating a SSA model. We
have identified that stochastic effects on the scale of invadopodia can allow for
a significant activation of MMP-2 (up to 25% over 1 hour) in comparison to the
approximation of the ODE model presented of 3.06% when there is a constraint
on the initial conditions of TIMP2(t = 0) = 0.95MT1-MMP(t = 0). Further,
we found that when TIMP2(t = 0) > 0.95MT1-MMP(t = 0), little to no ECM
degradation of ECM takes place (δ1
∫
MT1-MMP+δ2
∫
MMP-2 is very small as
can be seen from plot B of Figure 6.7).
In contrast to the in silico approach in Hoshino et al. (2012), we consider MT1-
MMP shuttling to invadopodia to be responsible for the increased ECM degrada-
tion at invadopodia. However, our result would match their in vitro observation
that the blocking of vesicle transport of MT1-MMP would eliminate this increased
ECM degradation.
6.5 Future Work
The results of our model can be formulated into a manner similar to the biological
imaging shown in Figure 6.1 by using the schematic illustrated in Figure 6.11,
where where we consider a layer of ECM constituent parts of dimensions 5×50×
50µm with a single cancer cell, placed on top of this region with a cell-ECM
interface of 5 × 10−6cm−2 and consider the ECM degradation that would take
place through both MT1-MMP and MMP-2. The size of the region of ECM
degraded by each invadopodium would be determined by the size and shape of
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Radius by Volume of MT1-MMP
Height (µm) Invadopodial Region (L) shuttling rate
A 0.5 7.5 1.99× 10−15 1
tshuttleA
B 0.4 5 1.12× 10−15 1
tshuttleB
C 0.6 8 2.48× 10−15 1
tshuttleC
D 0.3 6 1.05× 10−15 1
tshuttleD
E 0.8 9 3.60× 10−15 1
tshuttleE
Table 6.4: Characteristics of the invadopodia labelled A-E
each invadopodial region, along with the amount of ECM within that region that
is predicted to be degraded. Further, the amount of ECM degraded across the
entire domain will be dependent upon the amount of free MT1-MMP at regions
other than the invadopodia as well as MMP-2 across the entire domain.
We consider 5 invadopodium labelled A-E in Figure 6.11. We consider each
invadopodia to have a related domain of volume 1.05× 10−15–3.60× 10−15L and
MT1-MMP shuttling rate as described in Table 6.4. We define this related domain
to be the region in which enzyme reactions can take place between membrane
bound and freely diffusible proteins, prescribed from a radius of a = 0.2µm from
the invadopodia.
We present the form that a typical result of such a model would take in Figure
6.12 where for simplicity, we have defined the amount and distribution of ECM
degraded by each invadopodium to be identical.
Further fruitful extensions of the model would seem to fall in into three categories.
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Figure 6.11: The location of the 5 considered invadopodia (A-E).
The first is to include further dynamics relating to MT1-MMP such as dimerisa-
tion, catalytic shuttling etc. as was incorporated in the ODE model of Karagian-
nis and Popel (2004). The impact of these additional processes on invadopodial
function is not yet clear and so such an extension may offer insights into com-
plimentary biological works. The second is having an adaptive invadopodium
shape which adapts according to the lifespan of the invadopodium. This could be
coupled with a computational model that maps the lifecycle of invadopodia in-
cluding retraction and formation such as that proposed in Enderling et al. (2008)
or the implementation of a moving boundary framework such as that proposed
in Trucu et al. (2013). The third is to incorporate the proposed model into one
which considers the entire cell. To do so would provide the benefits of being able
to include intracellular processes and be useful for the identification of significant
pathways for MT1-MMP shuttling and resultant ECM degradation.
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Figure 6.12: Results of the proposed model in the future work would be of this form.
In this case, we have defined the related distribution and amount of ECM degraded by
each invadopodium to be identical as the figure is currently an artificial construct rather
than the direct interpretation of results of the model.
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Chapter 7
Conclusions and Future Work
Throughout this presented work, we have concurrently studied two aspects of
cancer cell invasion. Firstly, degradation of tissue mediated by the soluble MMP-
2 and the membrane bound MT1-MMP, secondly the activation system of MMP-2
mediated by MT1-MMP and TIMP2. We applied the study of these elements of
cancer cell invasion in three circumstances. In Chapter 4, we established a novel
model of cancer invasion at the tissue scale through a system of PDEs, advancing
upon previous mathematical models of cancer cell invasion that consider generic
matrix degrading enzymes and could be considered to be parallel to works that
focus on the uPA system in cancer cell invasion. The potential of the presented
model to consider rich ECM environments is explored in Chapter 5 where we
consider only a minor modification to the system of PDEs, where we note that
the original model can be recovered. In the third and final research chapter,
Chapter 6, we considered a motivating problem that happens on the smaller
scale, that of subcellular invadopodia.
To establish the bare bones of the cancer cell invasion model in Chapter 4, we
drew on existing models in an examination of the most appropriate way in which
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to model the competition for space between the cancer cells and ECM constituent
parts through the haptoatactic sensitivity function and production terms of both
the cancer cell population and ECM density. We then developed this framework
to consider degradation of ECM mediated by MT1-MMP and MMP-2 where
the latter protein is activated solely through the cleavage by MT1-MMP of the
pro domain region of proMMP-2 when the proMMP-2 protein is in a complex
formation of MT1-MMP, TIMP2 and proMMP-2. Rather than considering all of
the intermediary complexes that would be involved in this process, a simplified
schematic for this activation process was proposed to minimise computational
expense.
Parameterisation of the presented model came under two parts. Initially, a num-
ber of parameters could be drawn from the literature where similar mathematical
models of cancer cell invasion with ECM degradation mediated by generic matrix
degrading enzymes. The second part of the parameterisation came with the con-
sideration of the specific matrix degrading enzymes of MMP-2 and MT1-MMP
and the activation process of MMP-2 mediated by MT1-MMP and TIMP2. To
completer the parameterisation, we were required to briefly study two submod-
els of MMP-2 activation in order to validate the simplified schematic of MMP-2
activation by the use of biologically estimated parameters.
Despite the steps taken, there remained one parameter that was very poorly
parameterised. While this parameter is featured in every research chapter, we
feel that it is sufficient to remark upon it in the context of the initial research
chapter, only. The rate in which a free MT1-MMP protein binds to the complex
of MT1-MMP, TIMP2 and proMMP-2 was considered to be 3 × 103M−1s−1 in
Karagiannis and Popel (2004) and 2 × 106M−1s−1 where we chose to consider
this reaction rate to be 4.3× 104M−1s−1. As we consider this to be a significant
potential source of errors in our model, a better biological estimation of the rate
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at which this reaction takes place must be found before further validation of the
presented models against biological data and meaningful predictions can take
place.
By considering the definition of volume filling/competition for space, we noted
that only results of c + v ≤ 1 + α may be biologically relevant, where 0 ≤
α << 1, and only when the case of c + v > 1 is short lasting and righted to be
c + v ≤ 1. We noted that by considering volume filling terms in the haptotactic
sensitivity function, the likelihood of finite tie blow-up solutions was reduced and
the production terms of the cancer cells and ECM ensured that the populations
of c and v were reduced, but not below zero, such that c + v ≤ 1. Future work,
which would compliment the effects of considering volume filling terms in the
haptotactic sensitivity function of reducing the likelihood of finite time blow-
up solutions, would be in the consideration of cell-cell and cell-ECM adhesion
through the use of integer-PDEs, as outlined in the earlier chapter focusing on
providing a literature review. There would also be exciting possibilities that could
be considered in such models that have not, to the best of the author’s knowledge,
been investigated. MT1-MMP that is unbound from TIMP2 has the ability to not
only degrade extracellular components but can cause the dissociation of integrals
responsible for cellular adhesion. As a decrease in cellular adhesion has been
linked to an increased invasiveness of cancer cells, such a consideration in an
integro-PDE model of cancer cell invasion may provide a means of modelling a
cancer cell population that becomes progressively more invasive over time at a
rate determined by the amount of free MT1-MMP.
We identified an appropriate form of considering the significance of the degrada-
tion by the two types of matrix degrading proteins to be in measuring the running
total of how much degradation of ECM has taken taken place from each of the
specific MMPs. We found that the majority of bulk collagenolytic activity was
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due to degradation of ECM by MMP-2 after a short time interval. Where we con-
sidered the cancer-ECM interface to be defined as the region between c=0.01 and
v=0.01, we were able to provide approximations for the concentrations of MMP-2
(0A: 1-4nM, 0B:1-5.5nM) and MT1-MMP (0A&OB: 0.1-5nM) within this region.
These values are broadly defined by the parameters αmt, αT , βmtandβms, which
can be modified to form a closer match with biological observations that may
be obtained. We specifically note that where the parameter defining the produc-
tion rate of TIMP2, αT , was modified in isolation of all other parameters, there
was found to be a value that allowed for a peak amount of the activated MMP-2
steady state. We performed our simulations at the approximate value of this peak
of αT = 4 where we note that the ratio of the steady state concentrations of the
active MMP-2 to MT1-MMP can be modified to match desired results through
the varying of parameter for the production rate of TIMP2 (Figure 4.19) with the
knock on effect to the steady state concentrations of the intermediate complex,
f , and TIMP2 as indicated in Figure 4.20.
In Chapter 5, we introduced the concept of the “suitability of the matrix” through
only a small modification to the equations defining the model. This allowed for
a much larger range of richly composed ECM constructs that can be considered
with the model. We found the parameter δs to be significant in determining
the morphology of the cancer mass as evidenced by the comparison between
Invasion Scenario 1A and 1B where the only difference was the increase in the
parameter δs. We found that for a high enough δs, the results of the model are
similar to, but do not tend to, those obtained for when there is no suitability
modifier considered (Invasion Scenario 0A), unless there is a lack of diffusion for
the MMP-2 proteins. Specifically, an increase in parameter δs causes an increase
in the amount of suitability modifier that has been remodelled, an increase in the
amount of total cancer cells and an increase in the total degradation of ECM.
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A new role for MT1-MMP was now considered in which it was able modify the
suitability of the ECM to a neutral state. This granted a much more significant
role for MT1-MMP in determining the invasiveness of the cancer in some struc-
tured ECM in which there was considered to be a low initial suitability of the
matrix. However, we note that the ratio of active MT1-MMP to active MMP-2
is unaffected by the suitability of the matrix, as considered in this model.
A qualitative result that occurred across all simulations of the model proposed
in Chapters 4 & 5 was that near the leading front of the cell invasion boundary
(though not directly upon the boundary) there is an increase in both the con-
centrations of the intermediate complex f and TIMP2 from the concentration
where the cancer population has stabilised at the maximum non-dimensionalised
value of 1. This increase in the intermediate complex, f , was shown to not be
due to the initial condition being higher than this increased amount where in
Invasion Scenario 0B f began near its steady state and reached a maximum of
almost twice this value. An increase in TIMP2 and the intermediate complex, f ,
is therefore considered to take place at areas where there is active degradation of
ECM.
Computational simulation results showed that the matrix suitability modifier
and its regulation played an important role in determining the precise pattern of
invasion. As has been observed in the experimental data of Sabeh, Shimizu-Hirota
and Weiss (2009) and Li et al. (2008), we have shown that the architecture of
the tissue can negatively impact invasion under circumstances of pore-size being
below an optimal level or in environments of cross-linked collagen type I and IV,
with both of these conditions requiring tissue remodelling specifically by MT1-
MMP. Pampaloni et al. (2007) propose that 3D in vitro models can be used
to closer approximate whole-animal systems than 2D cell cultures where we note
that the model proposed in Chapter 4 may be sufficient for 2D in vivo cell cultures
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whereas the marginally more complex model of Chapter 5 is more appropriately
compared with 3D in vitro or in vivo observations.
To further investigate the matrix suitability modifier from a biological perspec-
tive, a number of biologically motivated works would need to take place. Firstly,
through imaging of defined 3D tissue constructs in vitro, quantification of ECM
constructs can take place. If this is coupled with the effect on cancer cell invasion
through these mediums, we can obtain quantification of the suitability of the ma-
trix and estimates of the parameter for the remodelling of suitability, δs. These
biological experiments could follow the approaches of the in vitro experiments
performed in Nystro¨m et al. (2005) and Martins et al. (2009) where instead of
using a collagen:matrigel assay, a 3D construct such as is considered in Sabeh,
Shimizu-Hirota and Weiss (2009) or Li et al. (2008) could be used to investi-
gate the invasiveness of cancer cells to establish a quantitative “invasive index”
in organotypic cultures. Once such thorough quantification of the parameter δs
has been undertaken with a working knowledge of how to quantify the suitability
of the matrix, comparison with accurate in vivo imaging data will allow for the
consideration of patient-specific predictions for how the cancer cell invasion will
progress.
If we were to investigate the impact of new inhibitors on cancer cell invasion, the
reduced schematic of MMP-2 activation would be too focused and would need to
be expanded back to the original format before the impact of selective inhibitors
to specific parts of the MMP-2 activation system could be considered.
To expand on these models mathematically, a multi scale approach, such as that
considered in Trucu et al. (2013), would more accurately allow for the consid-
eration of dynamics at the leading edge of the cancer cell mass. As we have
considered remodelling of the suitability of the matrix to be the sole domain of
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MT1-MMP, which are bound to cancer cells, the leading edge of the cancer cell
mass will face movement through ECM that is considered to be the least suitable
to move through. As such, the leading edge of cancer cell invasion would benefit
from a more focussed approach to better approximate the overall morphology of
the cancer cell mass.
Further, in order for a tumour to grow past 2–3mm in diameter, there needs to be
sufficient nutrients attracted towards the tumour through angiogenesis (Folkman
and Hochberg, 1973). As the models proposed in Chapters 4 & 5 can provide esti-
mates for how the cancer cell mass will progress for spatial considerations beyond
the 2-3mm limit, the inclusion of oxygen distribution and related dynamics offers
exciting capabilities for the inclusion of additional heterogeneity in the ECM and
cancer environment. This could be done through the inclusion of some of the dy-
namics from the many mathematical models for angiogenesis, which are covered
in the review papers of Mantzaris et al. (2004), Chaplain and Lolas (2006) and
Scianna et al. (2013).
In Chapter 6, we studied MMP-2 activation at the smaller spatial and temporal
scales that are relevant when considering invadopodia by considering a stochastic
approach with and without MT1-MMP shuttling to invadopodia. We identified
that stochastic effects could cause significant fluctuations in the activation of
MMP-2 which is in contrast to the ordinarily tightly regulated MMP system.
The possibility of an increased activation of MMP-2 at invadopodia in conjunction
with the shuttling of MT1-MMP to invadopodia allows for a potentially significant
increase in overall ECM degradation.
We identified a default value of MT1-MMP shuttling to invadopodia in accordance
to the biologically observed scenario (Yamaguchi et al., 2005) of the majority of
ECM degradation on the cell level being the result of MT1-MMP focalised at
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invadopodia. We constructed this scenario in accordance to the biological ob-
servation of ECM degradation at invadopodia being wiped out at set TIMP2
concentrations (Artym et al., 2006). In order to predict a range of MT1-MMP
shuttling rates, we made the assumption that invadopodia have a lifetime depen-
dent upon the amount of cortactin dissociated by MT1-MMP and then found the
limits of MT1-MMP shuttling that allowed for the lifetime of invadopodia to be
within biologically observed timeframes.
If we were to instead couple the dynamics proposed in this model to a model
of invadopodia formation and lifespan, more accurate approximations of generic
invadopodia could be approximated. Further, with the consideration of a growing
and moving invadopodia, we would be able to model a moving domain where
interactions with the membrane bound MT1-MMP and associated complexes
can take place.
We could again make use of a multi scale mathematical approach of the form
considered in Trucu et al. (2013) when applied to an individual cell as in Peng
(2015), coupled with a model for invadopodia formation and regulation, to ap-
proximate the amount of MMP-2 activated following a cell boundary and how
this compares to the increase of MMP-2 activated at invadopodia as a result of
MT1-MMP shuttling. Adapting such a model would allow for the examination
of how MT1-MMP is shuttled to invadopodia intracellularly and open up possi-
ble avenues of research related to what causes and affects this shuttling with the
result it would have on MMP-2 activation and ECM degradation.
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